_unit_id,_created_at,_canary,_id,_started_at,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,orig_e1,orig_e2,expertdecision,relation,sent_id,orig_sentence,term1,term2
503336081,7/15/2014 21:10:39,,1323843438,7/15/2014 21:10:14,irazoo,1,10644009,USA,,,166.137.94.104,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN,40,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:15:18,,1323845300,7/15/2014 21:14:52,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN challenge,40-47,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:15:53,,1323845551,7/15/2014 21:15:37,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN challenge,40-47,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:18:14,,1323846491,7/15/2014 21:17:28,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,40,99,,,46,114,GLUTEN,COELIAC DISEASE,importance of GLUTEN challenge,26-37-40-47,86-96-99-107,diagnosis of COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:20:06,,1323847175,7/15/2014 21:19:57,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN challenge,40-47,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:24:12,,1323848997,7/15/2014 21:24:00,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN,40,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:49:07,,1323857669,7/15/2014 21:48:36,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN,40,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:51:57,,1323858609,7/15/2014 21:51:29,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN challenge,40-47,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 21:58:53,,1323861512,7/15/2014 21:58:35,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN,40,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336081,7/15/2014 22:28:57,,1323875257,7/15/2014 22:28:44,clixsense,1,23585686,GBR,H9,London,31.51.221.173,40,99,,,46,114,GLUTEN,COELIAC DISEASE,GLUTEN coeliac disease,40-99-107,99-107,COELIAC DISEASE,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease.,40,99 107,40,99,46,114,1,RO-has_causative_agent,903990,The results highlight the importance of gluten challenge and intestinal biopsy in the diagnosis of coeliac disease and strongly suggest that a normal biopsy after a 3-month gluten challenge (as described above) excludes coeliac disease,gluten,coeliac disease
503336082,7/15/2014 21:08:42,,1323842549,7/15/2014 21:08:24,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM (CNS) embryonal tumors,0-8-16-29-39-23,97,"MEDULLOBLASTOMAS,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 21:10:26,,1323843328,7/15/2014 21:09:55,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM embryonal tumors,0-8-16-29-39,97-115-119-129-145,"MEDULLOBLASTOMAS, CNS primitive neuroectodermal tumors,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 21:22:21,,1323848169,7/15/2014 21:22:14,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM,0-8-16,97,"MEDULLOBLASTOMAS,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 21:25:12,,1323849461,7/15/2014 21:24:44,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM embryonal tumors,0-8-16-29-39,73-83-94-97-115-119-129,"children, consisting of MEDULLOBLASTOMAS, CNS primitive neuroectodermal","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 21:27:20,,1323850375,7/15/2014 21:27:09,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM,0-8-16,97,"MEDULLOBLASTOMAS,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 21:28:37,,1323850984,7/15/2014 21:28:28,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM,0-8-16,97,"MEDULLOBLASTOMAS,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 21:41:10,,1323855061,7/15/2014 21:40:49,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM (CNS),0-8-16-23,97,"MEDULLOBLASTOMAS,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 22:13:40,,1323868164,7/15/2014 22:13:17,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM,0-8-16,97,"MEDULLOBLASTOMAS,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 22:18:14,,1323870307,7/15/2014 22:17:58,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM,0-8-16,97,"MEDULLOBLASTOMAS,","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336082,7/15/2014 22:25:01,,1323873369,7/15/2014 22:24:20,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,0,97,,,22,113,CENTRAL NERVOUS SYSTEM,MEDULLOBLASTOMAS,CENTRAL NERVOUS SYSTEM embryonal tumors,0-8-16-29-39,97-115-119-129,"MEDULLOBLASTOMAS, CNS primitive neuroectodermal","Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors.",0 8 16,97,0,97,22,113,1,RO-disease_has_primary_anatomic_site,902273,"Central nervous system (CNS) embryonal tumors are devastating cancers in children, consisting of medulloblastomas, CNS primitive neuroectodermal tumors, and atypical teratoid/rhabdoid tumors",Central nervous system,medulloblastomas
503336083,7/15/2014 21:14:29,,1323845014,7/15/2014 21:13:57,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS (LELs):,115-132-140,200-205-215-219-222-227,MALT LYMPHOMAS (LG HG MALT lymphoma);,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:16:29,,1323845797,7/15/2014 21:16:11,neodev,1,26596102,GBR,,,128.199.166.81,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS,115-132,193-200-205-219-222-215,- MALT LYMPHOMAS (LG HG MALT,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:22:57,,1323848460,7/15/2014 21:22:39,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS,115-132,200-205,MALT LYMPHOMAS,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:25:24,,1323849531,7/15/2014 21:25:10,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS,115-132,200-205,MALT LYMPHOMAS,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:25:42,,1323849637,7/15/2014 21:25:22,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS (LELs): 1),115-132-140-148,200-205-215-219-222-227,MALT LYMPHOMAS (LG HG MALT lymphoma);,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:27:33,,1323850463,7/15/2014 21:27:11,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS,115-132,115-200-205-132,lymphoepithelial lesions MALT LYMPHOMAS,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:27:55,,1323850650,7/15/2014 21:27:37,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS,115-132,190-193-194-200-205,low - grade MALT LYMPHOMAS,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:38:40,,1323854272,7/15/2014 21:38:14,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS,115-132,200-205,MALT LYMPHOMAS,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 21:39:15,,1323854462,7/15/2014 21:39:04,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS 1) high,115-132-148-151,187-190-194-200-205-219-222,in low grade MALT LYMPHOMAS HG MALT,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336083,7/15/2014 22:03:11,,1323863546,7/15/2014 22:02:36,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,115,200,,,139,214,LYMPHOEPITHELIAL LESIONS,MALT LYMPHOMAS,LYMPHOEPITHELIAL LESIONS,115-132,190-194-200-205,low grade MALT LYMPHOMAS,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL.,115 132,200 205,115,200,139,214,-1,RO-disease_may_have_finding,902863,High-grade lymphomas were classified in three groups based on the presence or absence of a low-grade component and lymphoepithelial lesions (LELs): 1) high-grade MALT lymphomas appearing in low-grade MALT lymphomas (LG/HG MALT lymphoma); 2) large cell lymphoma with LELs composed of large cells (high-grade LELs) but without a low-grade component (HG MALT lymphoma); and 3) diffuse large cell lymphoma without a low-grade MALT lymphoma component or LELs (DLCL,lymphoepithelial lesions,MALT lymphomas
503336084,7/15/2014 21:11:27,,1323843759,7/15/2014 21:11:13,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,"SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE),",105-114-124-130-144,89-95,"LUPUS spectrum,","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 21:17:21,,1323846138,7/15/2014 21:17:08,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,"SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE),",105-114-124-130-144,89,LUPUS,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 21:21:16,,1323847661,7/15/2014 21:21:09,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,105-114-124-130,89-95,"LUPUS spectrum,","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 21:45:25,,1323856515,7/15/2014 21:42:59,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,105-114-124-130,89-95,"LUPUS spectrum,","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 22:00:54,,1323862526,7/15/2014 22:00:10,instagc,1,19636746,USA,NY,Andover,192.182.216.225,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,105-114-124-130,89-95,"LUPUS spectrum,","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 22:12:23,,1323867746,7/15/2014 22:12:19,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,"the lupus spectrum, SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS and we",85-89-95-105-114-124-130-152-156,89-95-105-114,"LUPUS spectrum, subacute cutaneous","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 22:14:54,,1323868753,7/15/2014 22:14:40,instagc,1,13763729,USA,,,75.182.89.225,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,105-114-124-130,89-95,"LUPUS spectrum,","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 22:30:12,,1323875891,7/15/2014 22:29:58,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,"SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (SCLE),",105-114-124-130-144,89-95,"LUPUS spectrum,","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 22:31:09,,1323876322,7/15/2014 22:30:50,clixsense,1,23585686,GBR,H9,London,31.51.221.173,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,105-114-124-130,89-144,"LUPUS (SCLE),","In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336084,7/15/2014 22:31:35,,1323876532,7/15/2014 22:31:05,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,105,89,,,143,94,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,LUPUS,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,105-114-124-130,89,LUPUS,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.",105 114 124 130,89,105,89,143,94,-1,RO-cause_of,900484,"In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil",subacute cutaneous lupus erythematosus,lupus
503336085,7/15/2014 21:12:35,,1323844233,7/15/2014 21:12:17,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,88,157,,,92,166,SKIN,PEMPHIGUS,SKIN,88,157,PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 21:20:55,,1323847526,7/15/2014 21:19:56,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,88,157,,,92,166,SKIN,PEMPHIGUS,re epithelialization of SKIN wounds and in,64-67-85-88-93-100-104,133-144-149-157-122,autoimmune blistering skin disease PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 21:31:58,,1323852154,7/15/2014 21:31:24,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,88,157,,,92,166,SKIN,PEMPHIGUS,re epithelialization of SKIN wounds,64-67-85-88-93,133-144-149-157,blistering skin disease PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 21:40:13,,1323854744,7/15/2014 21:40:10,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,88,157,,,92,166,SKIN,PEMPHIGUS,re epithelialization of SKIN wounds and in,64-67-85-88-93-100-104,133-144-149-157,blistering skin disease PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 21:49:14,,1323857716,7/15/2014 21:48:18,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,88,157,,,92,166,SKIN,PEMPHIGUS,SKIN wounds,88-93,133-144-149-157-122,autoimmune blistering skin disease PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 21:54:44,,1323859654,7/15/2014 21:54:12,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,88,157,,,92,166,SKIN,PEMPHIGUS,SKIN wounds,88-93,157,PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 21:59:23,,1323861709,7/15/2014 21:58:53,clixsense,1,26648627,GBR,,,80.189.8.210,88,157,,,92,166,SKIN,PEMPHIGUS,SKIN wounds,88-93,133-144-149-157-122,autoimmune blistering skin disease PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 21:59:49,,1323861972,7/15/2014 21:59:34,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,88,157,,,92,166,SKIN,PEMPHIGUS,SKIN,88,157,PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 22:07:11,,1323865293,7/15/2014 22:06:50,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,88,157,,,92,166,SKIN,PEMPHIGUS,re epithelialization of SKIN wounds and in pemphigus.,64-67-85-88-93-100-104-157,157,PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336085,7/15/2014 22:11:00,,1323867123,7/15/2014 22:10:46,instagc,1,13763729,USA,,,75.182.89.225,88,157,,,92,166,SKIN,PEMPHIGUS,SKIN wounds,88-93,157,PEMPHIGUS.,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus.,88,157,88,157,92,166,1,RO-disease_has_primary_anatomic_site,902059,The activation of the urokinase system has been observed during re-epithelialization of skin wounds and in lesions of the autoimmune blistering skin disease pemphigus,skin,pemphigus
503336086,7/15/2014 21:04:07,,1323840467,7/15/2014 21:04:04,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,aggravating factor for GRAVES' DISEASE and that thyrotoxicosis,53-65-72-76-84-92-96-101,84-92-96-101-116-125-127,disease and that THYROTOXICOSIS relapsed 2 months,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:10:40,,1323843449,7/15/2014 21:10:30,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,101,THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:12:55,,1323844364,7/15/2014 21:12:51,neodev,1,26596102,GBR,,,128.199.166.81,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,aggravating factor for GRAVES' DISEASE and that thyrotoxicosis,53-65-72-76-84-92-96-101,84-92-96-101-116-125-127,disease and that THYROTOXICOSIS relapsed 2 months,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:17:32,,1323846234,7/15/2014 21:17:17,elite,1,26544151,GBR,,,92.40.117.64,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,101,THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:21:25,,1323847716,7/15/2014 21:21:17,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,101,THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:21:28,,1323847733,7/15/2014 21:20:52,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,101,THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:22:44,,1323848332,7/15/2014 21:22:27,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,76-84-101,Graves' disease THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:25:21,,1323849510,7/15/2014 21:24:57,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,101,THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:26:39,,1323850077,7/15/2014 21:26:22,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,101,THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336086,7/15/2014 21:28:21,,1323850888,7/15/2014 21:28:09,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,76,101,,,91,115,GRAVES' DISEASE,THYROTOXICOSIS,GRAVES' DISEASE,76-84,101,THYROTOXICOSIS,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack.,76 84,101,76,101,91,115,-1,RO-cause_of,900139,We previously reported that allergic rhinitis was an aggravating factor for Graves' disease and that thyrotoxicosis relapsed 2 months after an allergic attack,Graves' disease,thyrotoxicosis
503336087,7/15/2014 21:09:18,,1323842761,7/15/2014 21:08:56,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,HYPERPIGMENTATION,24,54,"HYDROQUINONE,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 21:11:27,,1323843761,7/15/2014 21:11:18,neodev,1,26596102,GBR,,,128.199.166.81,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,"Treatment Treatment of HYPERPIGMENTATION may include hydroquinone,",0-11-21-24-42-46-54,24-42-46-54-68-74-80,"hyperpigmentation may include HYDROQUINONE, kojic acid, alpha","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 21:20:12,,1323847246,7/15/2014 21:19:56,elite,1,26544151,GBR,,,92.40.117.64,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,HYPERPIGMENTATION,24,54,"HYDROQUINONE,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 21:23:45,,1323848842,7/15/2014 21:22:19,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,"Treatment Treatment of HYPERPIGMENTATION may include hydroquinone, hydroxy acids,",0-11-21-24-42-46-54-86-94,24-42-46-54-68-74-80-86-94,"hyperpigmentation may include HYDROQUINONE, kojic acid, alpha hydroxy acids,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 21:28:40,,1323851000,7/15/2014 21:28:21,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,HYPERPIGMENTATION,24,54,"HYDROQUINONE,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 21:49:33,,1323857820,7/15/2014 21:47:55,instagc,1,19636746,USA,NY,Andover,192.182.216.225,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,HYPERPIGMENTATION,24,54,"HYDROQUINONE,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 21:57:54,,1323860994,7/15/2014 21:57:42,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,HYPERPIGMENTATION,24,54-68-74,"HYDROQUINONE, kojic acid,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 22:26:28,,1323874050,7/15/2014 22:26:14,clixsense,1,23585686,GBR,H9,London,31.51.221.173,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,HYPERPIGMENTATION,24,54,"HYDROQUINONE,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 22:29:44,,1323875717,7/15/2014 22:29:32,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,HYPERPIGMENTATION,24,54,"HYDROQUINONE,","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336087,7/15/2014 22:31:16,,1323876370,7/15/2014 22:30:59,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,24,54,,,41,66,HYPERPIGMENTATION,HYDROQUINONE,"HYPERPIGMENTATION hydroquinone,",24-54,24-54-68-74-80,"hyperpigmentation HYDROQUINONE, kojic acid, alpha","Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract.",24,54,24,54,41,66,1,RO-may_treat,907808,"Treatment  Treatment of hyperpigmentation may include hydroquinone, kojic acid, alpha hydroxy acids, azelaic acid, ascorbic acid, tretinoin (Retinol), topical glucocorticoids, and licorice extract",hyperpigmentation,hydroquinone
503336088,7/15/2014 21:02:42,,1323839860,7/15/2014 21:02:41,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,"disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis,",47-56-61-64-75-84-91-95-100,0-4-14-17-24-29-40-42-47,"The diagnosis of PLASMA CELL LEUKAEMIA, a rare disorder","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:17:02,,1323846051,7/15/2014 21:16:41,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,AGGRESSIVE CLINICAL COURSE,64-75-84,17-24-29,"PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:19:46,,1323847048,7/15/2014 21:19:28,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,"plasma cell leukaemia, AGGRESSIVE CLINICAL COURSE",17-24-29-64-75-84,17-24-29,"PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:27:21,,1323850381,7/15/2014 21:27:02,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,AGGRESSIVE CLINICAL COURSE,64-75-84,17-24-29,"PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:27:34,,1323850467,7/15/2014 21:27:13,elite,1,28276268,USA,MI,Taylor,67.149.247.166,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,AGGRESSIVE CLINICAL COURSE,64-75-84,17-24-29,"PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:34:15,,1323852852,7/15/2014 21:32:15,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,AGGRESSIVE CLINICAL COURSE,64-75-84,17-24-29,"PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:41:24,,1323855149,7/15/2014 21:41:21,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,"disorder with an AGGRESSIVE CLINICAL COURSE and poor prognosis,",47-56-61-64-75-84-91-95-100,0-4-14-17-24-29-40-42-47,"The diagnosis of PLASMA CELL LEUKAEMIA, a rare disorder","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:43:53,,1323855965,7/15/2014 21:41:55,clixsense,1,15189335,GBR,H9,London,188.29.165.86,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,AGGRESSIVE CLINICAL COURSE,64-75-84,17-24-29,"PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:45:06,,1323856367,7/15/2014 21:44:16,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,AGGRESSIVE CLINICAL COURSE,64-75-84,17-24-29,"PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336088,7/15/2014 21:54:26,,1323859514,7/15/2014 21:54:05,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,64,17,,,90,38,AGGRESSIVE CLINICAL COURSE,PLASMA CELL LEUKAEMIA,disorder with an AGGRESSIVE CLINICAL COURSE,47-56-61-64-75-84,0-4-14-17-24-29,"The diagnosis of PLASMA CELL LEUKAEMIA,","The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping.",64 75 84,17 24 29,64,17,90,38,1,RO-disease_may_have_finding,902607,"The diagnosis of plasma cell leukaemia, a rare disorder with an aggressive clinical course and poor prognosis, is not always straightforward and may be dependent on the results of immunophenotyping",aggressive clinical course,plasma cell leukaemia
503336090,7/15/2014 21:04:41,,1323840706,7/15/2014 21:04:39,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,62,21,,,74,31,HYPERTENSION,AMLODIPINE,combination Therapy for HYPERTENSION Oral: In studies,38-50-58-62-76-83-86,0-4-10-21-32-38-50,11 &gt; Benazepril AMLODIPINE Fixed combination Therapy,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 21:08:47,,1323842606,7/15/2014 21:08:31,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION,62,21,AMLODIPINE,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 21:09:07,,1323842688,7/15/2014 21:09:00,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,62,21,,,74,31,HYPERTENSION,AMLODIPINE,combination Therapy for HYPERTENSION Oral: In studies,38-50-58-62-76-83-86,0-4-10-21-32-38-50,11 &gt; Benazepril AMLODIPINE Fixed combination Therapy,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 21:19:27,,1323846948,7/15/2014 21:19:14,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION,62,21-62,AMLODIPINE Hypertension,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 21:48:27,,1323857495,7/15/2014 21:47:47,clixsense,1,15189335,GBR,H9,London,188.29.165.86,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION,62,21,AMLODIPINE,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 21:55:22,,1323859858,7/15/2014 21:55:00,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION,62,21,AMLODIPINE,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 22:14:09,,1323868359,7/15/2014 22:13:55,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION,62,21,AMLODIPINE,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 22:26:01,,1323873850,7/15/2014 22:25:41,clixsense,1,23585686,GBR,H9,London,31.51.221.173,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION,62,21-62,AMLODIPINE Hypertension,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 22:30:10,,1323875863,7/15/2014 22:29:50,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION Oral:,62-76,21-32,AMLODIPINE Fixed,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336090,7/15/2014 22:30:59,,1323876274,7/15/2014 22:30:27,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,62,21,,,74,31,HYPERTENSION,AMLODIPINE,HYPERTENSION,62,10-21-32-38-50,Benazepril AMLODIPINE Fixed combination Therapy,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups.",62,21,62,21,74,31,1,RO-may_treat,907516,"11  >     Benazepril/Amlodipine Fixed-combination Therapy for Hypertension  Oral:  In studies using benazepril/amlodipine fixed combination in dosages of benazepril hydrochloride 10-40 mg daily and amlodipine 2.5-10 mg daily, BP response increased with increasing amlodipine dosage in all patient groups and increased with increasing benazepril dosage in nonblack patient groups",Hypertension,Amlodipine
503336091,7/15/2014 21:05:20,,1323840938,7/15/2014 21:04:49,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,the correction of IRON DEFICIENCY ANEMIA,78-82-93-96-101-112,123-127-139-142-147,"the replacement of IRON stores,","? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:07:26,,1323841926,7/15/2014 21:07:14,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,96-101-112,123-142-147,"the IRON stores,","? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:07:59,,1323842176,7/15/2014 21:07:48,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,96-101-112,142-147,"IRON stores,","? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:14:46,,1323845153,7/15/2014 21:14:29,irazoo,1,10644009,USA,,,166.137.94.104,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,96-101-112,142,IRON,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:22:26,,1323848202,7/15/2014 21:22:08,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,celiac disease IRON DEFICIENCY ANEMIA,51-58-96-101-112,51-142-58,celiac disease IRON,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:23:27,,1323848666,7/15/2014 21:23:19,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,96-101-112,142-147,"IRON stores,","? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:30:02,,1323851503,7/15/2014 21:29:49,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,96-101-112,142,IRON,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:40:23,,1323854799,7/15/2014 21:40:21,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,the correction of IRON DEFICIENCY ANEMIA and the replacement,78-82-93-96-101-112-119-123-127,123-127-139-142-147-155-159,"the replacement of IRON stores, and it","? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:44:37,,1323856227,7/15/2014 21:44:12,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,96-101-112,142,IRON,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336091,7/15/2014 21:48:49,,1323857609,7/15/2014 21:48:12,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,96,142,,,118,146,IRON DEFICIENCY ANEMIA,IRON,IRON DEFICIENCY ANEMIA,96-101-112,142-147,"IRON stores,","? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency.",96 101 112,142,96,142,118,146,1,RO-may_prevent,907379,"? Adherence to a gluten-free diet in patients with celiac disease can lead to the correction of iron deficiency anemia and the replacement of iron stores, and it can prevent the recurrence of iron deficiency",iron deficiency anemia,iron
503336092,7/15/2014 21:06:42,,1323841667,7/15/2014 21:06:29,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,pathogenesis of DUODENAL ULCER DISEASE.,176-189-192-201-207,76-89-97-102,"conventional therapy with RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:10:28,,1323843332,7/15/2014 21:10:19,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,DUODENAL ULCER DISEASE.,192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:11:46,,1323843922,7/15/2014 21:11:25,irazoo,1,10644009,USA,,,166.137.94.104,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,DUODENAL ULCER DISEASE.,192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:15:22,,1323845348,7/15/2014 21:15:08,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,DUODENAL ULCER DISEASE.,192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:25:45,,1323849668,7/15/2014 21:25:28,elite,1,26544151,GBR,,,92.40.117.64,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,DUODENAL ULCER DISEASE.,192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:28:09,,1323850761,7/15/2014 21:27:57,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,DUODENAL ULCER DISEASE.,192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:32:13,,1323852246,7/15/2014 21:31:59,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,pathogenesis of DUODENAL ULCER DISEASE.,176-189-192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:46:51,,1323856951,7/15/2014 21:46:31,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,DUODENAL ULCER DISEASE.,192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:50:47,,1323858192,7/15/2014 21:50:15,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,DUODENAL ULCER DISEASE.,192-201-207,102,"RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336092,7/15/2014 21:52:52,,1323858882,7/15/2014 21:52:40,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,192,102,,,214,112,DUODENAL ULCER DISEASE,RANITIDINE,the pathogenesis of DUODENAL ULCER DISEASE.,172-176-189-192-201-207,76-89-97-102,"conventional therapy with RANITIDINE,","Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease.",192 201 207,102,192,102,214,112,1,RO-may_prevent,907235,"Famotidine 40 mg given once at night appears to be as safe and effective as conventional therapy with ranitidine, indicating the importance of overnight gastric acidity in the pathogenesis of duodenal ulcer disease",duodenal ulcer disease,ranitidine
503336093,7/15/2014 21:12:30,,1323844200,7/15/2014 21:12:17,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,68,99,,,80,101,HEPATOMEGALY,AL,marked HEPATOMEGALY,61-68,99-102-114-117-121,AL amyloidosis of the liver,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:15:45,,1323845467,7/15/2014 21:15:20,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,68,99,,,80,101,HEPATOMEGALY,AL,marked HEPATOMEGALY,61-68,84-99-102,a AL amyloidosis,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:24:21,,1323849065,7/15/2014 21:24:12,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,68,99,,,80,101,HEPATOMEGALY,AL,scan showing marked HEPATOMEGALY in a patient,48-53-61-68-81-84-86,84-86-94-99-102-114-117-121,a patient with AL amyloidosis of the liver,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:26:35,,1323850038,7/15/2014 21:26:22,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,68,99,,,80,101,HEPATOMEGALY,AL,HEPATOMEGALY,68,99-102,AL amyloidosis,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:30:09,,1323851537,7/15/2014 21:29:48,elite,1,28276268,USA,MI,Taylor,67.149.247.166,68,99,,,80,101,HEPATOMEGALY,AL,HEPATOMEGALY,68,99,AL,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:30:41,,1323851657,7/15/2014 21:30:17,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,68,99,,,80,101,HEPATOMEGALY,AL,HEPATOMEGALY,68,99-102-114-117-121,AL amyloidosis of the liver,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:36:18,,1323853561,7/15/2014 21:35:58,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,68,99,,,80,101,HEPATOMEGALY,AL,marked HEPATOMEGALY,61-68,99-102,AL amyloidosis,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:41:16,,1323855111,7/15/2014 21:41:14,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,68,99,,,80,101,HEPATOMEGALY,AL,scan showing marked HEPATOMEGALY in a patient,48-53-61-68-81-84-86,84-86-94-99-102-114-117,a patient with AL amyloidosis of the,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:53:10,,1323859020,7/15/2014 21:52:42,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,68,99,,,80,101,HEPATOMEGALY,AL,HEPATOMEGALY,68,99-102,AL amyloidosis,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336093,7/15/2014 21:57:29,,1323860800,7/15/2014 21:57:10,instagc,1,19636746,USA,NY,Andover,192.182.216.225,68,99,,,80,101,HEPATOMEGALY,AL,marked HEPATOMEGALY,61-68,99-102,AL amyloidosis,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen.,68,99,68,99,80,101,-1,RO-disease_may_have_finding,902820,Nuclear Liver Spleen Scan  Nuclear liver-spleen scan showing marked hepatomegaly in a patient with AL amyloidosis of the liver and spleen,hepatomegaly,AL
503336094,7/15/2014 21:22:07,,1323848058,7/15/2014 21:21:54,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 21:29:48,,1323851457,7/15/2014 21:29:36,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 21:48:35,,1323857528,7/15/2014 21:48:07,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 21:52:31,,1323858809,7/15/2014 21:52:16,instagc,1,19636746,USA,NY,Andover,192.182.216.225,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 22:01:08,,1323862622,7/15/2014 22:00:45,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 22:07:56,,1323865689,7/15/2014 22:07:12,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,the development of POSTTRAUMATIC EPILEPSY in individuals with,27-31-43-46-60-69-72-84,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 22:11:26,,1323867379,7/15/2014 22:11:11,instagc,1,13763729,USA,,,75.182.89.225,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 22:16:14,,1323869370,7/15/2014 22:15:50,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 22:17:18,,1323869871,7/15/2014 22:17:06,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336094,7/15/2014 22:22:55,,1323872401,7/15/2014 22:22:41,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,46,89,,,68,110,POSTTRAUMATIC EPILEPSY,CRANIOCEREBRAL TRAUMA,POSTTRAUMATIC EPILEPSY,46-60,89-104,CRANIOCEREBRAL TRAUMA,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past.,46 60,89 104,46,89,68,110,1,RO-cause_of,900492,It also allowed to predict the development of posttraumatic epilepsy in individuals with craniocerebral trauma in the past,posttraumatic epilepsy,craniocerebral trauma
503336095,7/15/2014 21:09:47,,1323843016,7/15/2014 21:09:23,irazoo,1,10644009,USA,,,166.137.94.104,477,406,,,482,414,FEVER,HEPATOMA,FEVER,477,406,"HEPATOMA,","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:12:07,,1323844011,7/15/2014 21:11:37,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER and generalized rigidity,445-457-467-477-483-487-499,384-390-395-406-416-420-431-437,"renal cell carcinoma, HEPATOMA, and metastatic liver disease","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:19:08,,1323846846,7/15/2014 21:18:54,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,477,406,,,482,414,FEVER,HEPATOMA,FEVER,477,406,"HEPATOMA,","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:22:50,,1323848387,7/15/2014 21:22:39,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER,445-457-467-477,406,"HEPATOMA,","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:23:26,,1323848659,7/15/2014 21:23:07,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER,445-457-467-477,406-445-457-467,"HEPATOMA, Neuroleptic malignant syndrome","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:30:40,,1323851656,7/15/2014 21:30:20,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER,445-457-477-467,406,"HEPATOMA,","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:37:26,,1323853863,7/15/2014 21:37:07,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER,445-457-467-477,406,"HEPATOMA,","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:39:53,,1323854568,7/15/2014 21:37:36,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER,445-457-467-477,406,"HEPATOMA,","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:52:14,,1323858710,7/15/2014 21:51:37,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER,445-457-467-477,406,"HEPATOMA,","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336095,7/15/2014 21:54:04,,1323859374,7/15/2014 21:53:34,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,477,406,,,482,414,FEVER,HEPATOMA,Neuroleptic malignant syndrome FEVER,445-457-467-477,384-390-395-406-416-420-431,"renal cell carcinoma, HEPATOMA, and metastatic liver","in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection.",477,406,477,406,482,414,-1,RO-disease_may_have_finding,902508,"in gout; knee involvement is most common with pseudogout  Onset anytime; oncologic surgery is a risk factor for postoperative gout; joint manipulation and hyperparathyroidism are risk factors for pseudogout Neoplasia  May or may not be localizing symptoms or signs depending upon nature of underlying malignancy  Onset anytime; most commonly associated with hematologic malignancies, renal cell carcinoma, hepatoma, and metastatic liver disease Neuroleptic malignant syndrome  Fever and generalized rigidity  Onset anytime; associated with antipsychotic drugs, especially haloperidol Transplant rejection  Evidence of transplant organ dysfunction  Onset variable; differential diagnosis includes opportunistic infection",Fever,hepatoma
503336096,7/15/2014 21:03:00,,1323839956,7/15/2014 21:02:57,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,113,72,,,117,81,DRUG,TOLERANCE,action of the DRUG and the effect,99-106-109-113-118-122-126,53-57-69-72-82-85-89,the development of TOLERANCE to the analgesic,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:06:31,,1323841579,7/15/2014 21:06:15,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,113,72,,,117,81,DRUG,TOLERANCE,DRUG,113,72,TOLERANCE,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:12:16,,1323844094,7/15/2014 21:12:01,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,113,72,,,117,81,DRUG,TOLERANCE,DRUG,113,72,TOLERANCE,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:12:48,,1323844338,7/15/2014 21:12:43,neodev,1,26596102,GBR,,,128.199.166.81,113,72,,,117,81,DRUG,TOLERANCE,action of the DRUG and the effect,99-106-109-113-118-122-126,53-57-69-72-82-85-89,the development of TOLERANCE to the analgesic,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:18:27,,1323846562,7/15/2014 21:18:09,elite,1,26544151,GBR,,,92.40.117.64,113,72,,,117,81,DRUG,TOLERANCE,DRUG,113,72,TOLERANCE,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:19:28,,1323846949,7/15/2014 21:19:00,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,113,72,,,117,81,DRUG,TOLERANCE,DRUG,113,72-82-85-89,TOLERANCE to the analgesic,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:19:56,,1323847104,7/15/2014 21:19:48,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,113,72,,,117,81,DRUG,TOLERANCE,DRUG,113,72,TOLERANCE,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:28:01,,1323850692,7/15/2014 21:27:35,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,113,72,,,117,81,DRUG,TOLERANCE,DRUG withdrawal of morphine,113-142-153-156,72-142-153-156,TOLERANCE withdrawal of morphine,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:40:31,,1323854816,7/15/2014 21:40:18,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,113,72,,,117,81,DRUG,TOLERANCE,DRUG,113,72-82-85-89,TOLERANCE to the analgesic,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336096,7/15/2014 21:40:53,,1323854939,7/15/2014 21:40:51,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,113,72,,,117,81,DRUG,TOLERANCE,action of the DRUG and the effect,99-106-109-113-118-122-126,53-57-69-72-82-85-89,the development of TOLERANCE to the analgesic,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2.,113,72,113,72,117,81,1,RO-has_causative_agent,903548,The state of dependence was established by recording the development of tolerance to the analgesic action of the drug and the effect of acute withdrawal of morphine and injection of nalorphine on one test group.2,drug,tolerance
503336097,7/15/2014 21:02:39,,1323839824,7/15/2014 21:02:22,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,patients with transient ELEVATED BLOOD PRESSURE from those with,75-84-89-99-108-114-123-128-134,134-139-144-154,with more sustained HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 21:02:57,,1323839950,7/15/2014 21:02:48,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,transient ELEVATED BLOOD PRESSURE,89-99-108-114,154,HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 21:19:06,,1323846823,7/15/2014 21:18:47,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,transient ELEVATED BLOOD PRESSURE,89-99-108-114,144-154,sustained HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 21:22:05,,1323848046,7/15/2014 21:21:46,elite,1,26544151,GBR,,,92.40.117.64,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,99-108-114,154,HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 21:40:46,,1323854907,7/15/2014 21:40:10,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,transient ELEVATED BLOOD PRESSURE,89-99-108-114,154,HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 21:56:21,,1323860371,7/15/2014 21:56:10,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,transient ELEVATED BLOOD PRESSURE,99-108-114-89,144-154,sustained HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 22:00:43,,1323862436,7/15/2014 22:00:28,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,transient ELEVATED BLOOD PRESSURE,89-99-108-114,154,HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 22:03:42,,1323863710,7/15/2014 22:03:24,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,patients with transient ELEVATED BLOOD PRESSURE from those with,75-84-89-99-108-114-123-128-134,134-139-144-154,with more sustained HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 22:12:59,,1323867938,7/15/2014 22:12:47,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,transient ELEVATED BLOOD PRESSURE,89-99-108-114,154,HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336097,7/15/2014 22:26:13,,1323873959,7/15/2014 22:26:03,clixsense,1,23585686,GBR,H9,London,31.51.221.173,99,154,,,122,166,ELEVATED BLOOD PRESSURE,HYPERTENSION,ELEVATED BLOOD PRESSURE,99-108-114,154,HYPERTENSION.,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension.,99 108 114,154,99,154,122,166,-1,RO-has_definitional_manifestation,904985,Ambulatory monitoring of blood pressure might allow for differentiation of patients with transient elevated blood pressure from those with more sustained hypertension,elevated blood pressure,hypertension
503336098,7/15/2014 21:04:03,,1323840442,7/15/2014 21:03:59,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,form of absence SEIZURES.,104-109-112-120,4-10-15-18-26-35-38-47,final form of ABSENCE EPILEPSY is epilepsy with,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 21:19:16,,1323846875,7/15/2014 21:19:05,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,absence SEIZURES.,112-120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 21:24:52,,1323849297,7/15/2014 21:24:30,elite,1,28276268,USA,MI,Taylor,67.149.247.166,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,SEIZURES.,120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 21:26:55,,1323850210,7/15/2014 21:26:44,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,SEIZURES.,120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 21:33:58,,1323852779,7/15/2014 21:33:06,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,absence SEIZURES.,112-120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 21:51:28,,1323858466,7/15/2014 21:51:03,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,absence SEIZURES.,112-120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 22:19:53,,1323871059,7/15/2014 22:19:17,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,SEIZURES.,120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 22:28:21,,1323875029,7/15/2014 22:28:08,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,absence SEIZURES.,112-120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 22:30:47,,1323876214,7/15/2014 22:30:36,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,SEIZURES.,120,18-26,ABSENCE EPILEPSY,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336098,7/15/2014 22:30:58,,1323876271,7/15/2014 22:30:41,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,120,18,,,128,34,SEIZURES,ABSENCE EPILEPSY,SEIZURES.,120,18-26-38,ABSENCE EPILEPSY epilepsy,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures.",120,18 26,120,18,128,34,1,RO-has_definitional_manifestation,904936,"The final form of absence epilepsy is epilepsy with myoclonic absences, a rare disorder with a specific form of absence seizures",seizures,absence epilepsy
503336099,7/15/2014 21:04:37,,1323840684,7/15/2014 21:04:35,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,mouse model of STATUS EPILEPTICUS.,116-122-128-131-138,35-38-50-55-64-67-77,in combination with DIAZEPAM or phenytoin was,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:05:58,,1323841261,7/15/2014 21:05:21,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,electroshock - induced mouse model of STATUS EPILEPTICUS.,95-107-116-122-128-131-138-108,55-64-67,DIAZEPAM or phenytoin,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:07:19,,1323841867,7/15/2014 21:07:02,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,mouse model of STATUS EPILEPTICUS.,116-122-128-131-138,55,DIAZEPAM,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:11:07,,1323843582,7/15/2014 21:10:55,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS.,131-138,55,DIAZEPAM,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:13:45,,1323844631,7/15/2014 21:13:19,neodev,1,26596102,GBR,,,128.199.166.81,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,nimodipine diazepam phenytoin STATUS EPILEPTICUS.,14-55-131-138-67,14-55-67-95-108-138,nimodipine DIAZEPAM phenytoin electroshock induced epilepticus.,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:22:38,,1323848290,7/15/2014 21:22:21,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS.,131-138,55,DIAZEPAM,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:31:28,,1323851974,7/15/2014 21:31:04,elite,1,28276268,USA,MI,Taylor,67.149.247.166,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS.,131-138,55,DIAZEPAM,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:58:57,,1323861539,7/15/2014 21:58:47,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS.,131-138,55,DIAZEPAM,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 21:59:43,,1323861869,7/15/2014 21:59:22,instagc,1,19636746,USA,NY,Andover,192.182.216.225,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS.,131-138,55,DIAZEPAM,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336099,7/15/2014 22:20:10,,1323871170,7/15/2014 22:19:52,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,131,55,,,149,63,STATUS EPILEPTICUS,DIAZEPAM,STATUS EPILEPTICUS.,131-138,55,DIAZEPAM,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus.,131 138,55,131,55,149,63,1,RO-may_treat,908055,The effect of nimodipine alone and in combination with diazepam or phenytoin was tested in the electroshock-induced mouse model of status epilepticus,status epilepticus,diazepam
503336100,7/15/2014 21:02:47,,1323839883,7/15/2014 21:02:33,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 21:16:43,,1323845902,7/15/2014 21:16:33,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 21:18:39,,1323846646,7/15/2014 21:18:18,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 21:20:51,,1323847518,7/15/2014 21:20:24,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 21:26:48,,1323850164,7/15/2014 21:26:36,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 21:35:10,,1323853160,7/15/2014 21:34:49,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"epilepsy, SEIZURES,",42-52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 21:45:56,,1323856684,7/15/2014 21:44:08,instagc,1,19636746,USA,NY,Andover,192.182.216.225,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 21:59:14,,1323861647,7/15/2014 21:58:54,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70,NON EPILEPTIC,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 22:13:43,,1323868188,7/15/2014 22:13:04,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"SEIZURES,",52,66-70-80-87,NON EPILEPTIC attack disorder,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336100,7/15/2014 22:16:16,,1323869385,7/15/2014 22:16:04,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,52,66,,,60,79,SEIZURES,NON-EPILEPTIC,"epilepsy, SEIZURES, and non epileptic attack disorder",42-52-62-66-70-80-87,42-52-62-66-70-80-87-96,"epilepsy, seizures, and NON EPILEPTIC attack disorder in","In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres.",52,66 70,52,66,60,79,-1,RO-has_definitional_manifestation,904528,"In this review I examine the portrayal of epilepsy, seizures, and non-epileptic attack disorder in 62 movies produced over three-quarters of a century, across four continents, covering nine cinematic genres",seizures,non-epileptic
503336101,7/15/2014 21:03:43,,1323840324,7/15/2014 21:03:23,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW (BM) cells,100-105-112-117,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:09:39,,1323842936,7/15/2014 21:09:21,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW (BM) cells,100-105-112-117,126-138-147,MYELOGENOUS LEUKEMIA patients,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:11:02,,1323843557,7/15/2014 21:10:46,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW (BM),100-105-112,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:11:02,,1323843558,7/15/2014 21:10:40,irazoo,1,10644009,USA,,,166.137.94.104,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW,100-105,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:14:06,,1323844839,7/15/2014 21:13:47,neodev,1,26596102,GBR,,,128.199.166.81,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,(rhIL)3 rhIL4 proliferation BONE MARROW,57-83-100-105-69,57-112-126-138-159-69,(rhIL)3 rhIL4 (BM) MYELOGENOUS LEUKEMIA a,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:21:53,,1323847954,7/15/2014 21:21:42,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW,100-105,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:22:20,,1323848167,7/15/2014 21:22:06,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW,100-105,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:22:54,,1323848440,7/15/2014 21:21:57,clixsense,1,15189335,GBR,H9,London,188.29.164.11,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW,100-105,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:26:21,,1323849953,7/15/2014 21:26:07,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW,100-105,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336101,7/15/2014 21:37:52,,1323854022,7/15/2014 21:37:27,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,100,126,,,111,146,BONE MARROW,MYELOGENOUS LEUKEMIA,BONE MARROW (BM) cells,100-105-112-117,126-138,MYELOGENOUS LEUKEMIA,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells.,100 105,126 138,100,126,111,146,1,RO-disease_has_primary_anatomic_site,902331,This study shows that both recombinant human interleukin (rhIL)3 and rhIL4 induced proliferation in bone marrow (BM) cells of myelogenous leukemia patients in a manner similar to that reported using normal BM cells,bone marrow,myelogenous leukemia
503336102,7/15/2014 21:14:43,,1323845141,7/15/2014 21:14:04,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,123,111,,,127,118,IDDM,INSULIN,IDDM,123,95-105-111-99,Pro (B29) human INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 21:23:18,,1323848600,7/15/2014 21:23:10,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,123,111,,,127,118,IDDM,INSULIN,IDDM,123,111,INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 21:31:21,,1323851911,7/15/2014 21:31:10,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,123,111,,,127,118,IDDM,INSULIN,IDDM,123,105-111,human INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 21:45:02,,1323856330,7/15/2014 21:44:38,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,123,111,,,127,118,IDDM,INSULIN,IDDM,123,111,INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 21:50:28,,1323858137,7/15/2014 21:48:04,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,123,111,,,127,118,IDDM,INSULIN,IDDM,123,95-105-111-99,Pro (B29) human INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 21:57:09,,1323860653,7/15/2014 21:56:27,instagc,1,19636746,USA,NY,Andover,192.182.216.225,123,111,,,127,118,IDDM,INSULIN,IDDM patients,123-138,95-99-105-111,Pro (B29) human INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 22:10:58,,1323867118,7/15/2014 22:10:53,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,123,111,,,127,118,IDDM,INSULIN,human insulin] in IDDM and NIDDM patients,105-111-120-123-128-132-138,95-99-105-111-120-123-128,Pro (B29) human INSULIN] in IDDM and,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 22:13:16,,1323868003,7/15/2014 22:13:00,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,123,111,,,127,118,IDDM,INSULIN,IDDM,123,105-111,human INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 22:23:01,,1323872456,7/15/2014 22:22:36,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,123,111,,,127,118,IDDM,INSULIN,IDDM,123,111,INSULIN],"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336102,7/15/2014 22:27:51,,1323874671,7/15/2014 22:27:30,clixsense,1,23585686,GBR,H9,London,31.51.221.173,123,111,,,127,118,IDDM,INSULIN,IDDM,123,111-123,INSULIN] IDDM,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.",123,111,123,111,127,118,1,RO-may_treat,907870,"Fineberg NS, Fineberg SE, Anderson JH et al. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin",IDDM,insulin
503336103,7/15/2014 21:19:34,,1323846968,7/15/2014 21:19:02,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,123-132-145-154,0-7-12-21,"During Gram negative SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 21:23:49,,1323848876,7/15/2014 21:23:33,bitcoinget,1,24792414,USA,,,166.181.81.37,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,123-132-145-154,7-12-21,"Gram negative SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 21:25:11,,1323849442,7/15/2014 21:24:48,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,123-132-145-154,21,"SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 21:35:52,,1323853345,7/15/2014 21:35:33,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,123-132-145-154,7-12-21,"Gram negative SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 21:46:45,,1323856899,7/15/2014 21:46:25,clixsense,1,15189335,GBR,H9,London,188.29.165.86,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,123-132-145-154,21,"SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 21:57:15,,1323860692,7/15/2014 21:57:01,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,123-132-145-154,7-12-21,"Gram negative SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 22:02:57,,1323863467,7/15/2014 22:00:30,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,116-119-123-132-145-154,7-12-21,"Gram negative SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 22:05:06,,1323864322,7/15/2014 22:05:00,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult,106-116-119-123-132-145-154-163-167-171,0-7-12-21-29-39-82,"During Gram negative SEPSIS, endotoxin lipopolysaccharide inflammatory","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 22:14:27,,1323868510,7/15/2014 22:14:13,instagc,1,13763729,USA,,,75.182.89.225,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,123-132-145-154,7-12-21,"Gram negative SEPSIS,","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336103,7/15/2014 22:17:14,,1323869837,7/15/2014 22:17:01,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,123,21,,,162,27,SYSTEMIC INFLAMMATORY RESPONSE SYNDROME,SEPSIS,resulting in the SYSTEMIC INFLAMMATORY RESPONSE SYNDROME and the adult,106-116-119-123-132-145-154-163-167-171,0-7-12-21-29-39-58,"During Gram negative SEPSIS, endotoxin lipopolysaccharide (LPS)","During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome.",123 132 145 154,21,123,21,162,27,-1,RO-cause_of,900353,"During Gram-negative sepsis, endotoxin lipopolysaccharide (LPS) may activate host inflammatory responses, resulting in the systemic inflammatory response syndrome and the adult respiratory distress syndrome",systemic inflammatory response syndrome,sepsis
503336104,7/15/2014 21:07:01,,1323841793,7/15/2014 21:06:46,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,65,73,,,72,81,ASCITES,HEPATOMA,rat ASCITES hepatoma,61-65-73,61-65-73,rat ascites HEPATOMA,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 21:23:48,,1323848869,7/15/2014 21:23:31,elite,1,26544151,GBR,,,92.40.117.64,65,73,,,72,81,ASCITES,HEPATOMA,ASCITES,65,73,HEPATOMA,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 21:41:03,,1323855014,7/15/2014 21:41:00,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,65,73,,,72,81,ASCITES,HEPATOMA,migration of rat ASCITES hepatoma MM1),48-58-61-65-73-89,58-61-65-73-89-94,of rat ascites HEPATOMA MM1) cells,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 21:50:19,,1323858098,7/15/2014 21:49:36,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,65,73,,,72,81,ASCITES,HEPATOMA,rat ASCITES hepatoma (AH130 MM1),61-65-73-89-82,61-65-73-82-89,rat ascites HEPATOMA (AH130 MM1),We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 22:04:26,,1323864010,7/15/2014 22:04:12,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,65,73,,,72,81,ASCITES,HEPATOMA,migration of rat ASCITES hepatoma (AH130 MM1),48-58-61-65-73-89-82,58-61-65-73-89-94-48,migration of rat ascites HEPATOMA MM1) cells,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 22:24:49,,1323873263,7/15/2014 22:24:29,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,65,73,,,72,81,ASCITES,HEPATOMA,rat ASCITES hepatoma (AH130 MM1),61-65-73-82-89,61-65-73-82-89,rat ascites HEPATOMA (AH130 MM1),We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 22:28:08,,1323874903,7/15/2014 22:27:40,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,65,73,,,72,81,ASCITES,HEPATOMA,ASCITES hepatoma MM1),65-89-73,65-73,ascites HEPATOMA,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 22:28:08,,1323874913,7/15/2014 22:27:52,clixsense,1,23585686,GBR,H9,London,31.51.221.173,65,73,,,72,81,ASCITES,HEPATOMA,ASCITES hepatoma,65-73,73,HEPATOMA,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 22:30:37,,1323876106,7/15/2014 22:30:23,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,65,73,,,72,81,ASCITES,HEPATOMA,ASCITES hepatoma,65-73,65-73,ascites HEPATOMA,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336104,7/15/2014 22:31:47,,1323876608,7/15/2014 22:31:29,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,65,73,,,72,81,ASCITES,HEPATOMA,ASCITES hepatoma MM1),65-73-89,65-73-89-94,ascites HEPATOMA MM1) cells,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade.,65,73,65,73,72,81,-1,RO-disease_may_have_finding,902945,We have previously shown that the transcellular migration of rat ascites hepatoma (AH130-MM1) cells through a cultured mesothelial cell monolayer (MCL) is triggered with lysophosphatidic acid (LPA) that stimulates actin polymerization and myosin light chain phosphorylation through the activation of Rho-ROCK (Rho-kinase) cascade,ascites,hepatoma
503336105,7/15/2014 21:04:55,,1323840777,7/15/2014 21:04:36,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,140,156,,,148,165,WARFARIN,PREGNANCY,maternal ingestion of WARFARIN,118-127-137-140,156,PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 21:07:31,,1323841950,7/15/2014 21:07:26,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,140,156,,,148,165,WARFARIN,PREGNANCY,maternal ingestion of WARFARIN during pregnancy.,118-127-137-140-149-156,137-140-149-156,of warfarin during PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 21:09:47,,1323843019,7/15/2014 21:09:36,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,140,156,,,148,165,WARFARIN,PREGNANCY,WARFARIN,140,156,PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 21:11:43,,1323843872,7/15/2014 21:11:28,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,140,156,,,148,165,WARFARIN,PREGNANCY,maternal ingestion of WARFARIN,118-127-137-140,156,PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 21:11:47,,1323843923,7/15/2014 21:11:29,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,140,156,,,148,165,WARFARIN,PREGNANCY,WARFARIN,140,156,PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 21:14:29,,1323845016,7/15/2014 21:14:08,neodev,1,26596102,GBR,,,128.199.166.81,140,156,,,148,165,WARFARIN,PREGNANCY,(FWS) warfarin (coumadin) embryopathy WARFARIN pregnancy.,24-33-53-140-156-42,24-42-156-53,(FWS) (coumadin) embryopathy PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 21:21:33,,1323847769,7/15/2014 21:21:26,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,140,156,,,148,165,WARFARIN,PREGNANCY,WARFARIN,140,156,PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 21:41:30,,1323855191,7/15/2014 21:41:12,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,140,156,,,148,165,WARFARIN,PREGNANCY,WARFARIN,140,156,PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 22:00:32,,1323862320,7/15/2014 22:00:06,clixsense,1,15189335,GBR,H9,London,188.29.165.113,140,156,,,148,165,WARFARIN,PREGNANCY,WARFARIN,140,156,PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336105,7/15/2014 22:13:03,,1323867947,7/15/2014 22:12:16,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,140,156,,,148,165,WARFARIN,PREGNANCY,WARFARIN,140,0-6-156-15,Fetal warfarin syndrome PREGNANCY.,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy.,140,156,140,156,148,165,1,RO-contraindicated_drug,901253,Fetal warfarin syndrome (FWS) or warfarin (coumadin) embryopathy is a rare condition as a result of fetal exposure to maternal ingestion of warfarin during pregnancy,warfarin,pregnancy
503336106,7/15/2014 21:15:34,,1323845406,7/15/2014 21:15:18,neodev,1,26596102,GBR,,,128.199.166.81,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,Simvastatin HYPERCHOLESTEROLEMIA.,134-84,112-134,EZETIMIBE hypercholesterolemia.,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:18:17,,1323846502,7/15/2014 21:17:58,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,familial HYPERCHOLESTEROLEMIA.,125-134,112,EZETIMIBE,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:20:01,,1323847145,7/15/2014 21:19:47,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,HYPERCHOLESTEROLEMIA.,134,112-134,EZETIMIBE hypercholesterolemia.,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:26:48,,1323850158,7/15/2014 21:26:30,elite,1,28276268,USA,MI,Taylor,67.149.247.166,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,HYPERCHOLESTEROLEMIA.,134,112,EZETIMIBE,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:27:18,,1323850359,7/15/2014 21:26:14,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,HYPERCHOLESTEROLEMIA.,134,112,EZETIMIBE,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:31:23,,1323851932,7/15/2014 21:31:08,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,familial HYPERCHOLESTEROLEMIA.,134-125,112,EZETIMIBE,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:40:12,,1323854742,7/15/2014 21:39:55,instagc,1,19636746,USA,NY,Andover,192.182.216.225,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,familial HYPERCHOLESTEROLEMIA.,125-134,112,EZETIMIBE,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:40:50,,1323854929,7/15/2014 21:40:48,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,ezetimibe in familial HYPERCHOLESTEROLEMIA.,112-122-125-134,96-101-104-112-122-125-134,with or without EZETIMIBE in familial hypercholesterolemia.,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 21:57:04,,1323860619,7/15/2014 21:56:32,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,familial HYPERCHOLESTEROLEMIA.,125-134,112,EZETIMIBE,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336106,7/15/2014 22:00:17,,1323862219,7/15/2014 22:00:02,clixsense,1,26648627,GBR,,,80.189.8.210,134,112,,,154,121,HYPERCHOLESTEROLEMIA,EZETIMIBE,familial HYPERCHOLESTEROLEMIA.,125-134,112,EZETIMIBE,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia.",134,112,134,112,154,121,1,RO-may_treat,907942,"2]  Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia",hypercholesterolemia,ezetimibe
503336107,7/15/2014 21:08:06,,1323842232,7/15/2014 21:07:32,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,refractory STATUS EPILEPTICUS,13-24-31,48-63-73-76,"pentobarbital, PROPOFOL, or midazolam:","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:09:41,,1323842987,7/15/2014 21:09:26,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,refractory STATUS EPILEPTICUS,13-24-31,63,"PROPOFOL,","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:09:56,,1323843112,7/15/2014 21:08:10,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,refractory STATUS EPILEPTICUS,13-24-31,63,"PROPOFOL,","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:10:14,,1323843211,7/15/2014 21:09:32,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,STATUS EPILEPTICUS,24-31,63,"PROPOFOL,","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:12:47,,1323844323,7/15/2014 21:12:32,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,refractory STATUS EPILEPTICUS,13-24-31,63,"PROPOFOL,","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:18:55,,1323846761,7/15/2014 21:18:35,clixsense,1,15189335,GBR,H9,London,188.29.164.11,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,STATUS EPILEPTICUS,24-31,63-87,"PROPOFOL, a","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:21:07,,1323847582,7/15/2014 21:20:42,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,refractory STATUS EPILEPTICUS,13-24-31,63,"PROPOFOL,","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:29:09,,1323851229,7/15/2014 21:28:52,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,refractory STATUS EPILEPTICUS,13-24-31,63,"PROPOFOL,","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 21:50:48,,1323858201,7/15/2014 21:50:25,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,STATUS EPILEPTICUS,24-31,63,"PROPOFOL,","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336107,7/15/2014 22:03:55,,1323863809,7/15/2014 22:03:43,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,24,63,,,42,71,STATUS EPILEPTICUS,PROPOFOL,"Treatment of refractory STATUS EPILEPTICUS with pentobarbital, propofol,",0-10-13-24-31-43-48-63,31-43-48-63-73-76-87,"epilepticus with pentobarbital, PROPOFOL, or midazolam: a","Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.",24 31,63,24,63,42,71,1,RO-may_treat,907626,"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review",status epilepticus,propofol
503336108,7/15/2014 21:12:59,,1323844384,7/15/2014 21:12:48,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,83,108,,,92,118,VARICELLA,CHICKENPOX,"VARICELLA,",83,108,"CHICKENPOX,","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 21:13:18,,1323844450,7/15/2014 21:12:57,neodev,1,26596102,GBR,,,128.199.166.81,83,108,,,92,118,VARICELLA,CHICKENPOX,"disease VARICELLA,",75-83,108-134-142,"CHICKENPOX, disease herpes","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 21:22:42,,1323848329,7/15/2014 21:22:18,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,83,108,,,92,118,VARICELLA,CHICKENPOX,"VARICELLA, as",83-105,108,"CHICKENPOX,","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 21:24:28,,1323849123,7/15/2014 21:24:11,elite,1,26544151,GBR,,,92.40.117.64,83,108,,,92,118,VARICELLA,CHICKENPOX,"VARICELLA,",83,108,"CHICKENPOX,","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 21:24:36,,1323849160,7/15/2014 21:24:18,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,83,108,,,92,118,VARICELLA,CHICKENPOX,"Varicella zoster virus VARICELLA,",0-10-17-83,0-10-108-17,"Varicella zoster virus CHICKENPOX,","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 21:32:07,,1323852212,7/15/2014 21:31:31,elite,1,28276268,USA,MI,Taylor,67.149.247.166,83,108,,,92,118,VARICELLA,CHICKENPOX,"VARICELLA,",83,108,"CHICKENPOX,","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 21:40:47,,1323854923,7/15/2014 21:40:42,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,83,108,,,92,118,VARICELLA,CHICKENPOX,"the childhood disease VARICELLA, also known as",61-65-75-83-94-99-105,94-99-105-108-120-124-128,"also known as CHICKENPOX, and the adult","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 21:54:33,,1323859551,7/15/2014 21:54:13,clixsense,1,26648627,GBR,,,80.189.8.210,83,108,,,92,118,VARICELLA,CHICKENPOX,"VARICELLA,",83,108,"CHICKENPOX,","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 22:10:20,,1323866784,7/15/2014 22:09:47,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,83,108,,,92,118,VARICELLA,CHICKENPOX,"VARICELLA,",83,108,"CHICKENPOX,","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336108,7/15/2014 22:14:37,,1323868604,7/15/2014 22:14:23,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,83,108,,,92,118,VARICELLA,CHICKENPOX,"the childhood disease VARICELLA, also known as chickenpox,",61-65-75-83-94-99-105-108,94-99-105-108-120-124-128-83,"varicella, also known as CHICKENPOX, and the adult","Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles.",83,108,83,108,92,118,-1,RO-has_causative_agent,903771,"Varicella zoster virus (VZV) is the herpesvirus which causes the childhood disease varicella, also known as chickenpox, and the adult disease herpes zoster, also known as shingles",varicella,chickenpox
503336109,7/15/2014 21:22:47,,1323848343,7/15/2014 21:22:31,elite,1,26544151,GBR,,,92.40.117.64,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 21:57:46,,1323860914,7/15/2014 21:57:30,instagc,1,19636746,USA,NY,Andover,192.182.216.225,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,mild to moderate HYPERTENSION.,100-105-108-117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 21:58:05,,1323861053,7/15/2014 21:57:55,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 22:14:22,,1323868476,7/15/2014 22:14:12,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,mild to moderate HYPERTENSION.,100-105-108-117,41-45-58-61-73,and tolerability of CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 22:21:46,,1323871818,7/15/2014 22:21:20,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 22:28:43,,1323875168,7/15/2014 22:28:32,clixsense,1,23585686,GBR,H9,London,31.51.221.173,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 22:29:45,,1323875721,7/15/2014 22:29:18,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 22:30:06,,1323875857,7/15/2014 22:28:47,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 22:31:14,,1323876362,7/15/2014 22:31:03,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336109,7/15/2014 22:31:39,,1323876548,7/15/2014 22:31:25,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,117,61,,,129,82,HYPERTENSION,CANDESARTAN CILEXETIL,HYPERTENSION.,117,61-73,CANDESARTAN CILEXETIL,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension.",117,61 73,117,61,129,82,1,RO-may_treat,907902,"Sever P, Holzgreve H. Long-term efficacy and tolerability of candesartan cilexetil in patients with mild to moderate hypertension",hypertension,candesartan cilexetil
503336110,7/15/2014 21:06:44,,1323841669,7/15/2014 21:05:59,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,62,77,,,75,82,HEAD AND NECK,SCCHN,"squamous cell carcinomas of the HEAD AND NECK (SCCHN),",30-39-44-55-58-62-67-71-76,30-39-44-55-58-62-67-71-76,"squamous cell carcinomas of the head and neck (SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 21:09:39,,1323842985,7/15/2014 21:09:35,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,62,77,,,75,82,HEAD AND NECK,SCCHN,carcinomas of the HEAD AND NECK we performed,44-55-58-62-67-71-85-88,67-71-76-85-88-98,"and neck (SCCHN), we performed sequence","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 21:15:34,,1323845402,7/15/2014 21:14:48,irazoo,1,10644009,USA,,,166.137.94.104,62,77,,,75,82,HEAD AND NECK,SCCHN,HEAD AND NECK,62-67-71,30-39-44-55-58-62-67-71-76,"squamous cell carcinomas of the head and neck (SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 21:17:15,,1323846093,7/15/2014 21:16:37,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,62,77,,,75,82,HEAD AND NECK,SCCHN,"squamous cell carcinomas of the HEAD AND NECK (SCCHN),",30-39-44-55-62-67-71-76-58,76,"(SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 21:22:07,,1323848059,7/15/2014 21:21:49,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,62,77,,,75,82,HEAD AND NECK,SCCHN,carcinomas HEAD AND NECK,44-62-67-71,44,carcinomas,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 21:41:21,,1323855116,7/15/2014 21:40:51,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,62,77,,,75,82,HEAD AND NECK,SCCHN,carcinomas of the HEAD AND NECK,44-55-58-62-67-71,76,"(SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 21:54:57,,1323859735,7/15/2014 21:54:42,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,62,77,,,75,82,HEAD AND NECK,SCCHN,"carcinomas of the HEAD AND NECK (SCCHN),",44-55-58-62-67-71-76,44-55-58-67-71-76-62,"carcinomas of the head and neck (SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 21:56:46,,1323860497,7/15/2014 21:56:22,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,62,77,,,75,82,HEAD AND NECK,SCCHN,"squamous cell carcinomas of the HEAD AND NECK (SCCHN),",30-39-44-55-58-62-67-71-76,30-39-44-55-58-67-71-76-62,"squamous cell carcinomas of the head and neck (SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 22:01:47,,1323862921,7/15/2014 22:01:08,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,62,77,,,75,82,HEAD AND NECK,SCCHN,"squamous cell carcinomas of the HEAD AND NECK (SCCHN),",30-39-44-55-58-62-67-71-76,30-44-55-58-62-67-71-76-39,"squamous cell carcinomas of the head and neck (SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336110,7/15/2014 22:05:12,,1323864355,7/15/2014 22:04:56,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,62,77,,,75,82,HEAD AND NECK,SCCHN,HEAD AND NECK,62-67-71,76,"(SCCHN),","In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18.",62 67 71,,62,77,75,82,1,RO-disease_has_primary_anatomic_site,902289,"In a series of 123 unselected squamous cell carcinomas of the head and neck (SCCHN), we performed sequence analysis of the entire coding region of p53 transcript and determined the presence of the E6 transcripts of HPV 16 and 18",head and neck,SCCHN
503336111,7/15/2014 21:03:08,,1323840005,7/15/2014 21:03:05,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,30,39,,,38,45,BACTERIA,CAVITY,(4.5 x 10(5) BACTERIA cavity) induced accumulation,17-22-24-30-39-47-55,22-24-30-39-47-55-68,x 10(5) bacteria CAVITY) induced accumulation of,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:13:45,,1323844629,7/15/2014 21:13:23,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,30,39,,,38,45,BACTERIA,CAVITY,BCG (4.5 x 10(5) BACTERIA cavity),17-22-24-30-39-13,17-22-24-30-39-13,BCG (4.5 x 10(5) bacteria CAVITY),injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:21:31,,1323847746,7/15/2014 21:19:21,clixsense,1,15189335,GBR,H9,London,188.29.164.11,30,39,,,38,45,BACTERIA,CAVITY,BACTERIA,30,39,CAVITY),injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:23:30,,1323848688,7/15/2014 21:23:09,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,30,39,,,38,45,BACTERIA,CAVITY,BACTERIA cavity) induced accumulation,30-39-47-55,22-24-30-39-47-55-68,x 10(5) bacteria CAVITY) induced accumulation of,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:26:02,,1323849805,7/15/2014 21:25:43,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,30,39,,,38,45,BACTERIA,CAVITY,BACTERIA cavity),30-39,30-39,bacteria CAVITY),injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:31:02,,1323851776,7/15/2014 21:30:32,elite,1,28276268,USA,MI,Taylor,67.149.247.166,30,39,,,38,45,BACTERIA,CAVITY,BACTERIA,30,39,CAVITY),injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:38:34,,1323854223,7/15/2014 21:38:25,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,30,39,,,38,45,BACTERIA,CAVITY,(4.5 x 10(5) BACTERIA cavity) induced accumulation,17-22-24-30-39-47-55,22-24-30-39-47-55-68,x 10(5) bacteria CAVITY) induced accumulation of,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:47:30,,1323857195,7/15/2014 21:46:34,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,30,39,,,38,45,BACTERIA,CAVITY,(4.5 x 10(5) BACTERIA cavity),17-22-24-30-39,22-24-30-39-17,(4.5 x 10(5) bacteria CAVITY),injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:48:02,,1323857374,7/15/2014 21:45:27,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,30,39,,,38,45,BACTERIA,CAVITY,BACTERIA,30,39,CAVITY),injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336111,7/15/2014 21:56:41,,1323860468,7/15/2014 21:56:26,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,30,39,,,38,45,BACTERIA,CAVITY,BACTERIA,30,39,CAVITY),injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice.,30,39,30,39,38,45,-1,RO-has_causative_agent,903875,injection of BCG (4.5 x 10(5) bacteria/cavity) induced accumulation of T lymphocytes in the pleural cavities of C57BL/6 mice,bacteria,cavity
503336112,7/15/2014 21:03:25,,1323840160,7/15/2014 21:03:22,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,"the pathophysiology of SIDS and, consequently, reduce",84-88-104-107-112-117-131,142-149-152-164-171-178,number of unexplained SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:10:18,,1323843240,7/15/2014 21:10:06,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,SIDS,107,164-171-178,SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:13:22,,1323844498,7/15/2014 21:12:58,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,pathophysiology of SIDS,88-104-107,152-164-171-178,unexplained SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:17:42,,1323846311,7/15/2014 21:17:16,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,SIDS,107,164-171-178,SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:19:01,,1323846810,7/15/2014 21:18:41,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,SIDS,107,164-171-178,SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:23:02,,1323848505,7/15/2014 21:22:52,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,SIDS,107,164-171-178,SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:24:00,,1323848935,7/15/2014 21:23:51,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,SIDS,107,164-171-178,SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:36:16,,1323853547,7/15/2014 21:34:16,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,SIDS,107,164-171-178,SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:38:53,,1323854357,7/15/2014 21:38:49,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,"the pathophysiology of SIDS and, consequently, reduce",84-88-104-107-112-117-131,142-149-152-164-171-178,number of unexplained SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336112,7/15/2014 21:54:35,,1323859597,7/15/2014 21:54:02,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,107,164,,,111,184,SIDS,SUDDEN INFANT DEATHS,SIDS,107,164-171-178,SUDDEN INFANT DEATHS.,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths.",107,164 171 178,107,164,111,184,-1,RO-cause_of,900196,"Identification of more LQTS mutations in SIDS cases could provide new insights into the pathophysiology of SIDS and, consequently, reduce the number of unexplained sudden infant deaths",SIDS,sudden infant deaths
503336113,7/15/2014 21:09:31,,1323842860,7/15/2014 21:08:56,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"SKIN Diseases,",67-72,147-153-163-174-183,TOXIC EPIDERMAL NECROLYSIS (Lyell's syndrome),"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:12:06,,1323844010,7/15/2014 21:12:01,neodev,1,26596102,GBR,,,128.199.166.81,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"Centre for Severe SKIN Diseases, which is",49-56-60-67-72-82-88,125-130-144-147-153-163-183-193,wide documentation of TOXIC EPIDERMAL NECROLYSIS syndrome) and,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:16:19,,1323845700,7/15/2014 21:15:54,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"Freiburg Documentation Centre for Severe SKIN Diseases,",26-35-49-60-67-72-56,147-153-163-174-183,TOXIC EPIDERMAL NECROLYSIS (Lyell's syndrome),"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:19:11,,1323846856,7/15/2014 21:18:53,elite,1,26544151,GBR,,,92.40.117.64,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"SKIN Diseases,",67-72,147-153-163,TOXIC EPIDERMAL NECROLYSIS,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:20:54,,1323847527,7/15/2014 21:20:46,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"Centre for Severe SKIN Diseases,",49-56-60-67-72,147-153-163,TOXIC EPIDERMAL NECROLYSIS,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:22:18,,1323848154,7/15/2014 21:21:57,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"Centre for Severe SKIN Diseases, is",49-56-60-67-72-88,125-130-144-147-153-163-183-193-174,wide documentation of TOXIC EPIDERMAL NECROLYSIS (Lyell's syndrome) and,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:23:11,,1323848555,7/15/2014 21:22:58,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,SKIN,67,147-153-163,TOXIC EPIDERMAL NECROLYSIS,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:29:26,,1323851341,7/15/2014 21:29:06,elite,1,28276268,USA,MI,Taylor,67.149.247.166,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,SKIN,67,147-153-163,TOXIC EPIDERMAL NECROLYSIS,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:34:48,,1323853028,7/15/2014 21:34:20,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"Freiburg Documentation Centre for Severe SKIN Diseases,",26-35-49-56-60-67-72,147-153-163-174-183,TOXIC EPIDERMAL NECROLYSIS (Lyell's syndrome),"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336113,7/15/2014 21:36:42,,1323853645,7/15/2014 21:36:19,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,67,147,,,71,173,SKIN,TOXIC EPIDERMAL NECROLYSIS,"Severe SKIN Diseases,",60-67-72,147-153-163-174-183,TOXIC EPIDERMAL NECROLYSIS (Lyell's syndrome),"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome.",67,147 153 163,67,147,71,173,1,RO-disease_has_primary_anatomic_site,902119,"The only exception is the Freiburg Documentation Centre for Severe Skin Diseases, which is attempting comprehensive, country-wide documentation of toxic epidermal necrolysis (Lyell's syndrome) and Stevens-Johnson syndrome",Skin,toxic epidermal necrolysis
503336114,7/15/2014 21:06:45,,1323841679,7/15/2014 21:06:31,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,HYPERTENSION,102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 21:14:50,,1323845173,7/15/2014 21:14:32,neodev,1,26596102,GBR,,,128.199.166.81,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,periodic alternating HYPERTENSION hypotension.,81-90-102-119,29-37-102-119,ADRENAL PHEOCHROMOCYTOMA hypertension hypotension.,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 21:26:12,,1323849881,7/15/2014 21:24:15,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,HYPERTENSION,102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 21:35:35,,1323853264,7/15/2014 21:35:17,instagc,1,19636746,USA,NY,Andover,192.182.216.225,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,periodic alternating HYPERTENSION,81-90-102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 21:46:28,,1323856821,7/15/2014 21:45:48,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,periodic alternating HYPERTENSION,81-90-102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 21:48:06,,1323857408,7/15/2014 21:47:43,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,HYPERTENSION,102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 22:05:31,,1323864496,7/15/2014 22:05:13,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,HYPERTENSION,102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 22:15:48,,1323869189,7/15/2014 22:15:26,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,HYPERTENSION,102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 22:17:38,,1323870038,7/15/2014 22:17:19,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,periodic alternating HYPERTENSION,81-90-102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336114,7/15/2014 22:29:31,,1323875623,7/15/2014 22:29:21,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,102,29,,,114,53,HYPERTENSION,ADRENAL PHEOCHROMOCYTOMA,periodic alternating HYPERTENSION,81-90-102,29-37,ADRENAL PHEOCHROMOCYTOMA,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension.,102,29 37,102,29,114,53,1,RO-disease_may_have_finding,902699,We present a patient with an adrenal pheochromocytoma with an unusual pattern of periodic alternating hypertension and hypotension,hypertension,adrenal pheochromocytoma
503336115,7/15/2014 21:07:44,,1323842086,7/15/2014 21:07:40,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"with ipsilateral adversive SEIZURES, ipsilateral oculogyric crisis,",28-33-45-55-65-77-88,0-8-11-20-28-33-45,Attacks of GELASTIC SEIZURE with ipsilateral adversive,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:10:02,,1323843134,7/15/2014 21:09:51,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"ipsilateral adversive SEIZURES,",33-45-55,11-20,GELASTIC SEIZURE,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:11:58,,1323843974,7/15/2014 21:11:33,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"ipsilateral adversive SEIZURES,",33-45-55,11-20,GELASTIC SEIZURE,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:21:56,,1323847974,7/15/2014 21:21:37,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"gelastic seizure with ipsilateral adversive SEIZURES, ipsilateral oculogyric crisis,",11-20-28-33-55-65-77-88-45,0-8-11-20-28-33-45-55-65-77,"Attacks of GELASTIC SEIZURE with ipsilateral adversive seizures, ipsilateral oculogyric","Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:25:09,,1323849430,7/15/2014 21:24:58,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"SEIZURES,",55,11-20,GELASTIC SEIZURE,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:35:49,,1323853325,7/15/2014 21:35:29,elite,1,28276268,USA,MI,Taylor,67.149.247.166,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"SEIZURES,",55,11-20,GELASTIC SEIZURE,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:49:32,,1323857810,7/15/2014 21:49:08,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"SEIZURES,",55,11-20,GELASTIC SEIZURE,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:55:15,,1323859843,7/15/2014 21:54:40,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"ipsilateral adversive SEIZURES,",33-45-55,11-20,GELASTIC SEIZURE,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 21:56:26,,1323860395,7/15/2014 21:54:28,instagc,1,19636746,USA,NY,Andover,192.182.216.225,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"ipsilateral adversive SEIZURES,",33-45-55,11-20,GELASTIC SEIZURE,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336115,7/15/2014 22:09:50,,1323866567,7/15/2014 22:08:54,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,55,11,,,63,27,SEIZURES,GELASTIC SEIZURE,"with ipsilateral adversive SEIZURES, ipsilateral oculogyric crisis,",28-33-45-55-65-77-88,11-20-33-45,GELASTIC SEIZURE ipsilateral adversive,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29.",55,11 20,55,11,63,27,-1,RO-has_definitional_manifestation,904849,"Attacks of gelastic seizure with ipsilateral adversive seizures, ipsilateral oculogyric crisis, and horizontal epileptic nystagmus were observed until her death at age 29",seizures,gelastic seizure
503336116,7/15/2014 21:03:59,,1323840422,7/15/2014 21:03:56,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES and abnormal vascular,86-96-105-113-122-126-135,159-168-171-175-184,vicinity of the ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 21:08:51,,1323842622,7/15/2014 21:08:41,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,86-96-105-113,175-184,ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 21:09:24,,1323842838,7/15/2014 21:09:09,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,96-105-113-86,175-184,ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 21:11:36,,1323843807,7/15/2014 21:10:58,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,86-96-105-113,126-135-144-152-159-168-171-175-184-155,abnormal vascular network in the vicinity of the ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 21:21:49,,1323847911,7/15/2014 21:21:30,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,86-96-105-113,175-184,ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 21:23:08,,1323848539,7/15/2014 21:22:14,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral carotid ARTERIES and abnormal vascular,86-105-113-122-126-135,159-168-171-175-184,vicinity of the ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 21:51:24,,1323858445,7/15/2014 21:50:52,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,86-96-105-113,175-184,ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 21:58:23,,1323861183,7/15/2014 21:57:54,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,86-96-105-113,175-184,ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 22:12:15,,1323867675,7/15/2014 22:12:02,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,86-96-105-113,175-184,ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336116,7/15/2014 22:18:31,,1323870443,7/15/2014 22:18:15,instagc,1,19636746,USA,NY,Andover,192.182.216.225,113,175,,,121,193,ARTERIES,ARTERIAL OCCLUSION,bilateral internal carotid ARTERIES,86-96-105-113,175-184,ARTERIAL OCCLUSION.,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion.,113,175 184,113,175,121,193,1,RO-has_finding_site,905037,The disease is characterized by stenosis or occlusion of the terminal portions of the bilateral internal carotid arteries and abnormal vascular network in the vicinity of the arterial occlusion,arteries,arterial occlusion
503336117,7/15/2014 21:07:20,,1323841875,7/15/2014 21:05:28,neodev,1,26596102,GBR,,,128.199.166.81,139,98,,,147,103,NONLUPUS,LUPUS,the NONLUPUS nephrotics.,135-139-148,85-89-95-98-104-114-123,the group of LUPUS nephrotic patients compared,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:08:01,,1323842219,7/15/2014 21:07:38,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,139,98,,,147,103,NONLUPUS,LUPUS,NONLUPUS nephrotics.,139-148,98-104,LUPUS nephrotic,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:08:06,,1323842237,7/15/2014 21:07:54,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,139,98,,,147,103,NONLUPUS,LUPUS,NONLUPUS nephrotics.,139-148,98-104,LUPUS nephrotic,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:09:59,,1323843132,7/15/2014 21:09:55,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,139,98,,,147,103,NONLUPUS,LUPUS,compared to the NONLUPUS nephrotics.,123-132-135-139-148,85-89-95-98-104-114-123,the group of LUPUS nephrotic patients compared,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:10:39,,1323843439,7/15/2014 21:10:09,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,139,98,,,147,103,NONLUPUS,LUPUS,NONLUPUS nephrotics.,139-148,98-104,LUPUS nephrotic,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:14:09,,1323844855,7/15/2014 21:13:56,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,139,98,,,147,103,NONLUPUS,LUPUS,NONLUPUS,139,98,LUPUS,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:26:47,,1323850157,7/15/2014 21:26:31,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,139,98,,,147,103,NONLUPUS,LUPUS,lupus nephrotic NONLUPUS,98-104-139,98-104,LUPUS nephrotic,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:33:21,,1323852622,7/15/2014 21:33:03,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,139,98,,,147,103,NONLUPUS,LUPUS,to NONLUPUS nephrotics.,132-139-148,98-104-114,LUPUS nephrotic patients,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 21:56:25,,1323860381,7/15/2014 21:56:07,clixsense,1,26648627,GBR,,,80.189.8.210,139,98,,,147,103,NONLUPUS,LUPUS,NONLUPUS nephrotics.,139-148,98-104-114,LUPUS nephrotic patients,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336117,7/15/2014 22:14:11,,1323868372,7/15/2014 22:13:50,instagc,1,13763729,USA,,,75.182.89.225,139,98,,,147,103,NONLUPUS,LUPUS,NONLUPUS nephrotics.,139-148,98-104,LUPUS nephrotic,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics.,139,98,139,98,147,103,-1,RO-cause_of,900403,The serum triglycerides and serum cholesterol levels were not significantly lower in the group of lupus nephrotic patients compared to the nonlupus nephrotics,nonlupus,lupus
503336118,7/15/2014 21:11:12,,1323843659,7/15/2014 21:10:59,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,97,54,,,101,64,PAIN,ANTIPYRINE,"ear PAIN (otalgia, earache)",93-97-102-112,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:13:43,,1323844627,7/15/2014 21:13:16,irazoo,1,10644009,USA,,,166.137.94.104,97,54,,,101,64,PAIN,ANTIPYRINE,PAIN,97,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:18:46,,1323846702,7/15/2014 21:18:15,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,97,54,,,101,64,PAIN,ANTIPYRINE,"relief of ear PAIN (otalgia, earache)",83-90-93-97-102-112,37-49-54,combination with ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:23:56,,1323848897,7/15/2014 21:23:47,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,97,54,,,101,64,PAIN,ANTIPYRINE,ear PAIN,93-97,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:27:16,,1323850347,7/15/2014 21:26:55,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,97,54,,,101,64,PAIN,ANTIPYRINE,PAIN,97,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:30:18,,1323851555,7/15/2014 21:30:03,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,97,54,,,101,64,PAIN,ANTIPYRINE,ear PAIN,93-97,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:31:01,,1323851772,7/15/2014 21:30:41,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,97,54,,,101,64,PAIN,ANTIPYRINE,ear PAIN,93-97,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:36:33,,1323853606,7/15/2014 21:35:51,elite,1,28276268,USA,MI,Taylor,67.149.247.166,97,54,,,101,64,PAIN,ANTIPYRINE,PAIN,97,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:49:57,,1323857988,7/15/2014 21:49:33,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,97,54,,,101,64,PAIN,ANTIPYRINE,PAIN,97,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336118,7/15/2014 21:51:59,,1323858629,7/15/2014 21:51:05,clixsense,1,26648627,GBR,,,80.189.8.210,97,54,,,101,64,PAIN,ANTIPYRINE,"ear PAIN (otalgia, earache) associated with otitis media",93-97-102-112-121-132-137-144,54,ANTIPYRINE,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US.",97,54,97,54,101,64,1,RO-may_treat,907711,"r  Otic Pain  Used alone or in fixed combination with antipyrine for the temporary relief of ear pain (otalgia, earache) associated with otitis media of various causes; however, single ingredient preparations no longer commercially available in the US",pain,antipyrine
503336119,7/15/2014 21:14:06,,1323844838,7/15/2014 21:13:43,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,metastatic MULTIPLE MYELOMA,150-161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 21:20:14,,1323847263,7/15/2014 21:20:07,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,MULTIPLE MYELOMA,161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 21:27:26,,1323850422,7/15/2014 21:27:05,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,metastatic MULTIPLE MYELOMA,150-161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 21:30:38,,1323851650,7/15/2014 21:30:20,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,metastatic MULTIPLE MYELOMA,150-161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 21:55:28,,1323859911,7/15/2014 21:55:08,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,metastatic MULTIPLE MYELOMA,150-161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 21:55:42,,1323859999,7/15/2014 21:55:23,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,MULTIPLE MYELOMA,161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 21:57:59,,1323861028,7/15/2014 21:57:24,clixsense,1,15189335,GBR,H9,London,188.29.165.113,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,MULTIPLE MYELOMA,161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 22:09:59,,1323866607,7/15/2014 22:09:43,instagc,1,13763729,USA,,,75.182.89.225,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,metastatic MULTIPLE MYELOMA,161-170-150,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 22:12:01,,1323867578,7/15/2014 22:11:27,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,metastatic MULTIPLE MYELOMA,150-161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336119,7/15/2014 22:20:35,,1323871341,7/15/2014 22:20:16,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,161,97,,,177,112,MULTIPLE MYELOMA,ZOLEDRONIC ACID,MULTIPLE MYELOMA,161-170,97-108,ZOLEDRONIC ACID,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion.,161 170,97 108,161,97,177,112,1,RO-may_treat,908304,We collected resource use data prospectively for 930 patients alongside a multinational trial of zoledronic acid versus pamidronate for patients with metastatic multiple myeloma or breast cancer and > or =1 bone lesion,multiple myeloma,zoledronic acid
503336120,7/15/2014 21:03:16,,1323840089,7/15/2014 21:03:13,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,185,220,,,196,229,MEDICATIONS,TOLERANCE,and,178,,,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:07:25,,1323841912,7/15/2014 21:07:20,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,185,220,,,196,229,MEDICATIONS,TOLERANCE,and,178,,,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:11:28,,1323843765,7/15/2014 21:10:41,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,-1,anti-CD11,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:11:44,,1323843892,7/15/2014 21:11:18,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,,,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:24:26,,1323849102,7/15/2014 21:24:13,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,-1,anti-CD11,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:26:09,,1323849852,7/15/2014 21:25:47,elite,1,28276268,USA,MI,Taylor,67.149.247.166,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,-1,anti-CD11,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:27:00,,1323850259,7/15/2014 21:26:49,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,-1,anti-CD11,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:46:24,,1323856787,7/15/2014 21:43:55,clixsense,1,15189335,GBR,H9,London,188.29.165.86,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,-1,anti-CD11,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:59:04,,1323861566,7/15/2014 21:58:23,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,-1,anti-CD11,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336120,7/15/2014 21:59:21,,1323861698,7/15/2014 21:58:06,instagc,1,19636746,USA,NY,Andover,192.182.216.225,185,220,,,196,229,MEDICATIONS,TOLERANCE,anti-CD11,-1,-1,anti-CD11,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system.",,,185,220,196,229,1,RO-has_causative_agent,903789,"Overall, they can be divided into: a) medications that act on the inflammatory response triggered by ischemia/reperfusion, such as anti-CD11/CD18 antibodies and anti-complement, and b) medications that enhance metabolic tolerance, such as glucose-insulin-potassium solution and inhibitors of the Na+/H+ ion exchange system",medications,tolerance
503336121,7/15/2014 21:03:51,,1323840387,7/15/2014 21:03:47,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,123,49,,,131,54,NONLUPUS,LUPUS,with primary (NONLUPUS) membranous glomerulopathy,109-114-122-133-144,30-35-44-49-55-66,from patients with LUPUS membranous glomerulopathy,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 21:15:56,,1323845561,7/15/2014 21:15:41,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,123,49,,,131,54,NONLUPUS,LUPUS,(NONLUPUS),122,49,LUPUS,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 21:21:28,,1323847731,7/15/2014 21:21:08,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,123,49,,,131,54,NONLUPUS,LUPUS,lupus membranous glomerulopathy,49-55-66,49-55-66,LUPUS membranous glomerulopathy,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 21:23:20,,1323848618,7/15/2014 21:22:59,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,123,49,,,131,54,NONLUPUS,LUPUS,primary (NONLUPUS) membranous glomerulopathy (NLMGN),114-122-133-144-159,49-55-66,LUPUS membranous glomerulopathy,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 21:55:06,,1323859790,7/15/2014 21:54:33,clixsense,1,26648627,GBR,,,80.189.8.210,123,49,,,131,54,NONLUPUS,LUPUS,primary (NONLUPUS) membranous glomerulopathy (NLMGN),114-122-133-144-159,49-55-66-81,LUPUS membranous glomerulopathy (LMGN),"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 22:05:51,,1323864653,7/15/2014 22:05:32,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,123,49,,,131,54,NONLUPUS,LUPUS,(NONLUPUS),122,49,LUPUS,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 22:15:12,,1323868878,7/15/2014 22:14:55,instagc,1,13763729,USA,,,75.182.89.225,123,49,,,131,54,NONLUPUS,LUPUS,primary (NONLUPUS) membranous glomerulopathy,114-122-133-144,49-55-66,LUPUS membranous glomerulopathy,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 22:15:33,,1323869047,7/15/2014 22:14:49,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,123,49,,,131,54,NONLUPUS,LUPUS,(NONLUPUS) membranous glomerulopathy,122-133-144,49-55-66,LUPUS membranous glomerulopathy,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 22:27:35,,1323874569,7/15/2014 22:26:27,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,123,49,,,131,54,NONLUPUS,LUPUS,membranous glomerulopathy,133-144,49-55-66,LUPUS membranous glomerulopathy,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336121,7/15/2014 22:29:15,,1323875466,7/15/2014 22:28:22,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,123,49,,,131,54,NONLUPUS,LUPUS,membranous glomerulopathy,144-133,49-55-66,LUPUS membranous glomerulopathy,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively.",,49,123,49,131,54,-1,RO-cause_of,900168,"Eleven renal biopsy specimens from patients with lupus membranous glomerulopathy (LMGN) and 16 from patients with primary (nonlupus) membranous glomerulopathy (NLMGN) for whom light, electron microscopy and immunofluorescence microscopy, and full clinical data were available were examined quantitatively",nonlupus,lupus
503336122,7/15/2014 21:03:46,,1323840344,7/15/2014 21:03:42,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,50,89,,,55,104,VIRUS,VIRAL INFECTION,principles of modelling VIRUS dynamics to the,26-37-40-50-56-65-68,72-78-81-89-95-106-120-125,"study of chronic VIRAL INFECTION, demonstrating that a","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 21:11:32,,1323843777,7/15/2014 21:11:07,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS,50,89-95,"VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 21:18:34,,1323846612,7/15/2014 21:18:06,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS,50,89-95,"VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 21:21:24,,1323847699,7/15/2014 21:21:08,elite,1,26544151,GBR,,,92.40.117.64,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS,50,89-95,"VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 21:26:08,,1323849839,7/15/2014 21:25:49,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS,50,89-95,"VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 22:02:29,,1323863207,7/15/2014 22:01:07,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS dynamics,50-56,81-89-95,"chronic VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 22:06:48,,1323865137,7/15/2014 22:06:13,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,50,89,,,55,104,VIRUS,VIRAL INFECTION,principles of modelling VIRUS dynamics to the,26-37-40-50-56-65-68,72-78-81-89-95-106-120-125,"study of chronic VIRAL INFECTION, demonstrating that a","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 22:11:17,,1323867258,7/15/2014 22:10:56,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS,50,89-95,"VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 22:13:34,,1323868118,7/15/2014 22:13:14,instagc,1,13763729,USA,,,75.182.89.225,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS,50,89-95,"VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336122,7/15/2014 22:25:29,,1323873571,7/15/2014 22:25:07,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,50,89,,,55,104,VIRUS,VIRAL INFECTION,VIRUS,50,89-95,"VIRAL INFECTION,","We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production.",50,89 95,50,89,55,104,-1,RO-has_causative_agent,903880,"We apply well-established principles of modelling virus dynamics to the study of chronic viral infection, demonstrating that a model which incorporates the distinct contributions of cytotoxic T lymphocytes (CTLs) and antibodies exhibits long periods of quiescence followed by brief bursts of viral production",virus,viral infection
503336123,7/15/2014 21:03:22,,1323840130,7/15/2014 21:03:09,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,TUBERCULOSIS INFECTION,143-156,104,TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:09:26,,1323842851,7/15/2014 21:09:22,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,potential to detect TUBERCULOSIS INFECTION using a single,123-133-136-143-156-166-172-174,77-87-99-104-115-119-123,following stimulation with TUBERCULIN has the potential,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:13:56,,1323844740,7/15/2014 21:13:23,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,to detect TUBERCULOSIS INFECTION using a single blood draw.,133-136-143-156-166-172-174-181-187,87-99-104,stimulation with TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:17:07,,1323846079,7/15/2014 21:16:57,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,TUBERCULOSIS INFECTION,143-156,104,TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:20:22,,1323847325,7/15/2014 21:20:16,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,TUBERCULOSIS INFECTION,143-156,104,TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:21:20,,1323847687,7/15/2014 21:20:55,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,TUBERCULOSIS INFECTION,143-156,104,TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:24:17,,1323849045,7/15/2014 21:23:19,clixsense,1,15189335,GBR,H9,London,188.29.164.11,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,TUBERCULOSIS INFECTION,143-156,104,TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:24:47,,1323849259,7/15/2014 21:24:30,elite,1,26544151,GBR,,,92.40.117.64,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,TUBERCULOSIS INFECTION,143-156,104,TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:32:48,,1323852431,7/15/2014 21:32:31,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,TUBERCULOSIS INFECTION,143-156,104,TUBERCULIN,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336123,7/15/2014 21:38:44,,1323854313,7/15/2014 21:38:35,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,143,104,,,165,114,TUBERCULOSIS INFECTION,TUBERCULIN,potential to detect TUBERCULOSIS INFECTION,123-133-136-143-156,77-87-99-104-115-119-123,following stimulation with TUBERCULIN has the potential,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw.,143 156,104,143,104,165,114,1,RO-may_diagnose,906709,A new test that measures interferon-gamma (IFN-gamma) release in whole blood following stimulation with tuberculin has the potential to detect tuberculosis infection using a single blood draw,tuberculosis infection,tuberculin
503336124,7/15/2014 21:06:30,,1323841575,7/15/2014 21:06:19,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,116,94,,,121,101,MITES,SCABIES,live MITES,111-116,87-94,normal SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 21:12:13,,1323844048,7/15/2014 21:11:56,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,116,94,,,121,101,MITES,SCABIES,live MITES,116-111,94-87,normal SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 21:23:30,,1323848686,7/15/2014 21:23:09,elite,1,26544151,GBR,,,92.40.117.64,116,94,,,121,101,MITES,SCABIES,MITES,116,94,SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 21:32:30,,1323852333,7/15/2014 21:31:22,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,116,94,,,121,101,MITES,SCABIES,MITES,116,94,SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 21:33:59,,1323852780,7/15/2014 21:33:36,elite,1,28276268,USA,MI,Taylor,67.149.247.166,116,94,,,121,101,MITES,SCABIES,MITES,116,94,SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 21:52:26,,1323858772,7/15/2014 21:52:03,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,116,94,,,121,101,MITES,SCABIES,scabies revealed live MITES from dust samples,94-102-111-116-122-127-132,78-84-87-94-102-111-116,cases of normal SCABIES revealed live mites,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 21:56:01,,1323860197,7/15/2014 21:55:29,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,116,94,,,121,101,MITES,SCABIES,MITES,116,94,SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 21:57:14,,1323860685,7/15/2014 21:56:58,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,116,94,,,121,101,MITES,SCABIES,MITES,116,94,SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 22:00:04,,1323862108,7/15/2014 21:59:36,clixsense,1,15189335,GBR,H9,London,188.29.165.113,116,94,,,121,101,MITES,SCABIES,MITES,116,94,SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336124,7/15/2014 22:00:29,,1323862307,7/15/2014 21:58:01,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,116,94,,,121,101,MITES,SCABIES,MITES,116,94,SCABIES,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",116,94,116,94,121,101,-1,RO-has_causative_agent,903877,"? Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",mites,scabies
503336125,7/15/2014 21:15:35,,1323845435,7/15/2014 21:15:10,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,45,75,,,58,83,DENTAL CARIES,FLUORIDE,mechanism of DENTAL CARIES,32-42-45-52,63-67-72-75,the role of FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 21:16:17,,1323845669,7/15/2014 21:16:02,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 21:19:54,,1323847092,7/15/2014 21:19:36,elite,1,26544151,GBR,,,92.40.117.64,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 22:11:08,,1323867199,7/15/2014 22:10:59,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,45,75,,,58,83,DENTAL CARIES,FLUORIDE,probable mechanism of DENTAL CARIES and the role,23-32-42-45-52-59-63-67,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 22:12:37,,1323867829,7/15/2014 22:12:24,instagc,1,13763729,USA,,,75.182.89.225,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 22:18:53,,1323870569,7/15/2014 22:18:33,instagc,1,19636746,USA,NY,Andover,192.182.216.225,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 22:28:20,,1323875004,7/15/2014 22:28:10,clixsense,1,23585686,GBR,H9,London,31.51.221.173,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 22:30:50,,1323876236,7/15/2014 22:30:38,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 22:31:53,,1323876636,7/15/2014 22:31:40,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336125,7/15/2014 22:32:04,,1323876704,7/15/2014 22:31:41,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,45,75,,,58,83,DENTAL CARIES,FLUORIDE,DENTAL CARIES,45-52,75,FLUORIDE,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process.,45 52,75,45,75,58,83,1,RO-may_prevent,907223,This paper reviews the probable mechanism of dental caries and the role of fluoride in the inhibition or reversal of that process,dental caries,fluoride
503336126,7/15/2014 21:03:04,,1323839984,7/15/2014 21:03:02,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,77,141,,,92,145,PREMATURE AGING,HGPS,mutations are the PREMATURE AGING disorders Hutchinson Gilford,59-69-73-77-87-93-103-114,122-131-140-147-151-160,progeria syndrome (HGPS) and atypical Werner's,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 21:07:50,,1323842110,7/15/2014 21:07:47,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,77,141,,,92,145,PREMATURE AGING,HGPS,mutations are the PREMATURE AGING disorders Hutchinson Gilford,59-69-73-77-87-93-103-114,122-131-140-147-151-160,progeria syndrome (HGPS) and atypical Werner's,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 21:09:19,,1323842767,7/15/2014 21:08:46,irazoo,1,10644009,USA,,,166.137.94.104,77,141,,,92,145,PREMATURE AGING,HGPS,PREMATURE AGING disorders,77-87-93,103-114-122-131-140,Hutchinson Gilford progeria syndrome (HGPS),The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 21:22:05,,1323848047,7/15/2014 21:21:48,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,77,141,,,92,145,PREMATURE AGING,HGPS,PREMATURE AGING,77-87,140,(HGPS),The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 21:22:28,,1323848214,7/15/2014 21:22:17,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,77,141,,,92,145,PREMATURE AGING,HGPS,PREMATURE AGING,77-87,140,(HGPS),The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 21:25:20,,1323849509,7/15/2014 21:25:07,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,77,141,,,92,145,PREMATURE AGING,HGPS,PREMATURE AGING,77-87,140,(HGPS),The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 21:26:24,,1323849982,7/15/2014 21:26:05,elite,1,26544151,GBR,,,92.40.117.64,77,141,,,92,145,PREMATURE AGING,HGPS,PREMATURE AGING,77-87,103-114-122-131-140,Hutchinson Gilford progeria syndrome (HGPS),The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 21:54:10,,1323859397,7/15/2014 21:53:47,instagc,1,19636746,USA,NY,Andover,192.182.216.225,77,141,,,92,145,PREMATURE AGING,HGPS,PREMATURE AGING disorders,77-87-93,122-131-140,progeria syndrome (HGPS),The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 22:11:54,,1323867545,7/15/2014 22:11:18,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,77,141,,,92,145,PREMATURE AGING,HGPS,PREMATURE AGING,77-87,140,(HGPS),The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336126,7/15/2014 22:12:12,,1323867650,7/15/2014 22:12:06,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,77,141,,,92,145,PREMATURE AGING,HGPS,mutations are the PREMATURE AGING disorders Hutchinson Gilford,59-69-73-77-87-93-103-114,122-131-140-147-151-160,progeria syndrome (HGPS) and atypical Werner's,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome.,77 87,,77,141,92,145,-1,RO-has_manifestation,906273,The most recently discovered diseases associated with LMNA mutations are the premature aging disorders Hutchinson-Gilford progeria syndrome (HGPS) and atypical Werner's syndrome,premature aging,HGPS
503336127,7/15/2014 21:04:26,,1323840607,7/15/2014 21:04:05,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,Percutaneous aspiration of the GALLBLADDER,13-24-27-31-0,116-120-130-133-139,the diagnosis of ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:04:33,,1323840674,7/15/2014 21:04:31,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,aspiration of the GALLBLADDER was performed for,13-24-27-31-43-47-57,116-120-130-133-139-153-157-161,the diagnosis of ACUTE CHOLECYSTITIS and its complications,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:05:10,,1323840877,7/15/2014 21:04:55,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,Percutaneous aspiration of the GALLBLADDER,0-13-24-27-31,133-139,ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:07:04,,1323841809,7/15/2014 21:06:53,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,aspiration of the GALLBLADDER was performed for,13-24-27-31-43-47-57,116-120-130-133-139-153-157-161,the diagnosis of ACUTE CHOLECYSTITIS and its complications,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:07:32,,1323841953,7/15/2014 21:07:11,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,GALLBLADDER,31,133-139,ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:16:57,,1323846016,7/15/2014 21:16:32,elite,1,26544151,GBR,,,92.40.117.64,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,GALLBLADDER,31,133-139,ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:23:09,,1323848545,7/15/2014 21:23:00,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,GALLBLADDER,31,133-139,ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:23:59,,1323848923,7/15/2014 21:23:45,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,GALLBLADDER,31,133-139,ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:25:50,,1323849699,7/15/2014 21:25:38,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,GALLBLADDER,31,133-139,ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336127,7/15/2014 21:40:17,,1323854786,7/15/2014 21:39:56,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,31,133,,,42,152,GALLBLADDER,ACUTE CHOLECYSTITIS,Percutaneous aspiration of the GALLBLADDER,13-24-27-31-0,133-139,ACUTE CHOLECYSTITIS,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis.",31,133 139,31,133,42,152,1,RO-has_finding_site,905242,"Percutaneous aspiration of the gallbladder was performed for nine hospitalized patients, most commonly to establish the diagnosis of acute cholecystitis and its complications in the critically ill patient or patient with sepsis",gallbladder,acute cholecystitis
503336128,7/15/2014 21:23:56,,1323848899,7/15/2014 21:23:46,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,47,8,,,55,16,HEADACHE,MIGRAINE,form of disabling HEADACHE presenting in headache,29-34-37-47-56-67-70,0-8-17-20-22-37-47-29,Chronic MIGRAINE is a common form disabling headache,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 21:25:26,,1323849557,7/15/2014 21:25:12,elite,1,26544151,GBR,,,92.40.117.64,47,8,,,55,16,HEADACHE,MIGRAINE,HEADACHE,47,8,MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 21:27:06,,1323850275,7/15/2014 21:26:56,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,47,8,,,55,16,HEADACHE,MIGRAINE,HEADACHE,47,8,MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 21:29:04,,1323851181,7/15/2014 21:28:46,elite,1,28276268,USA,MI,Taylor,67.149.247.166,47,8,,,55,16,HEADACHE,MIGRAINE,HEADACHE,47,8,MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 21:32:29,,1323852335,7/15/2014 21:32:14,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,47,8,,,55,16,HEADACHE,MIGRAINE,disabling HEADACHE,37-47,0-8,Chronic MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 22:01:08,,1323862623,7/15/2014 22:00:54,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,47,8,,,55,16,HEADACHE,MIGRAINE,HEADACHE,47,8,MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 22:02:04,,1323863042,7/15/2014 22:01:48,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,47,8,,,55,16,HEADACHE,MIGRAINE,disabling HEADACHE,37-47,0-8,Chronic MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 22:26:46,,1323874250,7/15/2014 22:26:29,clixsense,1,23585686,GBR,H9,London,31.51.221.173,47,8,,,55,16,HEADACHE,MIGRAINE,HEADACHE,47,8-0,Chronic MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 22:28:07,,1323874886,7/15/2014 22:27:51,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,47,8,,,55,16,HEADACHE,MIGRAINE,HEADACHE,47,0-8,Chronic MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336128,7/15/2014 22:29:00,,1323875280,7/15/2014 22:28:51,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,47,8,,,55,16,HEADACHE,MIGRAINE,disabling HEADACHE,37-47,0-8,Chronic MIGRAINE,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice.,47,8,47,8,55,16,1,RO-has_definitional_manifestation,904636,Chronic migraine is a common form of disabling headache presenting in headache subspecialty practice,headache,migraine
503336129,7/15/2014 21:14:02,,1323844807,7/15/2014 21:13:45,irazoo,1,10644009,USA,,,166.137.94.104,72,84,,,80,92,HEADACHE,MIGRAINE,HEADACHE,72,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 21:15:36,,1323845437,7/15/2014 21:15:23,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,72,84,,,80,92,HEADACHE,MIGRAINE,tension type HEADACHE,59-67-72,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 21:20:50,,1323847505,7/15/2014 21:20:31,elite,1,26544151,GBR,,,92.40.117.64,72,84,,,80,92,HEADACHE,MIGRAINE,HEADACHE,72,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 21:26:05,,1323849808,7/15/2014 21:25:51,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,72,84,,,80,92,HEADACHE,MIGRAINE,HEADACHE,72,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 21:31:45,,1323852056,7/15/2014 21:31:35,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,72,84,,,80,92,HEADACHE,MIGRAINE,tension type HEADACHE,59-67-72,84-107,"MIGRAINE, may","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 21:32:55,,1323852452,7/15/2014 21:32:33,elite,1,28276268,USA,MI,Taylor,67.149.247.166,72,84,,,80,92,HEADACHE,MIGRAINE,HEADACHE,72,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 21:52:56,,1323858922,7/15/2014 21:52:32,clixsense,1,26648627,GBR,,,80.189.8.210,72,84,,,80,92,HEADACHE,MIGRAINE,tension type HEADACHE,59-67-72,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 22:08:17,,1323865874,7/15/2014 22:08:09,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,72,84,,,80,92,HEADACHE,MIGRAINE,"usually tension type HEADACHE or migraine, but",51-59-67-72-81-84-94,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 22:12:47,,1323867873,7/15/2014 22:12:32,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,72,84,,,80,92,HEADACHE,MIGRAINE,tension type HEADACHE,59-67-72,84,"MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336129,7/15/2014 22:20:56,,1323871508,7/15/2014 22:20:28,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,72,84,,,80,92,HEADACHE,MIGRAINE,"tension type HEADACHE or migraine,",59-67-72-81-84,59-67-72-81-84,"tension type headache or MIGRAINE,","When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition.",72,84,72,84,80,92,-1,RO-has_definitional_manifestation,904704,"When pregnant women develop headache, the cause is usually tension-type headache or migraine, but headache may be a symptom of a more serious neurologic or medical condition",headache,migraine
503336130,7/15/2014 21:03:12,,1323840054,7/15/2014 21:03:09,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,Riluzole for AMYOTROPHIC LATERAL SCLEROSIS motor neuron,0-9-13-25-33-49-55,0-9-13-25,RILUZOLE for amyotrophic lateral,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:05:30,,1323841001,7/15/2014 21:05:12,irazoo,1,10644009,USA,,,166.137.94.104,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS,13-25-33,0,RILUZOLE,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:09:50,,1323843050,7/15/2014 21:09:31,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS (ALS),13-25-33-43,0,RILUZOLE,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:11:05,,1323843573,7/15/2014 21:10:48,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS,13-25-33,0,RILUZOLE,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:14:03,,1323844808,7/15/2014 21:13:49,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS (ALS),13-25-33-43,0,RILUZOLE,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:16:09,,1323845609,7/15/2014 21:15:54,neodev,1,26596102,GBR,,,128.199.166.81,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS (ALS),13-25-33-43,0-13-43,RILUZOLE amyotrophic (ALS),Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:17:50,,1323846354,7/15/2014 21:17:34,elite,1,26544151,GBR,,,92.40.117.64,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS,13-25-33,0,RILUZOLE,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:20:19,,1323847292,7/15/2014 21:20:03,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS,13-25-33,0-13-25-33,RILUZOLE amyotrophic lateral sclerosis,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:20:37,,1323847415,7/15/2014 21:20:32,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS,13-25-33,0,RILUZOLE,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336130,7/15/2014 21:21:53,,1323847957,7/15/2014 21:21:43,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,13,0,,,42,8,AMYOTROPHIC LATERAL SCLEROSIS,RILUZOLE,AMYOTROPHIC LATERAL SCLEROSIS,13-25-33,0,RILUZOLE,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND.,13 25 33,0,13,0,42,8,1,RO-may_treat,907922,Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND,amyotrophic lateral sclerosis,Riluzole
503336131,7/15/2014 21:02:32,,1323839732,7/15/2014 21:02:14,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"hypertrophic actinic KERATOSIS,",126-139-147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 21:12:44,,1323844289,7/15/2014 21:12:15,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"hypertrophic actinic KERATOSIS,",126-139-147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 21:25:20,,1323849501,7/15/2014 21:24:18,clixsense,1,15189335,GBR,H9,London,188.29.164.11,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"KERATOSIS,",147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 21:37:06,,1323853755,7/15/2014 21:36:43,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"hypertrophic actinic KERATOSIS,",126-139-147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 21:43:20,,1323855797,7/15/2014 21:42:51,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"KERATOSIS,",147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 21:57:54,,1323860992,7/15/2014 21:57:22,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"hypertrophic actinic KERATOSIS,",126-139-147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 22:02:12,,1323863071,7/15/2014 22:01:42,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"KERATOSIS,",147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 22:11:41,,1323867462,7/15/2014 22:11:27,instagc,1,13763729,USA,,,75.182.89.225,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"KERATOSIS,",147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 22:14:14,,1323868402,7/15/2014 22:13:45,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"KERATOSIS,",147,100-110,"VERRUCOUS CARCINOMA,","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336131,7/15/2014 22:29:43,,1323875714,7/15/2014 22:29:21,clixsense,1,23585686,GBR,H9,London,31.51.221.173,147,100,,,156,119,KERATOSIS,VERRUCOUS CARCINOMA,"BCC, hypertrophic actinic KERATOSIS, and common warts.",121-126-139-147-158-162-169,68-85-91-100-110-121-126-139,"keratoacanthoma, Bowen disease, VERRUCOUS CARCINOMA, BCC, hypertrophic actinic","Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts.",147,100 110,147,100,156,119,-1,RO-disease_has_finding,901795,"Differential diagnosis   The differential diagnosis of SCC includes keratoacanthoma, Bowen disease, verrucous carcinoma, BCC, hypertrophic actinic keratosis, and common warts",keratosis,verrucous carcinoma
503336132,7/15/2014 21:03:22,,1323840118,7/15/2014 21:03:09,irazoo,1,10644009,USA,,,166.137.94.104,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES,0,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 21:08:03,,1323842222,7/15/2014 21:07:59,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES associated with acute,0-10-21-26,51-61-64-70,precursor to later MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 21:15:11,,1323845243,7/15/2014 21:14:57,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES,0,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 21:28:44,,1323851030,7/15/2014 21:28:20,elite,1,28276268,USA,MI,Taylor,67.149.247.166,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES,0,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 21:41:13,,1323855076,7/15/2014 21:41:09,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES associated with acute,0-10-21-26,51-61-64-70,precursor to later MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 21:45:41,,1323856571,7/15/2014 21:45:10,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES,0,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 22:11:50,,1323867528,7/15/2014 22:11:41,instagc,1,13763729,USA,,,75.182.89.225,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES,0,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 22:11:53,,1323867543,7/15/2014 22:11:09,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES associated with acute,0-10-21-26,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 22:25:53,,1323873782,7/15/2014 22:25:13,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES,0,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336132,7/15/2014 22:29:19,,1323875493,7/15/2014 22:29:12,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,0,70,,,9,78,HEADACHES,MIGRAINE,HEADACHES,0,70,MIGRAINE.,Headaches associated with acute illnesses may be a precursor to later migraine.,0,70,0,70,9,78,-1,RO-has_definitional_manifestation,904999,Headaches associated with acute illnesses may be a precursor to later migraine,Headaches,migraine
503336133,7/15/2014 21:05:14,,1323840893,7/15/2014 21:04:52,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,127,72,,,141,76,CALCIFICATIONS,DCIS,"branching (casting type) CALCIFICATIONS,",102-112-127-121,72,"DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:07:21,,1323841884,7/15/2014 21:05:57,irazoo,1,10644009,USA,,,166.137.94.104,127,72,,,141,76,CALCIFICATIONS,DCIS,"branching (casting type) CALCIFICATIONS,",102-112-121-127,72,"DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:12:35,,1323844238,7/15/2014 21:12:29,neodev,1,26596102,GBR,,,128.199.166.81,127,72,,,141,76,CALCIFICATIONS,DCIS,"branching (casting type) CALCIFICATIONS, a hallmark of",102-112-121-127-143-145-154,54-57-61-72-78-88-91,"of the continuous DCIS, resulting in linear","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:12:58,,1323844383,7/15/2014 21:12:36,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,127,72,,,141,76,CALCIFICATIONS,DCIS,"branching CALCIFICATIONS,",102-127,72,"DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:19:37,,1323846993,7/15/2014 21:19:17,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,127,72,,,141,76,CALCIFICATIONS,DCIS,"CALCIFICATIONS,",127,61-72,"continuous DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:28:03,,1323850734,7/15/2014 21:27:46,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,127,72,,,141,76,CALCIFICATIONS,DCIS,"branching (casting type) CALCIFICATIONS,",102-112-121-127,61-72,"continuous DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:30:22,,1323851575,7/15/2014 21:29:11,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,127,72,,,141,76,CALCIFICATIONS,DCIS,"CALCIFICATIONS,",127,72,"DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:35:28,,1323853229,7/15/2014 21:35:08,elite,1,28276268,USA,MI,Taylor,67.149.247.166,127,72,,,141,76,CALCIFICATIONS,DCIS,"CALCIFICATIONS,",127,72,"DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:46:30,,1323856823,7/15/2014 21:46:06,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,127,72,,,141,76,CALCIFICATIONS,DCIS,"CALCIFICATIONS,",127,72,"DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336133,7/15/2014 21:51:02,,1323858259,7/15/2014 21:50:20,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,127,72,,,141,76,CALCIFICATIONS,DCIS,"linear and branching (casting type) CALCIFICATIONS,",91-98-102-112-121-127,61-72,"continuous DCIS,","Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms.",127,72,127,72,141,76,-1,RO-disease_may_have_finding,902562,"Multiple calcifications occurred in the necrotic core of the continuous DCIS, resulting in linear and branching (casting type) calcifications, a hallmark of high-grade DCIS on mammograms",calcifications,DCIS
503336134,7/15/2014 21:05:21,,1323840941,7/15/2014 21:05:12,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 21:23:06,,1323848515,7/15/2014 21:22:45,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,"SEIZURE medically intractable epilepsy,",5-83-93-105,50-83-93-105,"GANGLIOGLIOMAS, medically intractable epilepsy,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 21:24:12,,1323848999,7/15/2014 21:23:55,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 21:28:51,,1323851078,7/15/2014 21:28:39,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 21:39:16,,1323854461,7/15/2014 21:39:05,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 21:55:49,,1323860110,7/15/2014 21:55:21,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 21:55:49,,1323860120,7/15/2014 21:55:38,clixsense,1,26648627,GBR,,,80.189.8.210,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 22:26:21,,1323873999,7/15/2014 22:26:00,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 22:27:01,,1323874366,7/15/2014 22:26:47,clixsense,1,23585686,GBR,H9,London,31.51.221.173,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336134,7/15/2014 22:29:57,,1323875810,7/15/2014 22:29:44,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,5,50,,,12,64,SEIZURE,GANGLIOGLIOMAS,SEIZURE,5,50,"GANGLIOGLIOMAS,","Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected.",5,50,5,50,12,64,1,RO-disease_may_have_finding,902773,"Good seizure outcome is expected in patients with gangliogliomas, despite years of medically intractable epilepsy, once the tumor is resected",seizure,gangliogliomas
503336135,7/15/2014 21:04:00,,1323840423,7/15/2014 21:03:45,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,LIVER patients,6-12,21-28-34,"(ACUTE VIRAL HEPATITIS,","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:04:22,,1323840580,7/15/2014 21:03:57,irazoo,1,10644009,USA,,,166.137.94.104,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,LIVER,6,21-28-34,"(ACUTE VIRAL HEPATITIS,","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:06:52,,1323841727,7/15/2014 21:06:45,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,Sixty LIVER patients viral,0-6-12-28,6-12-21-28-34-45-55-61,"liver patients (ACUTE VIRAL HEPATITIS, alcoholic fatty liver","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:15:09,,1323845238,7/15/2014 21:14:30,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,"LIVER (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis),",6-21-28-34-45-55-61-67-71-77,21-28-34-45-55-61-67-71-77,"(ACUTE VIRAL HEPATITIS, alcoholic fatty liver and liver cirrhosis),","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:16:56,,1323846001,7/15/2014 21:16:44,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,LIVER,6,21-28-34,"(ACUTE VIRAL HEPATITIS,","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:22:02,,1323848023,7/15/2014 21:21:54,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,LIVER,6,21-28-34,"(ACUTE VIRAL HEPATITIS,","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:39:30,,1323854503,7/15/2014 21:39:20,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,Sixty LIVER patients viral,0-6-12-28,6-12-21-28-34-45-55-61,"liver patients (ACUTE VIRAL HEPATITIS, alcoholic fatty liver","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:56:10,,1323860254,7/15/2014 21:55:43,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,LIVER,6,21-28-34,"(ACUTE VIRAL HEPATITIS,","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 21:56:44,,1323860475,7/15/2014 21:56:26,clixsense,1,26648627,GBR,,,80.189.8.210,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,LIVER,6,21-28-34,"(ACUTE VIRAL HEPATITIS,","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336135,7/15/2014 22:14:41,,1323868630,7/15/2014 22:14:16,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,6,22,,,11,43,LIVER,ACUTE VIRAL HEPATITIS,LIVER,6,21-28-34,"(ACUTE VIRAL HEPATITIS,","Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls.",6,28 34,6,22,11,43,1,RO-has_finding_site,905028,"Sixty liver patients (acute viral hepatitis, alcoholic fatty liver and liver cirrhosis), without overt renal disease, have been studied and compared to controls",liver,acute viral hepatitis
503336136,7/15/2014 21:07:58,,1323842150,7/15/2014 21:07:52,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,A low TUBERCULOSIS risk differential was,0-2-6-19-24-37,41-51-60-68-79-88-92,similarly observed between TUBERCULIN negative and untreated,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:14:50,,1323845174,7/15/2014 21:14:25,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS risk,6-19,68-79,TUBERCULIN negative,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:15:21,,1323845328,7/15/2014 21:15:04,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,6,68-79,TUBERCULIN negative,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:15:52,,1323845531,7/15/2014 21:15:35,neodev,1,26596102,GBR,,,128.199.166.81,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS tuberculin negative,6-68-79,68-79-92,TUBERCULIN negative untreated,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:22:01,,1323848010,7/15/2014 21:21:29,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,6,68,TUBERCULIN,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:23:00,,1323848475,7/15/2014 21:22:51,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,6,68-78-79,TUBERCULIN - negative,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:53:25,,1323859119,7/15/2014 21:52:57,clixsense,1,26648627,GBR,,,80.189.8.210,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,6,68-79,TUBERCULIN negative,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:57:48,,1323860926,7/15/2014 21:57:35,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,6,68,TUBERCULIN,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 21:58:30,,1323861235,7/15/2014 21:57:50,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,A low TUBERCULOSIS risk,0-2-6-19,68-79,TUBERCULIN negative,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336136,7/15/2014 22:13:49,,1323868220,7/15/2014 22:13:35,instagc,1,13763729,USA,,,75.182.89.225,6,68,,,18,78,TUBERCULOSIS,TUBERCULIN,TUBERCULOSIS,6,68-79,TUBERCULIN negative,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort.,6,68,6,68,18,78,1,RO-may_diagnose,906819,A low tuberculosis risk differential was similarly observed between tuberculin-negative and untreated tuberculin-positive subjects in the historical cohort,tuberculosis,tuberculin
503336137,7/15/2014 21:08:46,,1323842599,7/15/2014 21:08:40,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,in the arthritis JOINTS of patients with,40-43-47-57-64-67-76,64-67-76-81-92-102-110-113,of patients with RHEUMATOID ARTHRITIS results in a,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 21:23:36,,1323848766,7/15/2014 21:23:19,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,JOINTS,57,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 21:24:14,,1323849014,7/15/2014 21:22:14,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,arthritis JOINTS,47-57,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 21:42:18,,1323855484,7/15/2014 21:41:26,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,arthritis JOINTS,47-57,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 21:52:02,,1323858647,7/15/2014 21:51:52,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,in the arthritis JOINTS of patients with rheumatoid arthritis,40-43-47-57-64-67-76-81-92,64-67-76-81-92-102-110-113,of patients with RHEUMATOID ARTHRITIS results in a,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 21:59:48,,1323861965,7/15/2014 21:59:30,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,arthritis JOINTS,47-57,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 22:07:16,,1323865318,7/15/2014 22:07:00,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,JOINTS,57,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 22:10:07,,1323866680,7/15/2014 22:09:51,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,in the arthritis JOINTS of patients with,40-43-47-57-64-67-76,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 22:15:05,,1323868848,7/15/2014 22:14:42,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,JOINTS,57,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336137,7/15/2014 22:17:57,,1323870150,7/15/2014 22:17:39,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,57,81,,,63,101,JOINTS,RHEUMATOID ARTHRITIS,JOINTS,57,81-92,RHEUMATOID ARTHRITIS,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo.,57,81 92,57,81,63,101,1,RO-disease_has_primary_anatomic_site,902088,Intra-articular application of Placenta in the arthritis joints of patients with rheumatoid arthritis results in a significant improvement as compared with placebo,joints,rheumatoid arthritis
503336138,7/15/2014 21:03:39,,1323840307,7/15/2014 21:03:06,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,IF antibody titers to HANTAAN VIRUS,105-114-121-124-132-102,43-55-61-66-72-81,HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS),"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:08:08,,1323842279,7/15/2014 21:07:32,irazoo,1,10644009,USA,,,166.137.94.104,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72,HEMORRHAGIC FEVER WITH RENAL SYNDROME,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:10:03,,1323843146,7/15/2014 21:09:43,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72-81,HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS),"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:16:01,,1323845569,7/15/2014 21:15:38,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72-81,HEMORRHAGIC FEVER WITH RENAL SYNDROME (HFRS),"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:20:22,,1323847321,7/15/2014 21:19:53,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72,HEMORRHAGIC FEVER WITH RENAL SYNDROME,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:25:24,,1323849519,7/15/2014 21:25:14,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,antibody titers to HANTAAN VIRUS than to nephropathia,105-114-121-124-132-138-143-146,24-29-38-43-55-61-66-72-88-95,from patients with HEMORRHAGIC FEVER WITH RENAL SYNDROME having higher,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:25:36,,1323849612,7/15/2014 21:25:22,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72,HEMORRHAGIC FEVER WITH RENAL SYNDROME,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:28:29,,1323850909,7/15/2014 21:28:04,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72,HEMORRHAGIC FEVER WITH RENAL SYNDROME,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 21:58:08,,1323861065,7/15/2014 21:57:49,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72,HEMORRHAGIC FEVER WITH RENAL SYNDROME,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336138,7/15/2014 22:10:46,,1323866980,7/15/2014 22:10:31,instagc,1,13763729,USA,,,75.182.89.225,124,43,,,137,80,HANTAAN VIRUS,HEMORRHAGIC FEVER WITH RENAL SYNDROME,HANTAAN VIRUS,124-132,43-55-61-66-72,HEMORRHAGIC FEVER WITH RENAL SYNDROME,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus.",124 132,43 55 61 66 72,124,43,137,80,1,RO-has_causative_agent,903692,"Convalescent phase sera from patients with hemorrhagic fever with renal syndrome (HFRS) having higher IF antibody titers to Hantaan virus than to nephropathia epidemica (NE) virus were capable of neutralizing Hantaan virus, while sera from patients with higher IF antibody titers to NE virus than Hantaan virus did not contain neutralizing antibody to Hantaan virus",Hantaan virus,hemorrhagic fever with renal syndrome
503336139,7/15/2014 21:08:18,,1323842343,7/15/2014 21:08:11,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IVIG therapy were IDIOPATHIC THROMBOCYTOPENIC PURPURA in six,16-21-29-34-45-62-76-79,0-12-16-21-29-34,Indications for IVIG therapy were idiopathic,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 21:10:26,,1323843331,7/15/2014 21:09:54,neodev,1,26596102,GBR,,,128.199.166.81,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IVIG IDIOPATHIC THROMBOCYTOPENIC PURPURA (ITP),16-34-45-62-70,16-34-45-62-70,IVIG idiopathic thrombocytopenic purpura (ITP),"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 21:19:19,,1323846890,7/15/2014 21:18:57,clixsense,1,15189335,GBR,H9,London,188.29.164.11,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16,IVIG,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 21:22:51,,1323848400,7/15/2014 21:22:37,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16,IVIG,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 21:23:46,,1323848851,7/15/2014 21:23:38,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16-21,IVIG therapy,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 21:25:28,,1323849565,7/15/2014 21:25:12,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16,IVIG,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 21:56:25,,1323860387,7/15/2014 21:56:10,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16,IVIG,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 22:05:24,,1323864464,7/15/2014 22:05:12,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16,IVIG,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 22:12:30,,1323867780,7/15/2014 22:12:16,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16-21,IVIG therapy,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336139,7/15/2014 22:23:46,,1323872837,7/15/2014 22:23:33,prodege,1,12537159,USA,MI,Sterling Heights,68.60.146.55,34,16,,,69,20,IDIOPATHIC THROMBOCYTOPENIC PURPURA,IVIG,IDIOPATHIC THROMBOCYTOPENIC PURPURA,34-45-62,16,IVIG,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID.",34 45 62,16,34,16,69,20,1,RO-may_treat,908158,"Indications for IVIG therapy were idiopathic thrombocytopenic purpura (ITP) in six patients and hypogammaglobulinemia in 7 patients with various hematologic disorders, who were defined immunodeficient (ID",idiopathic thrombocytopenic purpura,IVIG
503336140,7/15/2014 21:08:24,,1323842373,7/15/2014 21:08:18,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"the triad of ASTHMA, allergic rhinitis, and",44-48-54-57-65-74-84,65-74-84-88-95,"allergic rhinitis, and ATOPIC DERMATITIS.","The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 21:14:08,,1323844847,7/15/2014 21:12:53,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA,",57,88-95,ATOPIC DERMATITIS.,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 21:15:40,,1323845451,7/15/2014 21:15:24,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA,",57,88-95,ATOPIC DERMATITIS.,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 21:16:16,,1323845673,7/15/2014 21:15:58,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA, allergic rhinitis,",57-65-74,88-95,ATOPIC DERMATITIS.,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 21:17:14,,1323846116,7/15/2014 21:17:00,elite,1,26544151,GBR,,,92.40.117.64,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA,",57,88-95,ATOPIC DERMATITIS.,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 21:29:06,,1323851210,7/15/2014 21:28:52,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA, allergic rhinitis, atopic dermatitis.",57-65-74-88-95,65-74-88-95-57,"asthma, allergic rhinitis, ATOPIC DERMATITIS.","The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 21:36:12,,1323853504,7/15/2014 21:35:52,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA,",57,88-95,ATOPIC DERMATITIS.,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 21:51:04,,1323858287,7/15/2014 21:49:24,clixsense,1,26648627,GBR,,,80.189.8.210,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA,",57,88-95,ATOPIC DERMATITIS.,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 22:02:27,,1323863199,7/15/2014 22:02:05,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"ASTHMA,",57,88-95,ATOPIC DERMATITIS.,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336140,7/15/2014 22:04:59,,1323864258,7/15/2014 22:04:50,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,57,88,,,63,105,ASTHMA,ATOPIC DERMATITIS,"the triad of ASTHMA, allergic rhinitis, and",44-48-54-57-65-74-84,65-74-84-88-95-57,"asthma, allergic rhinitis, and ATOPIC DERMATITIS.","The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis.",57,88 95,57,88,63,105,-1,RO-has_manifestation,906019,"The atopic diseases of childhood consist of the triad of asthma, allergic rhinitis, and atopic dermatitis",asthma,atopic dermatitis
503336141,7/15/2014 21:04:11,,1323840519,7/15/2014 21:04:01,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION and,54-61-74,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 21:08:53,,1323842624,7/15/2014 21:08:44,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 21:22:13,,1323848105,7/15/2014 21:20:17,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 21:22:57,,1323848451,7/15/2014 21:22:26,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 21:27:36,,1323850496,7/15/2014 21:27:22,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 21:57:37,,1323860868,7/15/2014 21:57:22,clixsense,1,26648627,GBR,,,80.189.8.210,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 22:12:31,,1323867790,7/15/2014 22:12:24,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,who were in ATRIAL FIBRILLATION and receiving warfarin,42-46-51-54-61-74-78-88,61-88-97,fibrillation WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 22:18:14,,1323870309,7/15/2014 22:18:03,instagc,1,19636746,USA,NY,Andover,192.182.216.225,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 22:21:18,,1323871635,7/15/2014 22:20:57,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88-97,WARFARIN anticoagulation.,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336141,7/15/2014 22:21:26,,1323871700,7/15/2014 22:21:12,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,54,88,,,73,96,ATRIAL FIBRILLATION,WARFARIN,ATRIAL FIBRILLATION,54-61,88,WARFARIN,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation.,54 61,88,54,88,73,96,1,RO-may_treat,908209,Thromboembolism did not occur in patients who were in atrial fibrillation and receiving warfarin anticoagulation,atrial fibrillation,warfarin
503336142,7/15/2014 21:04:17,,1323840545,7/15/2014 21:04:09,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,of suppression of HYPERCORTISOLISM with dexamethasone in,106-109-121-124-141-146-160,121-124-141-146-160-163-169,of hypercortisolism with DEXAMETHASONE in doses of,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:08:39,,1323842506,7/15/2014 21:08:32,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,of suppression of HYPERCORTISOLISM with dexamethasone in,106-109-121-124-141-146-160,121-124-141-146-160-163-169,of hypercortisolism with DEXAMETHASONE in doses of,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:08:40,,1323842520,7/15/2014 21:08:22,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,146,DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:10:04,,1323843148,7/15/2014 21:09:49,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,146,DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:12:51,,1323844374,7/15/2014 21:12:31,irazoo,1,10644009,USA,,,166.137.94.104,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,146,DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:17:37,,1323846249,7/15/2014 21:17:22,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,124-141-146,hypercortisolism with DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:24:55,,1323849322,7/15/2014 21:24:23,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,146,DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:29:11,,1323851238,7/15/2014 21:28:30,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,146,DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:44:09,,1323856038,7/15/2014 21:43:36,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,146,DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336142,7/15/2014 21:57:33,,1323860847,7/15/2014 21:57:15,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,124,146,,,140,159,HYPERCORTISOLISM,DEXAMETHASONE,HYPERCORTISOLISM,124,146,DEXAMETHASONE,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol.",124,146,124,146,140,159,1,RO-may_diagnose,906846,"A 49-year-old man with classic manifestations of Cushing's syndrome had undetectable levels of ACTH, lack of suppression of hypercortisolism with dexamethasone in doses of 2, 8, or 16 mg per day, bilaterally enlarged adrenal glands on MRI, and bilateral adrenal uptake of iodocholesterol",hypercortisolism,dexamethasone
503336143,7/15/2014 21:03:08,,1323840001,7/15/2014 21:02:57,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP,62-71,86,HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:05:55,,1323841270,7/15/2014 21:05:31,irazoo,1,10644009,USA,,,166.137.94.104,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP,62-71,86,HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:08:36,,1323842480,7/15/2014 21:07:50,neodev,1,26596102,GBR,,,128.199.166.81,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP hypertension,62-71-86,86-71,BP HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:08:59,,1323842639,7/15/2014 21:08:55,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,62,86,,,73,98,ELEVATED BP,HYPERTENSION,both associated with ELEVATED BP and risk of,41-46-57-62-71-74-78-83,74-78-83-86-99-102-105,and risk of HYPERTENSION in an older,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:23:17,,1323848601,7/15/2014 21:22:54,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP,62-71,86,HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:29:46,,1323851425,7/15/2014 21:29:28,elite,1,28276268,USA,MI,Taylor,67.149.247.166,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP,62-71,86,HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:30:52,,1323851713,7/15/2014 21:30:41,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP,62-71,86,HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:35:58,,1323853421,7/15/2014 21:35:43,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP,62-71,86,HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:38:24,,1323854175,7/15/2014 21:38:14,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP and risk of,62-71-74-78-83,86-99-102-105,HYPERTENSION in an older,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336143,7/15/2014 21:47:45,,1323857264,7/15/2014 21:47:11,clixsense,1,15189335,GBR,H9,London,188.29.165.86,62,86,,,73,98,ELEVATED BP,HYPERTENSION,ELEVATED BP,62-71,86,HYPERTENSION,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population.,62 71,86,62,86,73,98,-1,RO-has_definitional_manifestation,904720,Alcohol sensitivity and alcohol use were both associated with elevated BP and risk of hypertension in an older Chinese population,elevated BP,hypertension
503336144,7/15/2014 21:16:35,,1323845837,7/15/2014 21:16:12,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,0-4-10-19-24,All TRANS RETINOIC ACID (ATRA),All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 21:19:55,,1323847100,7/15/2014 21:19:29,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,0-4-10-19-24,All TRANS RETINOIC ACID (ATRA),All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 21:23:38,,1323848782,7/15/2014 21:23:31,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,the treatment of ACUTE PROMYELOCYTIC LEUKEMIA (APL.,57-61-71-74-80-94-103,0-4-10-19-31-34,All TRANS RETINOIC ACID is the,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 21:24:52,,1323849304,7/15/2014 21:24:37,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,4-10-19-74-80-94-103,TRANS RETINOIC ACID acute promyelocytic leukemia (APL.,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 21:42:31,,1323855555,7/15/2014 21:42:12,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,4-10-19,TRANS RETINOIC ACID,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 22:11:10,,1323867220,7/15/2014 22:11:01,instagc,1,13763729,USA,,,75.182.89.225,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,4-10-19,TRANS RETINOIC ACID,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 22:11:26,,1323867366,7/15/2014 22:10:50,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,4-10-19-0,All TRANS RETINOIC ACID,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 22:29:20,,1323875508,7/15/2014 22:29:11,clixsense,1,23585686,GBR,H9,London,31.51.221.173,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,4-10-19-24,TRANS RETINOIC ACID (ATRA),All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 22:31:02,,1323876288,7/15/2014 22:30:51,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,0-3-4-10-19,All - TRANS RETINOIC ACID,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336144,7/15/2014 22:31:11,,1323876335,7/15/2014 22:31:03,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,74,4,,,107,23,ACUTE PROMYELOCYTIC LEUKEMIA (APL,TRANS RETINOIC ACID,ACUTE PROMYELOCYTIC LEUKEMIA (APL.,74-80-94-103,0-4-10-19-24,All TRANS RETINOIC ACID (ATRA),All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL.,74 80 94 103,4 10 19,74,4,107,23,1,RO-may_treat,908323,All-trans retinoic acid (ATRA) is the drug of choice for the treatment of acute promyelocytic leukemia (APL,acute promyelocytic leukemia (APL,trans retinoic acid
503336145,7/15/2014 21:03:53,,1323840399,7/15/2014 21:03:25,irazoo,1,10644009,USA,,,166.137.94.104,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,PAPULES,165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 21:15:16,,1323845298,7/15/2014 21:14:52,neodev,1,26596102,GBR,,,128.199.166.81,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,PAPULES histologic findings malignant lymphoma.,165-196-207-230-240,44-67-80,"histologic LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 21:18:44,,1323846680,7/15/2014 21:18:30,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,self healing PAPULES,152-157-165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 21:21:48,,1323847909,7/15/2014 21:21:29,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,"lymphomatoid papulosis, PAPULES",67-80-165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 21:38:49,,1323854325,7/15/2014 21:38:45,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,of self healing PAPULES and small nodules,149-152-157-165-173-177-183,44-55-64-67-80-91-93-103,"histologic features of LYMPHOMATOID PAPULOSIS, a cutaneous disorder","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 21:43:43,,1323855932,7/15/2014 21:43:21,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,PAPULES,165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 21:53:40,,1323859205,7/15/2014 21:53:11,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,self healing PAPULES,152-157-165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 22:00:31,,1323862312,7/15/2014 22:00:18,clixsense,1,26648627,GBR,,,80.189.8.210,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,self healing PAPULES,152-157-165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 22:01:25,,1323862736,7/15/2014 22:01:08,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,PAPULES,165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336145,7/15/2014 22:15:28,,1323869015,7/15/2014 22:15:13,instagc,1,13763729,USA,,,75.182.89.225,165,67,,,172,89,PAPULES,LYMPHOMATOID PAPULOSIS,PAPULES,165,67-80,"LYMPHOMATOID PAPULOSIS,","In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma.",165,67 80,165,67,172,89,1,RO-disease_may_have_finding,902774,"In this review, we discuss the clinical and histologic features of lymphomatoid papulosis, a cutaneous disorder characterized by recurrent eruptions of self-healing papules and small nodules with histologic findings suggestive of malignant lymphoma",papules,lymphomatoid papulosis
503336146,7/15/2014 21:08:10,,1323842287,7/15/2014 21:08:05,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"carcinomatous and a SARCOMATOUS COMPONENT, but differs from",59-73-77-79-91-102-106-114,114-119-125-128-133-136-142,from cases of MMMT in women in,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 21:23:18,,1323848579,7/15/2014 21:22:55,clixsense,1,15189335,GBR,H9,London,188.29.164.11,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 21:26:03,,1323849794,7/15/2014 21:25:46,elite,1,26544151,GBR,,,92.40.117.64,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 21:27:11,,1323850305,7/15/2014 21:26:51,elite,1,28276268,USA,MI,Taylor,67.149.247.166,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 21:28:12,,1323850801,7/15/2014 21:27:56,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 21:32:14,,1323852248,7/15/2014 21:30:23,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 21:42:11,,1323855412,7/15/2014 21:41:51,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 21:59:21,,1323861701,7/15/2014 21:59:08,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 22:22:09,,1323872008,7/15/2014 22:21:53,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336146,7/15/2014 22:30:08,,1323875858,7/15/2014 22:29:44,clixsense,1,23585686,GBR,H9,London,31.51.221.173,79,128,,,100,132,SARCOMATOUS COMPONENT,MMMT,"SARCOMATOUS COMPONENT,",79-91,128,MMMT,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized.",79 91,128,79,128,100,132,1,RO-disease_has_finding,901872,"This case fulfills all the criteria of an MMMT in having a carcinomatous and a sarcomatous component, but differs from cases of MMMT in women in that the sarcomatous component had decidualized",sarcomatous component,MMMT
503336147,7/15/2014 21:07:09,,1323841826,7/15/2014 21:06:53,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,12,29-42,HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:10:53,,1323843524,7/15/2014 21:10:42,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,Severe HYPERTENSION and Hypertensive Crisis,5-12-25-29-42,5-12-25-29-42,Severe Hypertension and HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:12:29,,1323844194,7/15/2014 21:12:12,irazoo,1,10644009,USA,,,166.137.94.104,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,12,29-42,HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:12:30,,1323844198,7/15/2014 21:12:08,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,Severe HYPERTENSION and Hypertensive Crisis,5-12-25-29-42,5-12-25-29-42,Severe Hypertension and HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:13:55,,1323844739,7/15/2014 21:13:28,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,12,29-42,HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:21:47,,1323847908,7/15/2014 21:21:33,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,12,29-42,HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:30:30,,1323851601,7/15/2014 21:30:11,elite,1,28276268,USA,MI,Taylor,67.149.247.166,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,12,29-42,HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:40:10,,1323854763,7/15/2014 21:40:06,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,333 Severe HYPERTENSION and Hypertensive Crisis,0-5-12-25-29-42,5-12-25-29-42-60-63-74,Severe Hypertension and HYPERTENSIVE CRISIS IV Injection Children,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:41:53,,1323855283,7/15/2014 21:41:11,clixsense,1,15189335,GBR,H9,London,188.29.165.86,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,12,29-42,HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336147,7/15/2014 21:47:16,,1323857082,7/15/2014 21:46:53,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,12,29,,,24,48,HYPERTENSION,HYPERTENSIVE CRISIS,HYPERTENSION,12,29-42,HYPERTENSIVE CRISIS,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose.,12,29 42,12,29,24,48,-1,RO-disease_has_finding,901613,333  Severe Hypertension and Hypertensive Crisis   +  >     IV Injection  Children 1-17 years of age: Maximum 40 mg per dose,Hypertension,Hypertensive Crisis
503336148,7/15/2014 21:09:14,,1323842734,7/15/2014 21:09:09,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,AI in the CEREBELLUM in patients with,70-73-76-80-91-94-103,0-4-15-18-29-36-40-54,The laterality of CEREBELLAR ATAXIA was significantly correlated,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 21:27:44,,1323850557,7/15/2014 21:27:21,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,CEREBELLUM,80,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 21:41:10,,1323855057,7/15/2014 21:38:47,clixsense,1,15189335,GBR,H9,London,188.29.165.86,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,CEREBELLUM,80,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 21:52:39,,1323858832,7/15/2014 21:52:26,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,AI in the CEREBELLUM in patients with sOPCA.,70-73-76-80-91-94-103-108,0-4-15-18-29-36-40-54-108-70,The laterality of CEREBELLAR ATAXIA was significantly correlated AI sOPCA.,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 21:53:11,,1323859023,7/15/2014 21:52:32,instagc,1,19636746,USA,NY,Andover,192.182.216.225,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,CEREBELLUM,80,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 22:10:51,,1323867054,7/15/2014 22:10:41,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,AI in the CEREBELLUM in patients with,70-73-76-80-91-94-103,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 22:10:54,,1323867099,7/15/2014 22:10:23,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,CEREBELLUM,80,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 22:22:25,,1323872148,7/15/2014 22:22:04,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,CEREBELLUM,80,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 22:23:11,,1323872564,7/15/2014 22:22:55,prodege,1,12537159,USA,MI,Sterling Heights,68.60.146.55,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,CEREBELLUM,80,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336148,7/15/2014 22:30:34,,1323876074,7/15/2014 22:30:22,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,80,18,,,90,35,CEREBELLUM,CEREBELLAR ATAXIA,CEREBELLUM,80,18-29,CEREBELLAR ATAXIA,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA.,80,18 29,80,18,90,35,1,RO-has_finding_site,905449,The laterality of cerebellar ataxia was significantly correlated with AI in the cerebellum in patients with sOPCA,cerebellum,cerebellar ataxia
503336149,7/15/2014 21:07:52,,1323842136,7/15/2014 21:07:27,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,89,52,,,93,59,IDDM,INSULIN,insulin - dependent diabetes mellitus (IDDM),52-60-70-79-88-59,52-60-70-79-88,INSULIN dependent diabetes mellitus (IDDM),LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 21:08:44,,1323842577,7/15/2014 21:08:10,irazoo,1,10644009,USA,,,166.137.94.104,89,52,,,93,59,IDDM,INSULIN,insulin dependent diabetes mellitus (IDDM),52-60-70-79-88,52-60-70-79-88,INSULIN dependent diabetes mellitus (IDDM),LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 21:10:06,,1323843166,7/15/2014 21:10:00,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,89,52,,,93,59,IDDM,INSULIN,diabetes mellitus (IDDM) as opposed to,70-79-88-95-98-106,34-38-47-52-60-70-79,238 patients with INSULIN dependent diabetes mellitus,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 21:12:25,,1323844146,7/15/2014 21:12:21,neodev,1,26596102,GBR,,,128.199.166.81,89,52,,,93,59,IDDM,INSULIN,diabetes mellitus (IDDM) as opposed to,70-79-88-95-98-106,34-38-47-52-60-70-79,238 patients with INSULIN dependent diabetes mellitus,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 21:18:04,,1323846425,7/15/2014 21:17:53,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,89,52,,,93,59,IDDM,INSULIN,diabetes mellitus (IDDM) as,70-79-88-95,52-60-70-79-88,INSULIN dependent diabetes mellitus (IDDM),LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 21:19:47,,1323847057,7/15/2014 21:19:37,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,89,52,,,93,59,IDDM,INSULIN,diabetes mellitus,70-79,52,INSULIN,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 21:22:20,,1323848161,7/15/2014 21:22:06,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,89,52,,,93,59,IDDM,INSULIN,(IDDM),88,52,INSULIN,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 22:00:27,,1323862295,7/15/2014 22:00:08,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,89,52,,,93,59,IDDM,INSULIN,diabetes mellitus (IDDM),70-79-88,52-60-70-79-88,INSULIN dependent diabetes mellitus (IDDM),LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 22:18:33,,1323870460,7/15/2014 22:18:14,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,89,52,,,93,59,IDDM,INSULIN,diabetes mellitus,70-79,52,INSULIN,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336149,7/15/2014 22:23:26,,1323872675,7/15/2014 22:23:11,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,89,52,,,93,59,IDDM,INSULIN,insulin dependent diabetes mellitus (IDDM),52-60-70-79-88,52-60-70-79-88,INSULIN dependent diabetes mellitus (IDDM),LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM.,,52,89,52,93,59,1,RO-may_treat,908143,LJM was noted in 131 (55%) of the 238 patients with insulin-dependent diabetes mellitus (IDDM) as opposed to 31 of the 41 patients (76%) with non-insulin-dependent diabetes mellitus (NIDDM,IDDM,insulin
503336150,7/15/2014 21:09:17,,1323842751,7/15/2014 21:08:52,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,immunosuppressive MEDICATIONS,147-165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:11:58,,1323843976,7/15/2014 21:11:52,neodev,1,26596102,GBR,,,128.199.166.81,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,granulomatosis or immunosuppressive MEDICATIONS An ophthalmologist for,129-144-147-165-179-182-198,225-228-236-240-245-250-259-264-267,"to monitor for DRUG SIDE EFFECTS, such as cataracts","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:13:10,,1323844435,7/15/2014 21:11:59,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,MEDICATIONS,165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:17:56,,1323846365,7/15/2014 21:17:32,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,immunosuppressive MEDICATIONS,147-165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:21:08,,1323847598,7/15/2014 21:20:55,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,immunosuppressive MEDICATIONS,147-165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:21:17,,1323847662,7/15/2014 21:21:01,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,MEDICATIONS,165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:25:10,,1323849439,7/15/2014 21:24:48,elite,1,26544151,GBR,,,92.40.117.64,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,MEDICATIONS,165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:25:18,,1323849499,7/15/2014 21:24:54,elite,1,28276268,USA,MI,Taylor,67.149.247.166,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,MEDICATIONS,165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:27:04,,1323850267,7/15/2014 21:26:30,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,immunosuppressive MEDICATIONS,147-165,240-245-250,"DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336150,7/15/2014 21:28:50,,1323851076,7/15/2014 21:28:28,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,165,240,,,176,257,MEDICATIONS,DRUG SIDE EFFECTS,Wegener's granulomatosis MEDICATIONS,119-129-165,119-129-240-245-250,"Wegener's granulomatosis DRUG SIDE EFFECTS,","? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end.",165,240 245 250,165,240,176,257,-1,RO-has_causative_agent,903594,"? An infectious disease specialist for management of prophylactic antibiotic therapy and concomitant infections due to Wegener's granulomatosis or immunosuppressive medications ? An ophthalmologist for ocular involvement and to monitor for drug side effects, such as cataracts from prednisone ? A neurologist for management of new neurologic complications ? Physical and occupational therapists to improve strength and function in patients with vasculitis and neurologic complications  Rationale: ? Organ-specific specialists in fields such as otolaryngology, pulmonology, dermatology, neurology, and nephrology should be consulted depending on the nature and severity of end",medications,drug side effects
503336151,7/15/2014 21:06:57,,1323841776,7/15/2014 21:06:43,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,96-105-118-90,right parietal PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:09:53,,1323843077,7/15/2014 21:09:47,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,an history of SEIZURES because of right,56-59-67-70-79-87-90,87-90-96-105-118,of right parietal PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:11:29,,1323843774,7/15/2014 21:11:08,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,96-105-118-90,right parietal PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:12:14,,1323844062,7/15/2014 21:11:48,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,105-118,PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:18:08,,1323846471,7/15/2014 21:17:52,elite,1,26544151,GBR,,,92.40.117.64,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,105-118,PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:40:19,,1323854791,7/15/2014 21:40:17,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,an history of SEIZURES because of right,56-59-67-70-79-87-90,87-90-96-105-118,of right parietal PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:49:31,,1323857759,7/15/2014 21:49:10,clixsense,1,15189335,GBR,H9,London,188.29.165.86,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,105-118,PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:58:52,,1323861508,7/15/2014 21:58:36,clixsense,1,26648627,GBR,,,80.189.8.210,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,90-96-105-118,right parietal PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:59:29,,1323861758,7/15/2014 21:59:04,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,90-96-105-118,right parietal PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336151,7/15/2014 21:59:29,,1323861767,7/15/2014 21:59:22,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,70,105,,,78,128,SEIZURES,PARASAGITTAL MENINGIOMA,SEIZURES,70,105-118,PARASAGITTAL MENINGIOMA.,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma.,70,105 118,70,105,78,128,1,RO-disease_may_have_finding,902637,The authors describe the case of a 58-year-old man with an history of seizures because of right parietal parasagittal meningioma,seizures,parasagittal meningioma
503336152,7/15/2014 21:02:51,,1323839920,7/15/2014 21:02:49,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,mechanism of the BRONCHIAL HYPERREACTIVITY in patients with,121-131-134-138-148-164-167-176,75-85-94-99-113-117-121,"bronchial response with METHACHOLINE, and the mechanism","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 21:08:30,,1323842438,7/15/2014 21:08:25,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,mechanism of the BRONCHIAL HYPERREACTIVITY in patients with,121-131-134-138-148-164-167-176,75-85-94-99-113-117-121,"bronchial response with METHACHOLINE, and the mechanism","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 21:31:34,,1323852023,7/15/2014 21:31:23,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,138-148,99,"METHACHOLINE,","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 21:34:18,,1323852870,7/15/2014 21:34:00,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,138-148,75-85-94-99,"bronchial response with METHACHOLINE,","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 21:41:21,,1323855114,7/15/2014 21:41:17,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,mechanism of the BRONCHIAL HYPERREACTIVITY in patients with,121-131-134-138-148-164-167-176,75-85-94-99-113-117-121,"bronchial response with METHACHOLINE, and the mechanism","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 22:17:00,,1323869720,7/15/2014 22:16:18,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,mechanism of the BRONCHIAL HYPERREACTIVITY in patients with,121-131-134-138-148-164-167-176,75-85-94-99-113-117-121-138-148,"bronchial response with METHACHOLINE, and the mechanism bronchial hyperreactivity","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 22:20:14,,1323871185,7/15/2014 22:19:55,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,138-148,99,"METHACHOLINE,","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 22:28:50,,1323875206,7/15/2014 22:28:37,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,138-148,75-85-94-99,"bronchial response with METHACHOLINE,","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 22:31:30,,1323876466,7/15/2014 22:31:11,clixsense,1,23585686,GBR,H9,London,31.51.221.173,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,138-148,99,"METHACHOLINE,","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336152,7/15/2014 22:31:31,,1323876470,7/15/2014 22:31:15,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,138,99,,,163,111,BRONCHIAL HYPERREACTIVITY,METHACHOLINE,BRONCHIAL HYPERREACTIVITY,138-148,99,"METHACHOLINE,","We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors.",138 148,99,138,99,163,111,1,RO-may_diagnose,906549,"We found that active pulmonary tuberculosis would increase the nonspecific bronchial response with methacholine, and the mechanism of the bronchial hyperreactivity in patients with active pulmonary tuberculosis may not be related to an immunologic mechanism but may be related to the stimulating receptors",bronchial hyperreactivity,methacholine
503336153,7/15/2014 21:10:15,,1323843252,7/15/2014 21:10:03,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 21:15:57,,1323845560,7/15/2014 21:15:37,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 21:27:51,,1323850610,7/15/2014 21:27:27,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 21:30:54,,1323851723,7/15/2014 21:30:41,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 21:40:16,,1323854789,7/15/2014 21:40:14,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,of patients with ANGINA PECTORIS.,145-148-157-162-169,103-108-113-116-128-131-135,with that of PROPRANOLOL in the treatment,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 21:42:50,,1323855618,7/15/2014 21:42:22,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 21:57:21,,1323860743,7/15/2014 21:57:05,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 22:14:38,,1323868608,7/15/2014 22:14:24,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 22:14:40,,1323868612,7/15/2014 22:14:28,instagc,1,13763729,USA,,,75.182.89.225,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336153,7/15/2014 22:18:58,,1323870603,7/15/2014 22:18:44,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,162,116,,,177,127,ANGINA PECTORIS,PROPRANOLOL,ANGINA PECTORIS.,162-169,116,PROPRANOLOL,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris.,162 169,116,162,116,177,127,1,RO-may_treat,907967,3 These results indicate that oxyfedrine is a safe and well-tolerated drug with an efficacy comparable with that of propranolol in the treatment of patients with angina pectoris,angina pectoris,propranolol
503336154,7/15/2014 21:05:43,,1323841160,7/15/2014 21:05:32,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,44-56,9-11,L DOPA,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 21:13:27,,1323844540,7/15/2014 21:13:11,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,44-56,9-11,L DOPA,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 21:16:58,,1323846017,7/15/2014 21:16:36,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,"PARKINSON'S DISEASE (PD),",44-56-64,9-11,L DOPA,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 21:16:59,,1323846019,7/15/2014 21:16:40,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,"treatment of PARKINSON'S DISEASE (PD),",31-41-44-56-64,4-9-11-16-19,drug L DOPA is used,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 21:23:08,,1323848541,7/15/2014 21:22:49,elite,1,26544151,GBR,,,92.40.117.64,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,44-56,9-11-10,L - DOPA,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 21:40:36,,1323854851,7/15/2014 21:40:33,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,the treatment of PARKINSON'S DISEASE and patients,27-31-41-44-56-70-74,0-4-9-11-16-19-24,The drug L DOPA is used in,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 22:01:41,,1323862883,7/15/2014 22:01:26,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,44-56,9-11,L DOPA,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 22:06:12,,1323864808,7/15/2014 22:05:42,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,"the treatment of PARKINSON'S DISEASE (PD), and patients",27-31-41-44-56-70-74-64,0-4-9-11-16-19-24,The drug L DOPA is used in,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 22:09:45,,1323866510,7/15/2014 22:09:32,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,44-56,9-11,L DOPA,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336154,7/15/2014 22:13:13,,1323868004,7/15/2014 22:12:56,instagc,1,13763729,USA,,,75.182.89.225,44,9,,,63,15,PARKINSON'S DISEASE,L-DOPA,PARKINSON'S DISEASE,44-56,9-11,L DOPA,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa.",44 56,9 11,44,9,63,15,1,RO-may_treat,908159,"The drug L-Dopa is used in the treatment of Parkinson's disease (PD), and patients often experience fluctuations in performance after a period of time taking L-Dopa",Parkinson's disease,L-Dopa
503336155,7/15/2014 21:05:41,,1323841154,7/15/2014 21:04:53,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,39-50-54,selegiline and LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 21:08:55,,1323842637,7/15/2014 21:08:32,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 21:19:51,,1323847079,7/15/2014 21:19:29,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 21:33:17,,1323852615,7/15/2014 21:32:57,elite,1,28276268,USA,MI,Taylor,67.149.247.166,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 21:42:51,,1323855624,7/15/2014 21:42:32,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 21:43:28,,1323855846,7/15/2014 21:42:55,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 21:54:27,,1323859542,7/15/2014 21:54:10,instagc,1,19636746,USA,NY,Andover,192.182.216.225,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 22:04:04,,1323863850,7/15/2014 22:03:38,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 22:10:12,,1323866715,7/15/2014 22:10:00,instagc,1,13763729,USA,,,75.182.89.225,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336155,7/15/2014 22:10:48,,1323867023,7/15/2014 22:10:36,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,66,54,,,85,62,PARKINSON'S DISEASE,LEVODOPA,PARKINSON'S DISEASE.,66-78,54,LEVODOPA,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease.,66 78,54,66,54,85,62,1,RO-may_treat,907899,Lieberman A. Long-term experience with selegiline and levodopa in Parkinson's disease,Parkinson's disease,levodopa
503336156,7/15/2014 21:02:56,,1323839947,7/15/2014 21:02:53,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,"HT) systems in NICOTINE reward, withdrawal and",83-87-95-98-107-115-126,0-7-14-17-26-37-46-58,Animal models of NICOTINE WITHDRAWAL indicate involvement of,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:09:04,,1323842649,7/15/2014 21:08:38,neodev,1,26596102,GBR,,,128.199.166.81,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,(5 HT) NICOTINE,80-83-98,17-26-80-83,NICOTINE WITHDRAWAL (5 HT),"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:13:54,,1323844719,7/15/2014 21:13:28,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,NICOTINE,98,17-26,NICOTINE WITHDRAWAL,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:21:36,,1323847789,7/15/2014 21:21:16,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,(5 HT) systems NICOTINE and,83-87-98-126-80,17-26-58,NICOTINE WITHDRAWAL of,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:23:49,,1323848870,7/15/2014 21:23:37,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,NICOTINE,98,17-26,NICOTINE WITHDRAWAL,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:24:42,,1323849205,7/15/2014 21:24:27,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,NICOTINE,98,17-26,NICOTINE WITHDRAWAL,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:26:29,,1323850018,7/15/2014 21:26:07,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,nicotine withdrawal NICOTINE,17-98-26,17-26,NICOTINE WITHDRAWAL,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:35:32,,1323853249,7/15/2014 21:35:11,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,"NICOTINE reward,",98-107,17-26,NICOTINE WITHDRAWAL,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:38:12,,1323854118,7/15/2014 21:37:40,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,NICOTINE,98,17-26,NICOTINE WITHDRAWAL,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336156,7/15/2014 21:58:13,,1323861117,7/15/2014 21:57:52,clixsense,1,26648627,GBR,,,80.189.8.210,98,17,,,106,36,NICOTINE,NICOTINE WITHDRAWAL,"NICOTINE reward,",98-107,17-26,NICOTINE WITHDRAWAL,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving.",98,17 26,98,17,106,36,-1,RO-has_causative_agent,903555,"Animal models of nicotine withdrawal indicate involvement of striatal serotonin (5-HT) systems in nicotine reward, withdrawal and craving",nicotine,nicotine withdrawal
503336157,7/15/2014 21:02:48,,1323839895,7/15/2014 21:02:43,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,of temporarily relieving BLEPHAROSPASM.,79-82-94-104,0-10-15-20-22-32-38-46-49,Treatment with TYPE A BOTULINUM TOXIN appears to be,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 21:06:00,,1323841299,7/15/2014 21:05:50,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 21:18:33,,1323846595,7/15/2014 21:18:09,clixsense,1,15189335,GBR,H9,London,188.29.164.11,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 21:20:30,,1323847360,7/15/2014 21:20:14,elite,1,26544151,GBR,,,92.40.117.64,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 21:41:21,,1323855118,7/15/2014 21:39:56,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 21:46:05,,1323856733,7/15/2014 21:45:47,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 21:47:53,,1323857319,7/15/2014 21:45:57,instagc,1,19636746,USA,NY,Andover,192.182.216.225,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 22:00:54,,1323862521,7/15/2014 22:00:05,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 22:04:11,,1323863916,7/15/2014 22:03:56,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,botulinum toxin of temporarily relieving BLEPHAROSPASM.,22-79-82-94-104-32,0-10-15-20-22-32-38-46-49-94-104,Treatment with TYPE A BOTULINUM TOXIN appears to be relieving blepharospasm.,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336157,7/15/2014 22:29:10,,1323875411,7/15/2014 22:28:57,clixsense,1,23585686,GBR,H9,London,31.51.221.173,104,15,,,117,37,BLEPHAROSPASM,TYPE A BOTULINUM TOXIN,BLEPHAROSPASM.,104,15-20-22-32,TYPE A BOTULINUM TOXIN,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm.,104,15 20 22 32,104,15,117,37,1,RO-may_treat,908035,Treatment with type A botulinum toxin appears to be a safe and effective means of temporarily relieving blepharospasm,blepharospasm,type A botulinum toxin
503336158,7/15/2014 21:04:25,,1323840618,7/15/2014 21:04:22,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,in treatment of HYPERTENSION.,25-28-38-41,0-10-14-25-28-38,Aldactone and ACEBUTOLOL in treatment of,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 21:07:31,,1323841947,7/15/2014 21:07:20,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,of HYPERTENSION.,38-41,14,ACEBUTOLOL,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 21:24:14,,1323849018,7/15/2014 21:23:51,bitcoinget,1,24792414,USA,,,166.181.81.170,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,HYPERTENSION.,41,14,ACEBUTOLOL,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 21:24:28,,1323849113,7/15/2014 21:24:13,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,HYPERTENSION.,41,14,ACEBUTOLOL,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 21:25:26,,1323849555,7/15/2014 21:25:15,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,HYPERTENSION.,41,14-41,ACEBUTOLOL hypertension.,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 21:40:33,,1323854831,7/15/2014 21:40:30,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,in treatment of HYPERTENSION.,25-28-38-41,0-10-14-25-28-38,Aldactone and ACEBUTOLOL in treatment of,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 21:53:22,,1323859113,7/15/2014 21:52:53,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,Aldactone acebutolol HYPERTENSION.,14-41-0,0-10-14,Aldactone and ACEBUTOLOL,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 22:15:57,,1323869253,7/15/2014 22:15:44,instagc,1,13763729,USA,,,75.182.89.225,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,HYPERTENSION.,41,14,ACEBUTOLOL,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 22:16:13,,1323869364,7/15/2014 22:15:54,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,HYPERTENSION.,41,14,ACEBUTOLOL,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336158,7/15/2014 22:28:31,,1323875089,7/15/2014 22:28:21,clixsense,1,23585686,GBR,H9,London,31.51.221.173,41,14,,,53,24,HYPERTENSION,ACEBUTOLOL,HYPERTENSION.,41,14,ACEBUTOLOL,Aldactone and acebutolol in treatment of hypertension.,41,14,41,14,53,24,1,RO-may_treat,907499,Aldactone and acebutolol in treatment of hypertension,hypertension,acebutolol
503336159,7/15/2014 21:01:47,,1323839338,7/15/2014 21:01:14,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 21:10:05,,1323843169,7/15/2014 21:09:53,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 21:12:52,,1323844356,7/15/2014 21:12:28,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 21:17:27,,1323846177,7/15/2014 21:17:00,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,causes of HYPERTENSION,39-46-49,26-39-49-62-67-70-87-91-97-46,identifiable causes of hypertension such as PHEOCHROMOCYTOMA and renal disease,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 21:19:46,,1323847042,7/15/2014 21:19:09,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 21:20:15,,1323847278,7/15/2014 21:18:16,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 21:27:38,,1323850504,7/15/2014 21:27:17,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 22:22:03,,1323871956,7/15/2014 22:21:46,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 22:22:28,,1323872170,7/15/2014 22:22:11,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336159,7/15/2014 22:28:38,,1323875129,7/15/2014 22:28:14,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,49,70,,,61,86,HYPERTENSION,PHEOCHROMOCYTOMA,HYPERTENSION,49,70,PHEOCHROMOCYTOMA,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12.,49,70,49,70,61,86,1,RO-disease_may_have_finding,902958,Evidence: ? Patients with identifiable causes of hypertension such as pheochromocytoma and renal disease have unique perioperative considerations ( 12,hypertension,pheochromocytoma
503336160,7/15/2014 21:02:19,,1323839563,7/15/2014 21:01:58,irazoo,1,10644009,USA,,,166.137.94.104,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,", ANXIETY",8-15,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:09:18,,1323842753,7/15/2014 21:08:55,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,ANXIETY Disorders,15-23,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:18:31,,1323846565,7/15/2014 21:18:06,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,", ANXIETY Disorders",8-15-23,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:18:51,,1323846735,7/15/2014 21:18:29,elite,1,26544151,GBR,,,92.40.117.64,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,ANXIETY,15,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:20:42,,1323847447,7/15/2014 21:20:19,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,", c ANXIETY Disorders Management",8-12-15-23-34,34-45-48-56,Management of ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:33:04,,1323852518,7/15/2014 21:32:44,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,ANXIETY Disorders Management,15-23-34,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:36:02,,1323853450,7/15/2014 21:35:35,instagc,1,19636746,USA,NY,Andover,192.182.216.225,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,ANXIETY Disorders,15-23,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:40:57,,1323854985,7/15/2014 21:40:54,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,"b , c ANXIETY Disorders Management of",6-8-12-15-23-34-45,23-34-45-48-56-66-70-76,Disorders Management of ANXIETY DISORDERS and short term,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 21:58:35,,1323861286,7/15/2014 21:58:14,clixsense,1,26648627,GBR,,,80.189.8.210,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,ANXIETY Disorders,15-23,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336160,7/15/2014 22:17:05,,1323869749,7/15/2014 22:16:50,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,15,48,,,22,65,ANXIETY,ANXIETY DISORDERS,ANXIETY Disorders,15-23,48-56,ANXIETY DISORDERS,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety.",15,48 56,15,48,22,65,-1,RO-has_definitional_manifestation,904618,"a ,   b ,   c  Anxiety Disorders  Management of anxiety disorders and short-term relief of symptoms of anxiety",Anxiety,anxiety disorders
503336161,7/15/2014 21:16:35,,1323845851,7/15/2014 21:16:17,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,61-71,3,TRICHURIASIS,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:20:17,,1323847279,7/15/2014 21:19:56,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,61-71,0-3,9 TRICHURIASIS,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:21:56,,1323847972,7/15/2014 21:21:32,clixsense,1,15189335,GBR,H9,London,188.29.164.11,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,61-71,3,TRICHURIASIS,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:25:13,,1323849468,7/15/2014 21:24:54,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,trichuriasis TRICHURIS TRICHIURA,30-61-71,3-30,TRICHURIASIS trichuriasis,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:29:35,,1323851385,7/15/2014 21:29:23,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,61-71,3,TRICHURIASIS,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:33:35,,1323852670,7/15/2014 21:33:18,elite,1,28276268,USA,MI,Taylor,67.149.247.166,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,caused TRICHURIS TRICHIURA,50-61-71,3,TRICHURIASIS,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:39:50,,1323854548,7/15/2014 21:39:30,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,61-71,3-17-27-30,TRICHURIASIS Treatment of trichuriasis,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:42:14,,1323855440,7/15/2014 21:40:14,instagc,1,19636746,USA,NY,Andover,192.182.216.225,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA (whipworm.,61-71-82,3-17,TRICHURIASIS Treatment,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 21:57:25,,1323860766,7/15/2014 21:57:16,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,61-71,3,TRICHURIASIS,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336161,7/15/2014 22:15:20,,1323868940,7/15/2014 22:15:07,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,61,3,,,80,15,TRICHURIS TRICHIURA,TRICHURIASIS,TRICHURIS TRICHIURA,61-71,0-3,9 TRICHURIASIS,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm.,61 71,3,61,3,80,15,1,RO-has_causative_agent,903707,9  Trichuriasis  Treatment of trichuriasis   +    caused by  Trichuris trichiura  (whipworm,Trichuris trichiura,Trichuriasis
503336162,7/15/2014 21:03:07,,1323840004,7/15/2014 21:02:45,irazoo,1,10644009,USA,,,166.137.94.104,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,86-98,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:05:35,,1323841087,7/15/2014 21:05:22,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA (VT),86-98-110,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:10:14,,1323843224,7/15/2014 21:10:07,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,couplets (VC) and VENTRICULAR TACHYCARDIA was compared,68-77-82-86-98-115-119,13-16-27-31-41-44-56,of mexiletine and QUINIDINE in controlling ventricular,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:12:16,,1323844074,7/15/2014 21:12:01,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA (VT),86-98-110,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:13:15,,1323844476,7/15/2014 21:12:59,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA (VT),86-98-110,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:18:14,,1323846498,7/15/2014 21:16:20,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,86-98,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:23:50,,1323848865,7/15/2014 21:23:39,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,couplets (VC) and VENTRICULAR TACHYCARDIA was compared,68-77-82-86-98-115-119,16-27-31-41-44-56,mexiletine and QUINIDINE in controlling ventricular,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:25:50,,1323849696,7/15/2014 21:25:38,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,86-98,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:48:13,,1323857438,7/15/2014 21:47:37,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA,86-98,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336162,7/15/2014 21:59:42,,1323861863,7/15/2014 21:59:30,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,86,31,,,109,40,VENTRICULAR TACHYCARDIA,QUINIDINE,VENTRICULAR TACHYCARDIA (VT),86-98-110,31,QUINIDINE,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients.,86 98,31,86,31,109,40,1,RO-may_prevent,907007,The efficacy of mexiletine and quinidine in controlling ventricular couplets (VC) and ventricular tachycardia (VT) was compared in 156 trials (78 for each drug) in 114 consecutive patients,ventricular tachycardia,quinidine
503336163,7/15/2014 21:07:33,,1323841981,7/15/2014 21:07:19,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,inflammatory BOWEL diseases,44-57-63,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:09:34,,1323842887,7/15/2014 21:09:28,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,"disease Typically, inflammatory BOWEL diseases ulcerative",23-33-44-57-63-79,57-63-72-79-90-98-102-108,"bowel diseases (e.g., ULCERATIVE COLITIS and Crohn disease)","29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:13:48,,1323844647,7/15/2014 21:13:34,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,inflammatory BOWEL diseases,44-57-63,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:15:35,,1323845424,7/15/2014 21:15:12,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,inflammatory BOWEL diseases,44-57-63,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:19:35,,1323846975,7/15/2014 21:19:13,elite,1,26544151,GBR,,,92.40.117.64,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,inflammatory BOWEL diseases,44-57-63,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:22:41,,1323848315,7/15/2014 21:22:29,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,inflammatory BOWEL diseases,44-57-63,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:24:35,,1323849154,7/15/2014 21:24:23,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,"disease Typically, inflammatory BOWEL diseases ulcerative",23-33-44-57-63-79,57-63-72-79-90-98-102-108,"bowel diseases (e.g., ULCERATIVE COLITIS and Crohn disease)","29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:26:31,,1323850024,7/15/2014 21:26:19,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,BOWEL,57,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:28:00,,1323850681,7/15/2014 21:27:40,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,BOWEL,57,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336163,7/15/2014 21:30:43,,1323851678,7/15/2014 21:27:55,clixsense,1,15189335,GBR,H9,London,188.29.164.11,57,79,,,62,97,BOWEL,ULCERATIVE COLITIS,BOWEL,57,79-90,ULCERATIVE COLITIS,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool.",57,79 90,57,79,62,97,1,RO-disease_has_primary_anatomic_site,902198,"29  Inflammatory bowel disease   Typically, inflammatory bowel diseases (e.g., ulcerative colitis and Crohn disease) produce inflammatory diarrhea, with blood and pus in the stool",bowel,ulcerative colitis
503336164,7/15/2014 21:04:34,,1323840677,7/15/2014 21:04:21,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,58,73,,,71,81,HERPES ZOSTER,SHINGLES,HERPES ZOSTER (shingles),58-65-72,58-65-72,herpes zoster (SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 21:09:21,,1323842775,7/15/2014 21:09:16,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,58,73,,,71,81,HERPES ZOSTER,SHINGLES,varicella (chickenpox) and HERPES ZOSTER in The,31-41-54-58-65-83-86,58-65-72-83-86-90,herpes zoster (SHINGLES) in The Netherlands,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 21:50:24,,1323858127,7/15/2014 21:49:58,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,58,73,,,71,81,HERPES ZOSTER,SHINGLES,HERPES ZOSTER,58-65,72,(SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 22:02:49,,1323863409,7/15/2014 22:02:29,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,58,73,,,71,81,HERPES ZOSTER,SHINGLES,HERPES ZOSTER (shingles),58-65-72,58-65-72,herpes zoster (SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 22:06:58,,1323865215,7/15/2014 22:06:43,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,58,73,,,71,81,HERPES ZOSTER,SHINGLES,HERPES ZOSTER,58-65,72,(SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 22:18:56,,1323870594,7/15/2014 22:18:37,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,58,73,,,71,81,HERPES ZOSTER,SHINGLES,HERPES ZOSTER,58-65,72,(SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 22:20:27,,1323871267,7/15/2014 22:20:11,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,58,73,,,71,81,HERPES ZOSTER,SHINGLES,HERPES ZOSTER,58-65,58-65-72,herpes zoster (SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 22:23:32,,1323872747,7/15/2014 22:23:12,prodege,1,12537159,USA,MI,Sterling Heights,68.60.146.55,58,73,,,71,81,HERPES ZOSTER,SHINGLES,varicella (chickenpox) and HERPES ZOSTER (shingles),31-41-54-58-65-72,31-41-58-65-72-54,varicella (chickenpox) and herpes zoster (SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 22:30:26,,1323875984,7/15/2014 22:30:08,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,58,73,,,71,81,HERPES ZOSTER,SHINGLES,varicella (chickenpox) and HERPES ZOSTER,31-41-54-58-65,58-65-72,herpes zoster (SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336164,7/15/2014 22:31:01,,1323876289,7/15/2014 22:30:48,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,58,73,,,71,81,HERPES ZOSTER,SHINGLES,HERPES ZOSTER (shingles),58-65-72,58-65-72,herpes zoster (SHINGLES),We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands.,58 65,,58,73,71,81,1,RO-has_causative_agent,903975,We studied the epidemiology of varicella (chickenpox) and herpes zoster (shingles) in The Netherlands to assess the desirability to implement routine varicella zoster virus vaccination in The Netherlands,herpes zoster,shingles
503336165,7/15/2014 21:09:52,,1323843074,7/15/2014 21:09:40,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,109-121,generalized HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 21:10:06,,1323843167,7/15/2014 21:09:10,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,121,HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 21:18:05,,1323846429,7/15/2014 21:17:44,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,109-121,generalized HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 21:23:32,,1323848714,7/15/2014 21:23:12,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,121,HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 21:23:37,,1323848779,7/15/2014 21:23:28,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,109-121,generalized HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 21:37:35,,1323853936,7/15/2014 21:36:18,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,109-121,generalized HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 21:38:43,,1323854310,7/15/2014 21:38:27,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,72,121,,,76,126,SKIN,HIVES,"SKIN, mucosal tissue,",72-78-86,109-121,generalized HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 21:44:07,,1323856037,7/15/2014 21:42:14,instagc,1,19636746,USA,NY,Andover,192.182.216.225,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,109-121,generalized HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 22:18:13,,1323870297,7/15/2014 22:17:57,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,109-121,generalized HIVES;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336165,7/15/2014 22:22:54,,1323872390,7/15/2014 22:19:53,prodege,1,12537159,USA,MI,Sterling Heights,68.60.146.55,72,121,,,76,126,SKIN,HIVES,"SKIN,",72,121-128-137-140,HIVES; pruritus or flushing;,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a.",72,121,72,121,76,126,1,RO-disease_has_primary_anatomic_site,902176,"Acute onset of an illness (over minutes to several hours) involving the skin, mucosal tissue, or both (e.g., generalized hives; pruritus or flushing; swollen lips, tongue, or uvula) and at least one of the following:  a",skin,hives
503336166,7/15/2014 21:10:56,,1323843540,7/15/2014 21:10:24,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,induced by HYPOGLYCEMIA,54-65-62,99-109-116,"restoring plasma GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 21:20:31,,1323847381,7/15/2014 21:20:23,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,65,109-116,"plasma GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 21:27:55,,1323850646,7/15/2014 21:27:22,clixsense,1,15189335,GBR,H9,London,188.29.164.11,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,65,116,"GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 21:29:10,,1323851230,7/15/2014 21:27:20,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,65,109-116,"plasma GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 21:31:09,,1323851832,7/15/2014 21:30:54,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,65,109-116,"plasma GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 21:33:02,,1323852492,7/15/2014 21:32:49,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,65,109-116,"plasma GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 22:10:23,,1323866807,7/15/2014 22:10:08,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,responses induced by HYPOGLYCEMIA protect the brain,44-54-62-65-78-86-90,109-116,"plasma GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 22:15:37,,1323869076,7/15/2014 22:15:23,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,"responses induced by HYPOGLYCEMIA protect the brain restoring plasma glucose,",44-54-62-65-78-86-90-99-109-116,96-99-109-116-125-129-136,"by restoring plasma GLUCOSE, but little is","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 22:17:04,,1323869748,7/15/2014 22:16:43,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,65,116,"GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336166,7/15/2014 22:25:06,,1323873417,7/15/2014 22:24:50,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,65,116,,,77,123,HYPOGLYCEMIA,GLUCOSE,HYPOGLYCEMIA,65,116,"GLUCOSE,","The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective.",65,116,65,116,77,123,1,RO-may_treat,908276,"The robust neuroendocrine counterregulatory responses induced by hypoglycemia protect the brain by restoring plasma glucose, but little is known about molecular responses to hypoglycemia that may also be neuroprotective",hypoglycemia,glucose
503336167,7/15/2014 21:03:37,,1323840299,7/15/2014 21:03:34,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,181,157,,,194,162,BREAST CANCER,GROUP,of poor prognosis BREAST CANCER.,163-166-171-181-188,143-149-152-157-163-166-171,0.13) in this GROUP of poor prognosis,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:04:27,,1323840622,7/15/2014 21:04:13,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,181,157,,,194,162,BREAST CANCER,GROUP,poor prognosis BREAST CANCER.,166-171-181-188,157,GROUP,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:07:47,,1323842095,7/15/2014 21:07:35,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,181,157,,,194,162,BREAST CANCER,GROUP,poor prognosis BREAST CANCER.,166-171-181-188,157,GROUP,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:09:46,,1323843011,7/15/2014 21:09:41,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,181,157,,,194,162,BREAST CANCER,GROUP,of poor prognosis BREAST CANCER.,163-166-171-181-188,143-149-152-157-163-166-171,0.13) in this GROUP of poor prognosis,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:10:13,,1323843183,7/15/2014 21:09:49,irazoo,1,10644009,USA,,,166.137.94.104,181,157,,,194,162,BREAST CANCER,GROUP,BREAST CANCER.,181-188,157,GROUP,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:10:34,,1323843392,7/15/2014 21:10:16,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,181,157,,,194,162,BREAST CANCER,GROUP,poor prognosis BREAST CANCER.,166-171-181-188,157,GROUP,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:24:15,,1323849021,7/15/2014 21:24:02,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,181,157,,,194,162,BREAST CANCER,GROUP,BREAST CANCER.,181-188,157,GROUP,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:26:06,,1323849838,7/15/2014 21:25:51,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,181,157,,,194,162,BREAST CANCER,GROUP,BREAST CANCER.,181-188,157-181-188,GROUP breast cancer.,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:45:24,,1323856474,7/15/2014 21:45:03,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,181,157,,,194,162,BREAST CANCER,GROUP,BREAST CANCER.,181-188,157,GROUP,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336167,7/15/2014 21:52:15,,1323858711,7/15/2014 21:51:56,instagc,1,19636746,USA,NY,Andover,192.182.216.225,181,157,,,194,162,BREAST CANCER,GROUP,poor prognosis BREAST CANCER.,166-171-181-188,157-163-166-171-181-188,GROUP of poor prognosis breast cancer.,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer.,181 188,157,181,157,194,162,-1,RO-has_manifestation,906080,No difference was found between presence or absence of circulating tumor cells and previous chemotherapy treatment (p = 0.5) or stage TNM (p = 0.13) in this group of poor-prognosis breast cancer,breast cancer,group
503336168,7/15/2014 21:11:44,,1323843912,7/15/2014 21:11:37,neodev,1,26596102,GBR,,,128.199.166.81,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,US in the STOMACH include staging of,27-30-33-37-45-53-61,45-53-61-64-72-83-96-100,"include staging of GASTRIC CARCINOMA, localization and characterization","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 21:11:54,,1323843954,7/15/2014 21:11:43,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 21:18:59,,1323846808,7/15/2014 21:18:31,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 21:22:39,,1323848297,7/15/2014 21:22:30,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 21:29:22,,1323851296,7/15/2014 21:29:10,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 21:59:41,,1323861856,7/15/2014 21:59:23,clixsense,1,26648627,GBR,,,80.189.8.210,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 22:05:10,,1323864354,7/15/2014 22:02:58,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 22:06:42,,1323865112,7/15/2014 22:05:51,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 22:09:04,,1323866180,7/15/2014 22:08:51,instagc,1,13763729,USA,,,75.182.89.225,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,STOMACH,37,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336168,7/15/2014 22:10:40,,1323866944,7/15/2014 22:10:24,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,37,64,,,44,81,STOMACH,GASTRIC CARCINOMA,US in the STOMACH include staging of,27-30-33-37-45-53-61,64-72,"GASTRIC CARCINOMA,","Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma.",37,64 72,37,64,44,81,1,RO-disease_has_primary_anatomic_site,902110,"Applications of endoscopic US in the stomach include staging of gastric carcinoma, localization and characterization of nonmucosal gastric masses, detection and evaluation of gastric varices, and evaluation of gastric lymphoma",stomach,gastric carcinoma
503336169,7/15/2014 21:09:52,,1323843071,7/15/2014 21:09:05,neodev,1,26596102,GBR,,,128.199.166.81,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"seizures psychogenic non epileptic SEIZURES,",121-141-153-157-167,194-206-210-239-249,psychogenic non epileptic EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:10:53,,1323843521,7/15/2014 21:10:27,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"psychogenic non epileptic SEIZURES,",141-153-157-167,239-249,EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:21:41,,1323847877,7/15/2014 21:21:34,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"non epileptic SEIZURES,",153-157-167,239-249,EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:24:27,,1323849105,7/15/2014 21:24:16,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"psychogenic non epileptic SEIZURES,",141-157-167-153,239-249,EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:26:22,,1323849952,7/15/2014 21:26:08,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",167,239-249,EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:27:56,,1323850653,7/15/2014 21:27:45,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"SEIZURES,",167,239-249,EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:32:43,,1323852416,7/15/2014 21:32:31,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"psychogenic non epileptic SEIZURES,",141-153-157-167,234-239-249,true EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:38:27,,1323854187,7/15/2014 21:38:10,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"psychogenic non epileptic SEIZURES,",141-153-157-167,234-239-249,true EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 21:53:45,,1323859225,7/15/2014 21:53:29,instagc,1,19636746,USA,NY,Andover,192.182.216.225,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"psychogenic non epileptic SEIZURES,",141-153-157-167,239-249,EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336169,7/15/2014 22:16:35,,1323869554,7/15/2014 22:16:24,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,167,239,,,175,257,SEIZURES,EPILEPTIC SEIZURES,"non epileptic SEIZURES,",153-157-167,239-249,EPILEPTIC SEIZURES.,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures.",167,239 249,167,239,175,257,-1,RO-has_definitional_manifestation,904653,"Depending on video-EEG recordings and witnessed accounts, 18 of the patients had no seizures recorded, 160 had epileptic seizures and 18 had psychogenic non-epileptic seizures, four of whom had psychogenic non-epileptic seizures plus true epileptic seizures",seizures,epileptic seizures
503336170,7/15/2014 21:02:13,,1323839504,7/15/2014 21:02:00,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"drug induced NEUTROPENIA,",132-137-145,108-119,"AUTOIMMUNE NEUTROPENIA,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 21:03:28,,1323840212,7/15/2014 21:03:26,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"neutropenia, drug induced NEUTROPENIA, and complement mediated",119-132-137-145-158-162-173,76-86-95-108-119-132-137-145,"isoimmune neonatal neutropenia, AUTOIMMUNE NEUTROPENIA, drug induced neutropenia,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 21:07:39,,1323842041,7/15/2014 21:07:33,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"neutropenia, drug induced NEUTROPENIA, and complement mediated",119-132-137-145-158-162-173,76-86-95-108-119-132-137-145,"isoimmune neonatal neutropenia, AUTOIMMUNE NEUTROPENIA, drug induced neutropenia,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 21:11:57,,1323843973,7/15/2014 21:11:44,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"drug induced NEUTROPENIA,",132-137-145,108-119,"AUTOIMMUNE NEUTROPENIA,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 21:16:39,,1323845864,7/15/2014 21:15:35,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"drug induced NEUTROPENIA, and complement - mediated neutropenia.",132-137-145-158-162-172-173-182,108-119-132-137-145-158-162-172-173-182,"AUTOIMMUNE NEUTROPENIA, drug induced neutropenia, and complement - mediated neutropenia.","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 21:25:43,,1323849649,7/15/2014 21:25:21,clixsense,1,15189335,GBR,H9,London,188.29.164.11,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"NEUTROPENIA,",145,108-119,"AUTOIMMUNE NEUTROPENIA,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 21:40:40,,1323854867,7/15/2014 21:40:38,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"neutropenia, drug induced NEUTROPENIA, and complement mediated",119-132-137-145-158-162-173,76-86-95-108-119-132-137-145,"isoimmune neonatal neutropenia, AUTOIMMUNE NEUTROPENIA, drug induced neutropenia,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 22:04:56,,1323864237,7/15/2014 22:04:05,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"NEUTROPENIA,",145,108-119,"AUTOIMMUNE NEUTROPENIA,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 22:12:23,,1323867743,7/15/2014 22:12:05,instagc,1,13763729,USA,,,75.182.89.225,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"NEUTROPENIA,",145,108-119,"AUTOIMMUNE NEUTROPENIA,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336170,7/15/2014 22:15:53,,1323869237,7/15/2014 22:15:34,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,145,108,,,156,130,NEUTROPENIA,AUTOIMMUNE NEUTROPENIA,"drug induced NEUTROPENIA,",132-137-145,108-119,"AUTOIMMUNE NEUTROPENIA,","The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia.",145,108 119,145,108,156,130,-1,RO-has_definitional_manifestation,904866,"The immune clinical syndromes predisposing to selective neutropenia include isoimmune neonatal neutropenia, autoimmune neutropenia, drug-induced neutropenia, and complement-mediated neutropenia",neutropenia,autoimmune neutropenia
503336171,7/15/2014 21:09:46,,1323843017,7/15/2014 21:09:14,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,337,372,,,341,381,SKIN,PETECHIAE,Physical exam SKIN,322-331-337,357-368-372,ecchymosis and PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:14:43,,1323845138,7/15/2014 21:14:10,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,337,372,,,341,381,SKIN,PETECHIAE,SKIN,337,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:16:19,,1323845701,7/15/2014 21:14:09,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,337,372,,,341,381,SKIN,PETECHIAE,SKIN,337,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:16:39,,1323845868,7/15/2014 21:16:20,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,337,372,,,341,381,SKIN,PETECHIAE,SKIN,337,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:18:52,,1323846755,7/15/2014 21:18:35,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,337,372,,,341,381,SKIN,PETECHIAE,SKIN,337,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:25:45,,1323849674,7/15/2014 21:25:20,elite,1,28276268,USA,MI,Taylor,67.149.247.166,337,372,,,341,381,SKIN,PETECHIAE,SKIN,337,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:28:27,,1323850916,7/15/2014 21:28:02,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,337,372,,,341,381,SKIN,PETECHIAE,SKIN Myelodysplastic Syndrome,337-410-426,372-410-426,PETECHIAE Myelodysplastic Syndrome,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:30:16,,1323851550,7/15/2014 21:29:35,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,337,372,,,341,381,SKIN,PETECHIAE,SKIN exam,337-342,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:44:10,,1323856040,7/15/2014 21:43:44,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,337,372,,,341,381,SKIN,PETECHIAE,SKIN,337,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336171,7/15/2014 21:55:36,,1323859984,7/15/2014 21:55:08,clixsense,1,26648627,GBR,,,80.189.8.210,337,372,,,341,381,SKIN,PETECHIAE,SKIN,337,372,PETECHIAE,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum.",337,372,337,372,341,381,1,RO-has_finding_site,905203,"Note medications that can induce cytopenias Physical exam  Oral exam  Look for mucosal ulceration Physical exam  Eye exam  Look for presence of vascularization of the conjunctivae Physical exam  Cardiac exam  Look for presence of murmurs or tachycardia Physical exam  Abdominal exam  Look for the presence of organomegaly Physical exam  Skin exam  Look for ecchymosis and petechiae   Differential Diagnosis of Myelodysplastic Syndrome  Normal;           Differential Diagnosis of Myelodysplastic Syndrome Disease  Characteristics  Notes Vitamin B12 deficiency  Macrocytic anemia with megaloblastic bone marrow abnormalities  Usually pernicious anemia, patients with a history of gastrectomy, or diseases that affect the terminal ileum",Skin,petechiae
503336172,7/15/2014 21:07:47,,1323842104,7/15/2014 21:07:32,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,131,142,,,140,149,KERATOSIS,VERRUCA,"actinic KERATOSIS,",123-131,142-150,"VERRUCA vulgaris,","Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 21:08:02,,1323842220,7/15/2014 21:07:49,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,131,142,,,140,149,KERATOSIS,VERRUCA,"actinic KERATOSIS,",123-131,142,VERRUCA,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 21:17:52,,1323846355,7/15/2014 21:17:37,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,131,142,,,140,149,KERATOSIS,VERRUCA,"actinic KERATOSIS,",123-131,142-150,"VERRUCA vulgaris,","Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 21:22:53,,1323848421,7/15/2014 21:22:42,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,131,142,,,140,149,KERATOSIS,VERRUCA,"actinic KERATOSIS,",123-131,142,VERRUCA,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 21:28:19,,1323850861,7/15/2014 21:27:57,elite,1,28276268,USA,MI,Taylor,67.149.247.166,131,142,,,140,149,KERATOSIS,VERRUCA,"KERATOSIS,",131,142,VERRUCA,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 21:28:27,,1323850908,7/15/2014 21:28:13,bitcoinget,1,24792414,USA,WI,Juneau,166.181.83.170,131,142,,,140,149,KERATOSIS,VERRUCA,"actinic KERATOSIS,",123-131,142-150,"VERRUCA vulgaris,","Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 21:56:06,,1323860236,7/15/2014 21:55:50,clixsense,1,26648627,GBR,,,80.189.8.210,131,142,,,140,149,KERATOSIS,VERRUCA,"actinic KERATOSIS,",123-131,142-150,"VERRUCA vulgaris,","Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 22:08:41,,1323866045,7/15/2014 22:08:18,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,131,142,,,140,149,KERATOSIS,VERRUCA,"carcinoma, keratoacanthoma, actinic KERATOSIS, verruca vulgaris, and",95-106-123-131-142-150-160,106-123-131-142-150-160-164-95,"carcinoma, keratoacanthoma, actinic keratosis, VERRUCA vulgaris, and seborrheic","Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 22:16:49,,1323869659,7/15/2014 22:16:36,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,131,142,,,140,149,KERATOSIS,VERRUCA,"actinic KERATOSIS,",123-131,142-150,"VERRUCA vulgaris,","Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336172,7/15/2014 22:27:29,,1323874550,7/15/2014 22:27:19,clixsense,1,23585686,GBR,H9,London,31.51.221.173,131,142,,,140,149,KERATOSIS,VERRUCA,"basal cell carcinoma, keratoacanthoma, actinic KERATOSIS, verruca vulgaris, and",84-95-106-123-131-142-150-160-90,106-123-131-142-150-160-164,"keratoacanthoma, actinic keratosis, VERRUCA vulgaris, and seborrheic","Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis.",131,142,131,142,140,149,-1,RO-disease_has_finding,901592,"Differential diagnosis includes many types of benign and malignant lesions, such as basal cell carcinoma, keratoacanthoma, actinic keratosis, verruca vulgaris, and seborrheic keratosis",keratosis,verruca
503336173,7/15/2014 21:03:05,,1323839999,7/15/2014 21:02:42,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,38,61,,,52,65,CALCIFICATIONS,DCIS,CALCIFICATIONS reveals DCIS.,38-53-61,38-53-61,calcifications reveals DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:04:46,,1323840727,7/15/2014 21:04:43,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,38,61,,,52,65,CALCIFICATIONS,DCIS,of the remaining CALCIFICATIONS reveals DCIS.,21-24-28-38-53-61,28-38-53-61,remaining calcifications reveals DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:11:41,,1323843854,7/15/2014 21:11:31,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,38,61,,,52,65,CALCIFICATIONS,DCIS,CALCIFICATIONS,38,61,DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:11:50,,1323843938,7/15/2014 21:11:46,neodev,1,26596102,GBR,,,128.199.166.81,38,61,,,52,65,CALCIFICATIONS,DCIS,of the remaining CALCIFICATIONS reveals DCIS.,21-24-28-38-53-61,28-38-53-61,remaining calcifications reveals DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:14:24,,1323844972,7/15/2014 21:14:07,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,38,61,,,52,65,CALCIFICATIONS,DCIS,CALCIFICATIONS,38,61,DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:23:44,,1323848827,7/15/2014 21:23:04,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,38,61,,,52,65,CALCIFICATIONS,DCIS,CALCIFICATIONS,38,61,DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:24:11,,1323848998,7/15/2014 21:23:52,neodev,1,17344784,GBR,G7,Kingston Upon Thames,80.43.164.136,38,61,,,52,65,CALCIFICATIONS,DCIS,of the remaining CALCIFICATIONS reveals DCIS.,21-24-28-38-53-61,28-38-53-61,remaining calcifications reveals DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:24:16,,1323849027,7/15/2014 21:23:46,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,38,61,,,52,65,CALCIFICATIONS,DCIS,CALCIFICATIONS,38,38-61,calcifications DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:51:07,,1323858306,7/15/2014 21:50:51,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,38,61,,,52,65,CALCIFICATIONS,DCIS,CALCIFICATIONS,38,61,DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336173,7/15/2014 21:53:05,,1323859009,7/15/2014 21:52:30,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,38,61,,,52,65,CALCIFICATIONS,DCIS,CALCIFICATIONS,38,61,DCIS.,C. Excisional biopsy of the remaining calcifications reveals DCIS.,38,61,38,61,52,65,1,RO-disease_may_have_finding,902978,C. Excisional biopsy of the remaining calcifications reveals DCIS,calcifications,DCIS
503336174,7/15/2014 21:03:21,,1323840111,7/15/2014 21:03:17,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,191,160,,,199,168,HEADACHE,MIGRAINE,aura) and 17 HEADACHE free controls.,178-184-188-191-200-205,143-146-155-160-173-178,23 patients with MIGRAINE with aura),"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 21:05:10,,1323840874,7/15/2014 21:04:26,irazoo,1,10644009,USA,,,166.137.94.104,191,160,,,199,168,HEADACHE,MIGRAINE,HEADACHE free controls.,191-200-205,160,MIGRAINE,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 21:20:18,,1323847281,7/15/2014 21:20:00,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,191,160,,,199,168,HEADACHE,MIGRAINE,HEADACHE,191,160,MIGRAINE,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 21:21:29,,1323847736,7/15/2014 21:21:08,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,191,160,,,199,168,HEADACHE,MIGRAINE,HEADACHE free controls.,191-200-205,160,MIGRAINE,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 21:39:04,,1323854415,7/15/2014 21:38:43,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,191,160,,,199,168,HEADACHE,MIGRAINE,HEADACHE free controls.,191-200-205,160,MIGRAINE,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 21:39:19,,1323854463,7/15/2014 21:39:16,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,191,160,,,199,168,HEADACHE,MIGRAINE,aura) and 17 HEADACHE free controls.,178-184-188-191-200-205,143-146-155-160-173-178,23 patients with MIGRAINE with aura),"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 21:57:00,,1323860594,7/15/2014 21:56:47,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,191,160,,,199,168,HEADACHE,MIGRAINE,HEADACHE,191,160-173-178-169,MIGRAINE (10 with aura),"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 22:04:50,,1323864214,7/15/2014 22:04:32,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,191,160,,,199,168,HEADACHE,MIGRAINE,(10 with aura) and 17 HEADACHE free controls.,173-178-184-188-191-200-205-169,143-146-155-160-173-178-133,"headache, 23 patients with MIGRAINE with aura)","Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 22:08:30,,1323865985,7/15/2014 22:08:11,instagc,1,13763729,USA,,,75.182.89.225,191,160,,,199,168,HEADACHE,MIGRAINE,HEADACHE free,191-200,160,MIGRAINE,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336174,7/15/2014 22:13:53,,1323868266,7/15/2014 22:13:41,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,191,160,,,199,168,HEADACHE,MIGRAINE,HEADACHE,191,160,MIGRAINE,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls.",191,160,191,160,199,168,-1,RO-has_definitional_manifestation,904644,"Blink reflex R2 amplitude was investigated in seven patients with cervicogenic headache (CEH), 12 patients with chronic tension-type headache, 23 patients with migraine (10 with aura) and 17 headache-free controls",headache,migraine
503336175,7/15/2014 21:02:41,,1323839851,7/15/2014 21:02:07,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,chronic PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA and Kearns Sayre syndrome.,85-93-105-114-130-134-141-147,85-105-114-130-134-141-147-93,chronic progressive external ophthalmoplegia and KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 21:02:43,,1323839866,7/15/2014 21:02:22,irazoo,1,10644009,USA,,,166.137.94.104,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 21:11:05,,1323843564,7/15/2014 21:09:57,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 21:18:29,,1323846564,7/15/2014 21:18:15,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,chronic PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,85-93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 21:54:12,,1323859407,7/15/2014 21:53:49,clixsense,1,26648627,GBR,,,80.189.8.210,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,chronic PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,85-93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 21:57:41,,1323860884,7/15/2014 21:57:09,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,chronic PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,85-93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 22:16:23,,1323869471,7/15/2014 22:16:14,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 22:19:15,,1323870733,7/15/2014 22:18:57,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 22:30:22,,1323875963,7/15/2014 22:30:13,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,chronic PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,85-93-105-114,134-141-147,KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336175,7/15/2014 22:30:40,,1323876126,7/15/2014 22:30:27,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,93,134,,,129,155,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA,KEARNS-SAYRE SYNDROME,PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA and Kearns Sayre,93-105-114-130-134-141,105-114-130-134-141-147,external ophthalmoplegia and KEARNS SAYRE SYNDROME.,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome.,93 105 114,134 141 147,93,134,129,155,-1,RO-has_manifestation,906425,Mitochondrial DNA (mtDNA) deletions have been found in the majority of patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome,progressive external ophthalmoplegia,Kearns-Sayre syndrome
503336176,7/15/2014 21:04:22,,1323840579,7/15/2014 21:04:18,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"appendicular bone, no PATHOLOGIC FRACTURES, performance status 1",128-141-147-150-161-172-184-191,60-65-81-90-95-107-110-121,"with adenocarcinoma, solitary BONE METASTASIS, no metastases to","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 21:06:28,,1323841555,7/15/2014 21:06:08,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,81-90-95,"solitary BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 21:07:49,,1323842109,7/15/2014 21:07:22,neodev,1,26596102,GBR,,,128.199.166.81,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,81-90-95,"solitary BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 21:13:43,,1323844626,7/15/2014 21:13:15,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,81-90-95,"solitary BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 21:24:21,,1323849062,7/15/2014 21:23:50,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,81-90-95,"solitary BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 21:34:42,,1323852997,7/15/2014 21:34:23,elite,1,28276268,USA,MI,Taylor,67.149.247.166,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,90-95,"BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 22:00:00,,1323862079,7/15/2014 21:59:42,clixsense,1,26648627,GBR,,,80.189.8.210,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,81-90-95,"solitary BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 22:00:48,,1323862477,7/15/2014 22:00:14,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,81-90-95,"solitary BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 22:08:02,,1323865744,7/15/2014 22:07:40,instagc,1,19636746,USA,NY,Andover,192.182.216.225,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,81-90-95,"solitary BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336176,7/15/2014 22:08:11,,1323865854,7/15/2014 22:07:57,instagc,1,13763729,USA,,,75.182.89.225,150,90,,,170,105,PATHOLOGIC FRACTURES,BONE METASTASIS,"PATHOLOGIC FRACTURES,",150-161,90-95,"BONE METASTASIS,","A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor.",150 161,90 95,150,90,170,105,-1,RO-disease_may_have_finding,902860,"A favorable prognosis was more likely in women and patients with adenocarcinoma, solitary bone metastasis, no metastases to the appendicular bone, no pathologic fractures, performance status 1 or less, use of systemic chemotherapy, and use of an epithelial growth factor receptor inhibitor",pathologic fractures,bone metastasis
503336177,7/15/2014 21:05:49,,1323841211,7/15/2014 21:05:37,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,recurrent venous THROMBOEMBOLISM,69-79-86,0-4-14-21,Low molecular weight HEPARIN,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:10:22,,1323843293,7/15/2014 21:09:47,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,recurrent venous THROMBOEMBOLISM,69-79-86,21-29-36-38,HEPARIN versus a coumarin,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:11:18,,1323843705,7/15/2014 21:11:03,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,venous THROMBOEMBOLISM,79-86,0-4-14-21,Low molecular weight HEPARIN,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:12:19,,1323844101,7/15/2014 21:12:14,neodev,1,26596102,GBR,,,128.199.166.81,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,of recurrent venous THROMBOEMBOLISM in patients with,66-69-79-86-102-105-114,0-4-14-21-29-36-38,Low molecular weight HEPARIN versus a coumarin,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:13:22,,1323844503,7/15/2014 21:13:11,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,recurrent venous THROMBOEMBOLISM,69-79-86,0-4-14-21,Low molecular weight HEPARIN,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:14:27,,1323845004,7/15/2014 21:13:56,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,venous THROMBOEMBOLISM,79-86,21,HEPARIN,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:24:47,,1323849265,7/15/2014 21:24:29,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,THROMBOEMBOLISM,86,21,HEPARIN,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:31:07,,1323851820,7/15/2014 21:30:54,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,recurrent venous THROMBOEMBOLISM,69-79-86,0-4-14-21,Low molecular weight HEPARIN,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:31:20,,1323851909,7/15/2014 21:31:02,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,recurrent venous THROMBOEMBOLISM,69-79-86,0-4-14-21,Low molecular weight HEPARIN,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336177,7/15/2014 21:40:06,,1323854685,7/15/2014 21:39:55,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,86,21,,,101,28,THROMBOEMBOLISM,HEPARIN,of recurrent venous THROMBOEMBOLISM,66-69-79-86,0-4-14-21-29-36-38,Low molecular weight HEPARIN versus a coumarin,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.,86,21,86,21,101,28,1,RO-may_prevent,907025,Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer,thromboembolism,heparin
503336178,7/15/2014 21:06:17,,1323841479,7/15/2014 21:05:45,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,40,57,,,49,65,HEADACHES,MIGRAINE,Adults Vascular HEADACHES,31-40-23,57,MIGRAINE,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 21:08:29,,1323842439,7/15/2014 21:08:11,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,40,57,,,49,65,HEADACHES,MIGRAINE,Vascular HEADACHES,31-40,57,MIGRAINE,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 21:34:20,,1323852875,7/15/2014 21:34:01,elite,1,28276268,USA,MI,Taylor,67.149.247.166,40,57,,,49,65,HEADACHES,MIGRAINE,HEADACHES,40,57,MIGRAINE,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 21:39:03,,1323854411,7/15/2014 21:38:53,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,40,57,,,49,65,HEADACHES,MIGRAINE,Limits Adults Vascular HEADACHES Migraine Oral:,15-23-31-40-57-67,31-40-51-57-67,Vascular Headaches &gt; MIGRAINE Oral:,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 21:39:47,,1323854549,7/15/2014 21:39:17,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,40,57,,,49,65,HEADACHES,MIGRAINE,Adults Vascular HEADACHES,23-31-40,57-67,MIGRAINE Oral:,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 21:42:57,,1323855664,7/15/2014 21:41:22,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,40,57,,,49,65,HEADACHES,MIGRAINE,Vascular HEADACHES,31-40,51-57-67,&gt; MIGRAINE Oral:,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 21:53:31,,1323859134,7/15/2014 21:53:23,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,40,57,,,49,65,HEADACHES,MIGRAINE,Limits Adults Vascular HEADACHES Migraine Oral: Maximum,15-23-31-40-57-67-74,31-40-51-57-67-74,Vascular Headaches &gt; MIGRAINE Oral: Maximum,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 22:08:52,,1323866107,7/15/2014 22:08:43,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,40,57,,,49,65,HEADACHES,MIGRAINE,Limits Adults Vascular HEADACHES Migraine Oral: Maximum,15-23-31-40-57-67-74,31-40-51-57,Vascular Headaches &gt; MIGRAINE,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 22:17:31,,1323869990,7/15/2014 22:17:06,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,40,57,,,49,65,HEADACHES,MIGRAINE,HEADACHES,40,57,MIGRAINE,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336178,7/15/2014 22:29:49,,1323875759,7/15/2014 22:29:28,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,40,57,,,49,65,HEADACHES,MIGRAINE,Vascular HEADACHES,31-40,57-67,MIGRAINE Oral:,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period.,40,57,40,57,49,65,-1,RO-has_definitional_manifestation,904531,1  Prescribing Limits  Adults  Vascular Headaches  >     Migraine  Oral:  Maximum 30 mg in any 24-hour period,Headaches,Migraine
503336179,7/15/2014 21:06:14,,1323841451,7/15/2014 21:06:02,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 21:26:18,,1323849938,7/15/2014 21:26:06,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 21:57:20,,1323860741,7/15/2014 21:57:05,clixsense,1,26648627,GBR,,,80.189.8.210,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 21:59:54,,1323862000,7/15/2014 21:59:43,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,76,60,,,80,71,PAIN,PARACETAMOL,receive paracetamol for PAIN and fever,52-60-72-76-81-85,60-72-76-81-85,PARACETAMOL for pain and fever,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 22:09:42,,1323866459,7/15/2014 22:09:29,instagc,1,13763729,USA,,,75.182.89.225,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 22:14:24,,1323868479,7/15/2014 22:14:10,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 22:18:35,,1323870473,7/15/2014 22:18:16,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 22:23:10,,1323872557,7/15/2014 22:22:55,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 22:29:13,,1323875448,7/15/2014 22:28:43,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336179,7/15/2014 22:29:28,,1323875587,7/15/2014 22:29:16,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,76,60,,,80,71,PAIN,PARACETAMOL,PAIN,76,60,PARACETAMOL,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection.,76,60,76,60,80,71,1,RO-may_treat,908195,Measles patients with an acute ear infection should receive paracetamol for pain and fever and an antibiotic for the infection,pain,paracetamol
503336180,7/15/2014 21:07:19,,1323841869,7/15/2014 21:07:13,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,multi allergy (clinical ALLERGY to one or,137-143-151-161-169-172-176,123-129-134-137-143-161-169,SPT); mono or MULTI ALLERGY allergy to,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:08:10,,1323842283,7/15/2014 21:07:49,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,(clinical ALLERGY,151-161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:12:27,,1323844164,7/15/2014 21:12:00,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,(clinical ALLERGY,151-161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:17:31,,1323846214,7/15/2014 21:16:58,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,(clinical ALLERGY,151-161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:21:44,,1323847892,7/15/2014 21:21:25,elite,1,26544151,GBR,,,92.40.117.64,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,ALLERGY,161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:23:45,,1323848839,7/15/2014 21:23:27,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,multi allergy (clinical ALLERGY,137-143-151-161,137-143-151-161,MULTI ALLERGY (clinical allergy,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:23:48,,1323848864,7/15/2014 21:23:22,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,(clinical ALLERGY,151-161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:30:19,,1323851560,7/15/2014 21:29:12,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,multi allergy (clinical ALLERGY,137-143-151-161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:45:46,,1323856615,7/15/2014 21:45:25,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,ALLERGY,161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336180,7/15/2014 21:50:12,,1323858056,7/15/2014 21:49:19,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,161,137,,,168,150,ALLERGY,MULTI-ALLERGY,multi allergy (clinical ALLERGY,137-143-151-161,137-143,MULTI ALLERGY,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type.",161,137 143,161,137,168,150,-1,RO-cause_of,900047,"The main outcome measures were mono or multi-sensitization (specific IgE to one or more than one nut type, demonstrated by SPT); mono or multi-allergy (clinical allergy to one or more than one nut type",allergy,multi-allergy
503336181,7/15/2014 21:04:04,,1323840454,7/15/2014 21:03:40,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,85,114,,,89,126,LUNG,LUNG DISEASE,ventilatory strategies in each LUNG,54-66-77-80-85,108-114-119,"focal LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 21:04:29,,1323840635,7/15/2014 21:04:26,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,85,114,,,89,126,LUNG,LUNG DISEASE,strategies in each LUNG in a patient,66-77-80-85-90-93-95,95-103-108-114-119-128-134-136,"patient with focal LUNG DISEASE, e.g., a patient","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 21:19:12,,1323846853,7/15/2014 21:18:45,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,85,114,,,89,126,LUNG,LUNG DISEASE,"LUNG focal lung disease,",85-108-114-119,108-114-119,"focal LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 21:28:49,,1323851074,7/15/2014 21:28:21,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,85,114,,,89,126,LUNG,LUNG DISEASE,LUNG,85,108-114-119,"focal LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 21:55:31,,1323859918,7/15/2014 21:53:00,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,85,114,,,89,126,LUNG,LUNG DISEASE,LUNG,85,108-114-119,"focal LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 21:59:36,,1323861835,7/15/2014 21:58:44,clixsense,1,15189335,GBR,H9,London,188.29.165.113,85,114,,,89,126,LUNG,LUNG DISEASE,LUNG,85,114-119,"LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 22:12:05,,1323867607,7/15/2014 22:11:54,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,85,114,,,89,126,LUNG,LUNG DISEASE,strategies in each LUNG in a patient,66-77-80-85-90-93-95,114-119,"LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 22:12:56,,1323867920,7/15/2014 22:12:38,instagc,1,13763729,USA,,,75.182.89.225,85,114,,,89,126,LUNG,LUNG DISEASE,LUNG,85,114-119,"LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 22:20:07,,1323871159,7/15/2014 22:18:53,instagc,1,19636746,USA,NY,Andover,192.182.216.225,85,114,,,89,126,LUNG,LUNG DISEASE,LUNG,85,108-114-119,"focal LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336181,7/15/2014 22:23:45,,1323872835,7/15/2014 22:23:26,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,85,114,,,89,126,LUNG,LUNG DISEASE,LUNG,85,108-114-119,"focal LUNG DISEASE,","differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another.",85,114 119,85,114,89,126,1,RO-has_finding_site,905021,"differential lung ventilation    The use of different ventilatory strategies in each lung in a patient with focal lung disease, e.g., a patient undergoing surgery to remove a tumor in one lobe of a lung but not another, or a patient with more severe COPD on one side of the chest than another",lung,lung disease
503336182,7/15/2014 21:09:07,,1323842687,7/15/2014 21:08:49,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 21:52:59,,1323858946,7/15/2014 21:50:29,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 21:54:10,,1323859413,7/15/2014 21:53:41,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 22:00:04,,1323862111,7/15/2014 21:59:51,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 22:00:08,,1323862150,7/15/2014 21:59:44,instagc,1,19636746,USA,NY,Andover,192.182.216.225,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 22:14:48,,1323868719,7/15/2014 22:14:39,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 22:15:22,,1323868951,7/15/2014 22:14:38,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,Chronic diarrhea 3 LOOSE STOOLS per day during,0-8-62-68-75-79-83-60,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 22:20:52,,1323871481,7/15/2014 22:20:37,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 22:29:11,,1323875434,7/15/2014 22:29:00,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336182,7/15/2014 22:30:22,,1323875959,7/15/2014 22:30:10,tremorgames,1,26860817,NLD,6,Boxmeer,84.29.157.221,62,0,,,74,16,LOOSE STOOLS,CHRONIC DIARRHEA,LOOSE STOOLS,62-68,0-8,CHRONIC DIARRHEA,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks.,62 68,0 8,62,0,74,16,1,RO-has_definitional_manifestation,904910,Chronic diarrhea can be defined as the passage of more than 3 loose stools per day during more than 4 weeks,loose stools,Chronic diarrhea
503336183,7/15/2014 21:07:48,,1323842105,7/15/2014 21:07:33,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,121,91,,,125,100,BONE,BONE PAIN,lamelar BONE.,113-121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:10:58,,1323843551,7/15/2014 21:10:36,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,121,91,,,125,100,BONE,BONE PAIN,normal lamelar BONE.,106-113-121,71-76-87-91-96,bone thickening and BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:11:23,,1323843756,7/15/2014 21:11:04,irazoo,1,10644009,USA,,,166.137.94.104,121,91,,,125,100,BONE,BONE PAIN,lamelar BONE.,113-121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:22:16,,1323848126,7/15/2014 21:22:08,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,121,91,,,125,100,BONE,BONE PAIN,BONE.,121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:26:28,,1323850016,7/15/2014 21:26:11,elite,1,28276268,USA,MI,Taylor,67.149.247.166,121,91,,,125,100,BONE,BONE PAIN,BONE.,121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:26:54,,1323850197,7/15/2014 21:26:40,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,121,91,,,125,100,BONE,BONE PAIN,BONE.,121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:40:29,,1323854813,7/15/2014 21:40:24,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,121,91,,,125,100,BONE,BONE PAIN,with normal lamelar BONE.,101-106-113-121,71-76-87-91-96-101-106-113,bone thickening and BONE PAIN with normal lamelar,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:53:58,,1323859300,7/15/2014 21:53:18,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,121,91,,,125,100,BONE,BONE PAIN,normal lamelar BONE.,106-113-121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 21:55:07,,1323859789,7/15/2014 21:54:45,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,121,91,,,125,100,BONE,BONE PAIN,lamelar BONE.,113-121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336183,7/15/2014 22:12:14,,1323867664,7/15/2014 22:11:56,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,121,91,,,125,100,BONE,BONE PAIN,BONE.,121,91-96,BONE PAIN,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone.",121,91 96,121,91,125,100,1,RO-has_finding_site,905427,"The patient was compatible with HCAO, characterized by high bone mass, bone thickening and bone pain with normal lamelar bone",bone,bone pain
503336184,7/15/2014 21:13:33,,1323844578,7/15/2014 21:13:17,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,episodic tension type HEADACHE),101-110-118-123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 21:15:06,,1323845223,7/15/2014 21:14:45,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,HEADACHE),123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 21:16:32,,1323845816,7/15/2014 21:16:19,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,episodic tension type HEADACHE),101-110-118-123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 21:21:32,,1323847764,7/15/2014 21:21:18,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,HEADACHE),123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 21:40:48,,1323854925,7/15/2014 21:40:33,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,episodic tension type HEADACHE),101-110-118-123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 21:52:31,,1323858808,7/15/2014 21:52:00,clixsense,1,26648627,GBR,,,80.189.8.210,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,episodic tension type HEADACHE),101-110-118-123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 22:19:17,,1323870745,7/15/2014 22:18:59,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,episodic tension type HEADACHE),101-110-118-123,68-79-87-97-101-110-118-123,"(migraine, CLUSTER HEADACHE, and episodic tension type headache)","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 22:30:49,,1323876239,7/15/2014 22:30:25,clixsense,1,23585686,GBR,H9,London,31.51.221.173,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,cluster HEADACHE),79-123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 22:31:24,,1323876405,7/15/2014 22:31:12,instagc,1,15445601,USA,FL,Jacksonville,24.129.68.254,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,episodic tension type HEADACHE),101-110-118-123,79-87,"CLUSTER HEADACHE,","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336184,7/15/2014 22:31:28,,1323876449,7/15/2014 22:31:18,clixsense,1,7265596,USA,IA,Neola,199.120.116.136,123,79,,,131,95,HEADACHE,CLUSTER HEADACHE,episodic tension type HEADACHE) and chronic or,101-110-118-123-133-137-145,53-58-68-79-87-97-101-110,"type headaches (migraine, CLUSTER HEADACHE, and episodic tension","The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache.",123,79 87,123,79,131,95,-1,RO-has_definitional_manifestation,904944,"The analysis of the data primarily focused on attack-type headaches (migraine, cluster headache, and episodic tension-type headache) and chronic or daily headaches (chronic tension-type headache and migraine combined with tension-type headache",headache,cluster headache
503336185,7/15/2014 21:10:47,,1323843481,7/15/2014 21:10:15,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31-40,POST TRAUMATIC EPILEPSY seizures,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:11:36,,1323843814,7/15/2014 21:11:19,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP post traumatic epilepsy seizures,7-16-21-31-40,3-7-13-16-21-31-40-49-59,the group of POST TRAUMATIC EPILEPSY seizures developed twice,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:15:04,,1323845212,7/15/2014 21:14:44,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31-40,POST TRAUMATIC EPILEPSY seizures,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:22:14,,1323848106,7/15/2014 21:22:03,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31-40,POST TRAUMATIC EPILEPSY seizures,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:22:36,,1323848284,7/15/2014 21:22:21,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31,POST TRAUMATIC EPILEPSY,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:25:48,,1323849693,7/15/2014 21:25:29,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31,POST TRAUMATIC EPILEPSY,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:29:34,,1323851382,7/15/2014 21:29:13,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31-40,POST TRAUMATIC EPILEPSY seizures,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:51:55,,1323858607,7/15/2014 21:49:34,instagc,1,19636746,USA,NY,Andover,192.182.216.225,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP of post traumatic epilepsy seizures,7-13-16-21-31-40,7-13-16-21-31-40,group of POST TRAUMATIC EPILEPSY seizures,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:58:00,,1323861034,7/15/2014 21:55:32,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31-40,POST TRAUMATIC EPILEPSY seizures,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336185,7/15/2014 21:58:45,,1323861421,7/15/2014 21:58:33,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,7,16,,,12,39,GROUP,POST-TRAUMATIC EPILEPSY,GROUP,7,16-21-31-40,POST TRAUMATIC EPILEPSY seizures,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma.,7,16 21 31,7,16,12,39,-1,RO-has_definitional_manifestation,904975,In the group of post-traumatic epilepsy seizures developed twice as frequently after severe trauma than after light trauma,group,post-traumatic epilepsy
503336186,7/15/2014 21:01:57,,1323839381,7/15/2014 21:01:29,irazoo,1,10644009,USA,,,166.137.94.104,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,atrioventricular nodal reentrant TACHYCARDIA,96-113-119-129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:08:23,,1323842365,7/15/2014 21:08:03,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,atrioventricular nodal reentrant TACHYCARDIA,96-113-119-129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:09:30,,1323842855,7/15/2014 21:09:18,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,atrioventricular nodal reentrant TACHYCARDIA,96-113-119-129,163-175-186-189-201,"spontaneous recurrence of VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:13:26,,1323844536,7/15/2014 21:12:54,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,atrioventricular nodal reentrant TACHYCARDIA,96-113-119-129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:19:59,,1323847134,7/15/2014 21:19:47,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,TACHYCARDIA,129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:21:00,,1323847545,7/15/2014 21:20:38,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,TACHYCARDIA,129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:22:17,,1323848135,7/15/2014 21:21:50,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,atrioventricular nodal reentrant TACHYCARDIA,96-113-119-129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:57:04,,1323860618,7/15/2014 21:56:45,clixsense,1,26648627,GBR,,,80.189.8.210,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,atrioventricular nodal reentrant TACHYCARDIA,96-113-119-129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:58:34,,1323861259,7/15/2014 21:58:09,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,TACHYCARDIA,129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336186,7/15/2014 21:58:41,,1323861371,7/15/2014 21:58:01,clixsense,1,15189335,GBR,H9,London,188.29.165.113,129,189,,,140,212,TACHYCARDIA,VENTRICULAR TACHYCARDIA,TACHYCARDIA,129,189-201,"VENTRICULAR TACHYCARDIA,","Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia.",129,189 201,129,189,140,212,-1,RO-has_definitional_manifestation,904794,"Radiofrequency catheter ablation of the slow atrioventricular nodal pathway resulted in cure of atrioventricular nodal reentrant tachycardia and the prevention of spontaneous recurrence of ventricular tachycardia, suggesting a role of atrioventricular nodal reentrant tachycardia in triggering the clinical episodes of ventricular tachycardia",tachycardia,ventricular tachycardia
503336187,7/15/2014 21:01:27,,1323839154,7/15/2014 21:00:18,irazoo,1,10644009,USA,,,166.137.94.104,47,110,,,55,120,SEIZURES,PYRIDOXINE,"pyridoxine dependent SEIZURES,",26-37-47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:13:10,,1323844440,7/15/2014 21:13:01,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,47,110,,,55,120,SEIZURES,PYRIDOXINE,"pyridoxine dependent SEIZURES,",26-37-47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:19:55,,1323847099,7/15/2014 21:19:35,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,47,110,,,55,120,SEIZURES,PYRIDOXINE,"pyridoxine dependent SEIZURES,",26-37-47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:20:38,,1323847416,7/15/2014 21:20:21,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,47,110,,,55,120,SEIZURES,PYRIDOXINE,"pyridoxine dependent SEIZURES,",26-37-47,26-37-47-110,"pyridoxine dependent seizures, PYRIDOXINE.","In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:22:29,,1323848231,7/15/2014 21:22:22,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,47,110,,,55,120,SEIZURES,PYRIDOXINE,"pyridoxine - dependent SEIZURES,",26-36-37-47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:27:55,,1323850648,7/15/2014 21:27:36,elite,1,28276268,USA,MI,Taylor,67.149.247.166,47,110,,,55,120,SEIZURES,PYRIDOXINE,"SEIZURES,",47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:38:59,,1323854386,7/15/2014 21:38:41,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,47,110,,,55,120,SEIZURES,PYRIDOXINE,"SEIZURES,",47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:48:46,,1323857604,7/15/2014 21:48:28,clixsense,1,15189335,GBR,H9,London,188.29.165.86,47,110,,,55,120,SEIZURES,PYRIDOXINE,"SEIZURES,",47,88-110,before PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:57:51,,1323860962,7/15/2014 21:57:38,clixsense,1,26648627,GBR,,,80.189.8.210,47,110,,,55,120,SEIZURES,PYRIDOXINE,"pyridoxine dependent SEIZURES,",26-37-47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336187,7/15/2014 21:58:32,,1323861242,7/15/2014 21:58:23,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,47,110,,,55,120,SEIZURES,PYRIDOXINE,"pyridoxine dependent SEIZURES,",26-37-47,110,PYRIDOXINE.,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine.",47,110,47,110,55,120,1,RO-may_treat,908322,"In an infant with typical pyridoxine-dependent seizures, CSF GABA level, was determined before treatment with pyridoxine",seizures,pyridoxine
503336188,7/15/2014 21:08:10,,1323842286,7/15/2014 21:08:01,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,62,149,,,69,157,ASCITES,HEPATOMA,transient ASCITES,52-62,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:08:21,,1323842362,7/15/2014 21:08:06,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,62,149,,,69,157,ASCITES,HEPATOMA,transient ASCITES,52-62,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:13:12,,1323844443,7/15/2014 21:12:46,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,62,149,,,69,157,ASCITES,HEPATOMA,transient ASCITES,52-62,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:21:42,,1323847884,7/15/2014 21:21:21,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,62,149,,,69,157,ASCITES,HEPATOMA,transient ASCITES,62-52,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:27:09,,1323850284,7/15/2014 21:26:49,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,62,149,,,69,157,ASCITES,HEPATOMA,ASCITES hepatoma.,62-149,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:32:31,,1323852345,7/15/2014 21:32:10,elite,1,28276268,USA,MI,Taylor,67.149.247.166,62,149,,,69,157,ASCITES,HEPATOMA,ASCITES,62,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:41:50,,1323855276,7/15/2014 21:41:31,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,62,149,,,69,157,ASCITES,HEPATOMA,ASCITES,62,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:57:04,,1323860615,7/15/2014 21:56:42,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,62,149,,,69,157,ASCITES,HEPATOMA,transient ASCITES,52-62,124-132-139-149,hepatic nodule (probably HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 21:59:32,,1323861809,7/15/2014 21:59:15,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,62,149,,,69,157,ASCITES,HEPATOMA,ASCITES,62,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336188,7/15/2014 22:09:31,,1323866369,7/15/2014 22:08:50,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,62,149,,,69,157,ASCITES,HEPATOMA,ASCITES,62,149,HEPATOMA.,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma.,62,149,62,149,69,157,-1,RO-disease_may_have_finding,902723,Two early postoperative complications were noticed: transient ascites and pancreatic pseudocyst and a late development of a hepatic nodule (probably hepatoma,ascites,hepatoma
503336189,7/15/2014 21:01:58,,1323839402,7/15/2014 21:01:48,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,177,198,,,181,206,LENS,CATARACT,LENS,177,198-207,CATARACT formation.,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:03:55,,1323840402,7/15/2014 21:03:51,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,177,198,,,181,206,LENS,CATARACT,seen in the LENS with age and,165-170-173-177-182-187-191,187-191-195-198-207,age and in CATARACT formation.,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:13:14,,1323844442,7/15/2014 21:12:54,irazoo,1,10644009,USA,,,166.137.94.104,177,198,,,181,206,LENS,CATARACT,LENS,177,198,CATARACT,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:20:54,,1323847525,7/15/2014 21:20:19,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,177,198,,,181,206,LENS,CATARACT,LENS,177,198,CATARACT,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:21:07,,1323847589,7/15/2014 21:20:52,elite,1,26544151,GBR,,,92.40.117.64,177,198,,,181,206,LENS,CATARACT,LENS,177,198,CATARACT,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:25:37,,1323849613,7/15/2014 21:25:25,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,177,198,,,181,206,LENS,CATARACT,LENS,177,198,CATARACT,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:28:19,,1323850865,7/15/2014 21:27:52,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,177,198,,,181,206,LENS,CATARACT,LENS,177,198-207,CATARACT formation.,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:53:48,,1323859238,7/15/2014 21:53:26,clixsense,1,26648627,GBR,,,80.189.8.210,177,198,,,181,206,LENS,CATARACT,LENS,177,198-207,CATARACT formation.,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 21:59:07,,1323861608,7/15/2014 21:58:57,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,177,198,,,181,206,LENS,CATARACT,LENS,177,198-207,CATARACT formation.,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336189,7/15/2014 22:00:10,,1323862157,7/15/2014 21:59:20,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,177,198,,,181,206,LENS,CATARACT,LENS,177,198-207,CATARACT formation.,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation.,177,198,177,198,181,206,1,RO-has_finding_site,905038,The evidence reviewed here supports the hypothesis that metal catalyzed oxidation reactions occur in the lens and may make a significant contribution to the changes seen in the lens with age and in cataract formation,lens,cataract
503336190,7/15/2014 21:05:31,,1323841022,7/15/2014 21:05:15,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,DEPRESSION,185,196-207,"(TRICYCLIC ANTIDEPRESSANTS,","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:06:57,,1323841774,7/15/2014 21:06:32,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,DEPRESSION,185,196-207-224,"(TRICYCLIC ANTIDEPRESSANTS, venlafaxine),","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:07:12,,1323841828,7/15/2014 21:07:06,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,"hypertension (beta blockers), DEPRESSION antidepressants, venlafaxine),",155-168-174-185-207-224,174-185-196-207-224-238-246,"blockers), depression (TRICYCLIC ANTIDEPRESSANTS, venlafaxine), bipolar disorder","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:09:13,,1323842719,7/15/2014 21:08:07,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,DEPRESSION,185,196-207-224-238-246-255-267-276-285-296,"(TRICYCLIC ANTIDEPRESSANTS, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants),","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:11:58,,1323843980,7/15/2014 21:11:45,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,DEPRESSION,185,196-207,"(TRICYCLIC ANTIDEPRESSANTS,","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:12:10,,1323844042,7/15/2014 21:11:48,irazoo,1,10644009,USA,,,166.137.94.104,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,DEPRESSION,185,196-207,"(TRICYCLIC ANTIDEPRESSANTS,","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:12:42,,1323844266,7/15/2014 21:12:38,neodev,1,26596102,GBR,,,128.199.166.81,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,"hypertension (beta blockers), DEPRESSION antidepressants, venlafaxine),",155-168-174-185-207-224,174-185-196-207-224-238-246,"blockers), depression (TRICYCLIC ANTIDEPRESSANTS, venlafaxine), bipolar disorder","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:18:15,,1323846499,7/15/2014 21:18:05,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,DEPRESSION,185,196-207,"(TRICYCLIC ANTIDEPRESSANTS,","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:21:06,,1323847592,7/15/2014 21:20:39,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,epilepsy hypertension DEPRESSION bipolar disorder,97-155-185-238-246,97-155-185-207-238-246,"epilepsy hypertension depression ANTIDEPRESSANTS, bipolar disorder","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336190,7/15/2014 21:29:12,,1323851249,7/15/2014 21:28:51,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,185,197,,,195,222,DEPRESSION,TRICYCLIC ANTIDEPRESSANTS,DEPRESSION,185,196-207,"(TRICYCLIC ANTIDEPRESSANTS,","Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate.",185,207,185,197,195,222,1,RO-may_treat,907737,"Other disorders, along with the migraine medications that may be effective against them, include epilepsy (divalproex sodium, topiramate, and gabapentin), hypertension (beta blockers), depression (tricyclic antidepressants, venlafaxine), bipolar disorder (divalproex sodium), insomnia (tricyclic antidepressants), essential tremor (beta blockers and topiramate), and overweight or obesity (topiramate",depression,tricyclic antidepressants
503336191,7/15/2014 21:12:13,,1323844054,7/15/2014 21:12:08,neodev,1,26596102,GBR,,,128.199.166.81,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,proliferation with prominent HEMOPHAGOCYTOSIS associated with a,95-109-114-124-141-152-157,0-2-8-19-34-50-53,A virus associated HEMOPHAGOCYTIC SYNDROME is a,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 21:14:56,,1323845200,7/15/2014 21:14:28,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,19-34-43,HEMOPHAGOCYTIC SYNDROME (VAHS),"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 21:25:21,,1323849513,7/15/2014 21:24:28,clixsense,1,16827630,GBR,A7,Birmingham,86.146.169.103,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,19-34,HEMOPHAGOCYTIC SYNDROME,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 21:41:09,,1323855053,7/15/2014 21:41:05,clixsense,1,6610277,CAN,ON,Oshawa,174.117.79.122,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,proliferation with prominent HEMOPHAGOCYTOSIS associated with a,95-109-114-124-141-152-157,0-2-8-19-34-50-53,A virus associated HEMOPHAGOCYTIC SYNDROME is a,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 21:49:09,,1323857677,7/15/2014 21:48:48,clixsense,1,15189335,GBR,H9,London,188.29.165.86,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,19-34,HEMOPHAGOCYTIC SYNDROME,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 21:49:34,,1323857825,7/15/2014 21:48:50,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,2-8-19-34-43,virus associated HEMOPHAGOCYTIC SYNDROME (VAHS),"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 22:08:50,,1323866095,7/15/2014 22:08:31,instagc,1,13763729,USA,,,75.182.89.225,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,2-8-19-34,virus associated HEMOPHAGOCYTIC SYNDROME,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 22:19:51,,1323871042,7/15/2014 22:19:17,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,2-19-34-43-8,virus associated HEMOPHAGOCYTIC SYNDROME (VAHS),"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 22:21:50,,1323871864,7/15/2014 22:21:29,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,19-34,HEMOPHAGOCYTIC SYNDROME,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336191,7/15/2014 22:30:21,,1323875958,7/15/2014 22:29:51,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,124,19,,,140,42,HEMOPHAGOCYTOSIS,HEMOPHAGOCYTIC SYNDROME,HEMOPHAGOCYTOSIS,124,2-8-19-34,virus associated HEMOPHAGOCYTIC SYNDROME,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection.",124,19 34,124,19,140,42,1,RO-disease_has_finding,901971,"A virus-associated hemophagocytic syndrome (VAHS) is a non-neoplastic, generalized histiocytic proliferation with prominent hemophagocytosis associated with a systemic viral infection",hemophagocytosis,hemophagocytic syndrome
503336192,7/15/2014 21:14:28,,1323845013,7/15/2014 21:14:04,irazoo,1,10644009,USA,,,166.137.94.104,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTHEMIA),62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 21:16:10,,1323845628,7/15/2014 21:15:47,clixsense,1,25595227,CAN,SK,North Battleford,24.72.96.119,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,Primary THROMBOCYTHEMIA),54-62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 21:26:43,,1323850142,7/15/2014 21:26:33,prodege,1,6579519,USA,OH,Mansfield,71.55.46.27,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTHEMIA),62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 21:40:48,,1323854926,7/15/2014 21:40:15,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTHEMIA),62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 21:56:57,,1323860581,7/15/2014 21:56:42,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTHEMIA),62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 22:00:08,,1323862138,7/15/2014 21:59:50,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,Primary THROMBOCYTHEMIA),54-62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 22:16:03,,1323869309,7/15/2014 22:15:38,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,(Essential Thrombocytosis; Primary THROMBOCYTHEMIA) Essential thrombocythemia is,27-38-54-62-80-90-106,0-10-38-54-62,ESSENTIAL THROMBOCYTHEMIA Thrombocytosis; Primary Thrombocythemia),"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 22:21:10,,1323871582,7/15/2014 22:20:54,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,THROMBOCYTHEMIA),62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 22:24:28,,1323873127,7/15/2014 22:23:47,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,(Essential Thrombocytosis; Primary THROMBOCYTHEMIA),27-38-54-62,0-10-27-38-54-62,ESSENTIAL THROMBOCYTHEMIA (Essential Thrombocytosis; Primary Thrombocythemia),"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336192,7/15/2014 22:27:17,,1323874470,7/15/2014 22:27:03,clixsense,1,23585686,GBR,H9,London,31.51.221.173,62,0,,,77,25,THROMBOCYTHEMIA,ESSENTIAL THROMBOCYTHEMIA,Primary THROMBOCYTHEMIA),54-62,0-10,ESSENTIAL THROMBOCYTHEMIA,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency.",62,0 10,62,0,77,25,-1,RO-disease_has_finding,901683,"ESSENTIAL THROMBOCYTHEMIA  (Essential Thrombocytosis; Primary Thrombocythemia)  Essential thrombocythemia is characterized by an increased platelet count, megakaryocytic hyperplasia, and a hemorrhagic or thrombotic tendency",Thrombocythemia,ESSENTIAL THROMBOCYTHEMIA
503336193,7/15/2014 21:07:30,,1323841940,7/15/2014 21:06:45,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,202,211,,,206,219,PAIN,SCIATICA,acute low - back PAIN and sciatica,187-193-196-197-202-207-211,187-193-196-197-202-207-211,acute low - back pain and SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 21:11:35,,1323843813,7/15/2014 21:11:29,neodev,1,26596102,GBR,,,128.199.166.81,202,211,,,206,219,PAIN,SCIATICA,acute low back PAIN and sciatica,187-193-197-202-207-211,197-202-207-211-230-239,back pain and SCIATICA Review) Journal,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 21:24:09,,1323848994,7/15/2014 21:23:50,elite,1,26544151,GBR,,,92.40.117.64,202,211,,,206,219,PAIN,SCIATICA,PAIN,202,211,SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 21:25:49,,1323849695,7/15/2014 21:25:28,instagc,1,28301350,GBR,O4,Torquay,89.241.101.166,202,211,,,206,219,PAIN,SCIATICA,sciatica: PAIN,18-202,18-211,sciatica: SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 21:47:42,,1323857237,7/15/2014 21:47:17,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,202,211,,,206,219,PAIN,SCIATICA,PAIN,202,211,SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 22:10:30,,1323866836,7/15/2014 22:10:13,instagc,1,13763729,USA,,,75.182.89.225,202,211,,,206,219,PAIN,SCIATICA,acute low back PAIN,187-193-197-202,211,SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 22:10:36,,1323866879,7/15/2014 22:10:21,elite,1,28466071,CAN,AB,Edmonton,68.150.39.46,202,211,,,206,219,PAIN,SCIATICA,acute low back PAIN,187-193-197-202,211,SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 22:16:41,,1323869614,7/15/2014 22:16:16,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,202,211,,,206,219,PAIN,SCIATICA,PAIN,202,211,SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 22:24:07,,1323872962,7/15/2014 22:21:15,onestopgpt,1,21275875,CAN,ON,Hamilton,216.209.129.155,202,211,,,206,219,PAIN,SCIATICA,low back PAIN sciatica,193-197-202-211,193-197-202-211,low back pain SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336193,7/15/2014 22:30:24,,1323875982,7/15/2014 22:30:09,clixsense,1,23585686,GBR,H9,London,31.51.221.173,202,211,,,206,219,PAIN,SCIATICA,low back PAIN and sciatica,193-197-202-207-211,193-197-202-207-211,low back pain and SCIATICA,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.",202,211,202,211,206,219,-1,RO-has_definitional_manifestation,904690,"Low back pain and sciatica: chronic  Cochrane Library  Acupuncture for low back pain (Cochrane Review)  Neuroreflexotherapy for non-specific low-back pain (Cochrane Review)  Bed rest for acute low-back pain and sciatica (Cochrane Review)  Journal of the American Academy of Orthopaedic Surgeons  Spinal manipulative therapy for low back pain    Cancer (Complementary/Alternative Medicine)  WHAT'S NEW  Newly Cited Reference  2010-03-01  Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer",pain,sciatica
503336194,7/15/2014 21:03:41,,1323840305,7/15/2014 21:03:38,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"X linked HYDROCEPHALUS, MASA syndrome, X",0-2-9-24-29-39,0-2-9-24-29-39-41-48,"X linked hydrocephalus, MASA SYNDROME, X linked complicated","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 21:04:51,,1323840772,7/15/2014 21:04:28,clixsense,1,27871219,NLD,7,Amsterdam,87.210.207.223,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"X linked HYDROCEPHALUS,",0-2-9,24-29-40,"MASA SYNDROME, -","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 21:07:13,,1323841844,7/15/2014 21:06:58,quickrewards,1,20452113,USA,NY,Port Henry,108.176.206.207,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"X linked HYDROCEPHALUS,",0-2-9,24-29,"MASA SYNDROME,","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 21:12:52,,1323844349,7/15/2014 21:11:06,prodege,1,2143114,CAN,BC,Vancouver,24.84.160.12,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"HYDROCEPHALUS,",9,24-29,"MASA SYNDROME,","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 21:28:20,,1323850873,7/15/2014 21:28:01,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"HYDROCEPHALUS,",9,24-29,"MASA SYNDROME,","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 21:53:28,,1323859131,7/15/2014 21:53:12,instagc,1,19636746,USA,NY,Andover,192.182.216.225,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"X linked HYDROCEPHALUS,",0-2-9,24-29,"MASA SYNDROME,","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 21:54:42,,1323859617,7/15/2014 21:54:28,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"X linked HYDROCEPHALUS, MASA syndrome,",0-2-9-24-29,0-2-9-24-29-39-41,"X linked hydrocephalus, MASA SYNDROME, X linked","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 21:58:22,,1323861187,7/15/2014 21:58:06,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"X linked HYDROCEPHALUS,",0-2-9,24-29,"MASA SYNDROME,","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 22:01:20,,1323862691,7/15/2014 22:00:35,clixsense,1,15189335,GBR,H9,London,188.29.165.113,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"HYDROCEPHALUS,",9,24-29,"MASA SYNDROME,","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336194,7/15/2014 22:12:17,,1323867695,7/15/2014 22:12:12,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,9,24,,,22,37,HYDROCEPHALUS,MASA SYNDROME,"X linked HYDROCEPHALUS, MASA syndrome, X",0-2-9-24-29-39,0-2-9-24-29-39-41-48,"X linked hydrocephalus, MASA SYNDROME, X linked complicated","X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene.",9,24 29,9,24,22,37,-1,RO-has_manifestation,906399,"X-linked hydrocephalus, MASA syndrome, X-linked complicated Spastic Paraplegia Type I and X-linked partial agenesis of the corpus callosum are the four rare diseases usually referred to L1 syndrome, caused by mutations in the L1CAM gene",hydrocephalus,MASA syndrome
503336195,7/15/2014 21:07:17,,1323841860,7/15/2014 21:06:58,elite,1,28503042,USA,NJ,Woodbridge,54.191.150.115,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"Preeclampsia, a common COMPLICATION OF PREGNANCY,",0-14-23-36-39-16,0-14-16-23-36-39,"PREECLAMPSIA, a common complication of pregnancy,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 21:10:44,,1323843476,7/15/2014 21:10:04,instagc,1,24252915,GBR,B7,Bristol,77.98.139.82,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 21:20:45,,1323847464,7/15/2014 21:20:38,tremorgames,1,24449707,CAN,QC,Laval,96.21.249.72,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 21:21:15,,1323847656,7/15/2014 21:20:56,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"Preeclampsia, a common COMPLICATION OF PREGNANCY,",0-14-16-23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 21:41:11,,1323855063,7/15/2014 21:40:48,elite,1,27385296,GBR,U8,Edinburgh,77.102.46.226,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 21:58:05,,1323861052,7/15/2014 21:57:47,instagc,1,19636746,USA,NY,Andover,192.182.216.225,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 21:59:11,,1323861636,7/15/2014 21:58:37,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 22:03:37,,1323863660,7/15/2014 22:02:13,pedtoclick,1,20864559,GBR,B8,Bromley,213.106.94.78,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 22:12:04,,1323867590,7/15/2014 22:11:51,instagc,1,13763729,USA,,,75.182.89.225,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336195,7/15/2014 22:22:40,,1323872305,7/15/2014 22:22:26,zapbux,1,27754872,USA,SC,Graniteville,24.145.86.46,23,0,,,48,12,COMPLICATION OF PREGNANCY,PREECLAMPSIA,"COMPLICATION OF PREGNANCY,",23-36-39,0,"PREECLAMPSIA,","Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood.",23 36 39,0,23,0,48,12,-1,RO-disease_has_finding,901620,"Preeclampsia, a common complication of pregnancy, is associated with alteration in the concentration of leptin in maternal blood",complication of pregnancy,Preeclampsia
503336196,7/15/2014 21:03:33,,1323840246,7/15/2014 21:03:30,instagc,1,25990856,USA,NV,Las Vegas,68.108.98.78,353,382,,,361,390,SEIZURES,EPILEPSY,? Complex febrile SEIZURES Family history of,335-337-345-353-364-371-379,364-371-379-382-393-403-411,Family history of EPILEPSY Recurrent febrile seizures,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 21:04:48,,1323840734,7/15/2014 21:04:26,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,353,382,,,361,390,SEIZURES,EPILEPSY,Complex febrile SEIZURES,337-345-353,364-371-379-382,Family history of EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 21:08:36,,1323842469,7/15/2014 21:08:03,clixsense,1,19803139,NLD,6,Veldhoven,212.61.84.196,353,382,,,361,390,SEIZURES,EPILEPSY,Complex febrile SEIZURES,337-345-353,382,EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 21:11:18,,1323843704,7/15/2014 21:10:56,sendearnings,1,20717796,USA,CA,San Jose,99.27.90.128,353,382,,,361,390,SEIZURES,EPILEPSY,? Complex febrile SEIZURES,335-337-345-353,382,EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 21:24:32,,1323849139,7/15/2014 21:24:16,bitcoinget,1,24792414,USA,,,166.181.81.170,353,382,,,361,390,SEIZURES,EPILEPSY,? Complex febrile SEIZURES,335-337-345-353,382,EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 21:26:29,,1323850017,7/15/2014 21:26:02,prodege,1,28255346,GBR,L9,Sheffield,2.125.183.137,353,382,,,361,390,SEIZURES,EPILEPSY,Complex febrile SEIZURES,337-345-353,382,EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 21:38:09,,1323854084,7/15/2014 21:37:53,instagc,1,27770607,USA,TX,El Paso,72.183.248.75,353,382,,,361,390,SEIZURES,EPILEPSY,Complex febrile SEIZURES,337-345-353,382,EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 21:56:27,,1323860396,7/15/2014 21:55:55,instagc,1,28519532,USA,IA,Honey Creek,12.73.110.17,353,382,,,361,390,SEIZURES,EPILEPSY,Complex febrile SEIZURES,337-345-353,382,EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 22:05:15,,1323864381,7/15/2014 22:05:06,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,353,382,,,361,390,SEIZURES,EPILEPSY,? Complex febrile SEIZURES Family history of,335-337-345-353-364-371-379,364-371-379-382-393-403-411,Family history of EPILEPSY Recurrent febrile seizures,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336196,7/15/2014 22:15:43,,1323869149,7/15/2014 22:15:28,instagc,1,13763729,USA,,,75.182.89.225,353,382,,,361,390,SEIZURES,EPILEPSY,febrile SEIZURES,345-353,382,EPILEPSY,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an.",353,382,353,382,361,390,-1,RO-has_definitional_manifestation,904843,"B]  Specific recommendation: ? Tell parents and caretakers that: ? The risk of developing epilepsy after a simple febrile seizure is small and is only slightly greater than the background risk in the population ? The following factors place the child at a higher risk for the development of epilepsy: ? Previous neurologic abnormality ? Complex febrile seizures ? Family history of epilepsy ? Recurrent febrile seizures  Rationale: ? Development of epilepsy is another major concern that families often have, and it can be difficult to assess the risk of epilepsy on an",seizures,epilepsy
503336197,7/15/2014 21:08:53,,1323842625,7/15/2014 21:08:48,neodev,1,25224036,CAN,ON,Sudbury,67.204.218.187,112,142,,,126,152,PANIC DISORDER,PAROXETINE,the treatment of PANIC DISORDER: Collaborative Paroxetine Panic,95-99-109-112-118-128-142-153,112-118-128-142-153-159-165,panic disorder: Collaborative PAROXETINE Panic Study Investigators.,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 21:12:57,,1323844368,7/15/2014 21:12:32,neodev,1,21515166,NLD,11,Nootdorp,83.86.58.179,112,142,,,126,152,PANIC DISORDER,PAROXETINE,the treatment of PANIC DISORDER:,95-99-109-112-118,128-142-153-159-165,Collaborative PAROXETINE Panic Study Investigators.,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 21:22:28,,1323848213,7/15/2014 21:22:06,elite,1,26544151,GBR,,,92.40.117.64,112,142,,,126,152,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,112-118,142,PAROXETINE,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 21:23:54,,1323848894,7/15/2014 21:23:33,clixsense,1,19162475,GBR,M3,Frome,82.33.126.30,112,142,,,126,152,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,112-118,142,PAROXETINE,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 21:47:09,,1323857050,7/15/2014 21:46:46,clixsense,1,15189335,GBR,H9,London,188.29.165.86,112,142,,,126,152,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,112-118,142,PAROXETINE,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 21:56:41,,1323860471,7/15/2014 21:56:02,neodev,1,11087793,GBR,K6,Southsea,82.24.115.185,112,142,,,126,152,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,112-118,128-142-153-159,Collaborative PAROXETINE Panic Study,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 21:57:41,,1323860886,7/15/2014 21:57:26,neodev,1,28175665,CAN,ON,Brampton,99.228.31.59,112,142,,,126,152,PANIC DISORDER,PAROXETINE,PANIC DISORDER: Collaborative Paroxetine Panic Study Investigators.,112-118-128-142-153-159-165,128-142-153-159-165,Collaborative PAROXETINE Panic Study Investigators.,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 22:05:41,,1323864593,7/15/2014 22:05:16,instagc,1,26706653,USA,IL,Elk Grove Village,99.99.9.247,112,142,,,126,152,PANIC DISORDER,PAROXETINE,the treatment of PANIC DISORDER: Collaborative Paroxetine Panic,95-99-109-112-118-128-142-153,112-118-128-142-153-159-165,panic disorder: Collaborative PAROXETINE Panic Study Investigators.,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 22:09:28,,1323866366,7/15/2014 22:09:05,instagc,1,13763729,USA,,,75.182.89.225,112,142,,,126,152,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,112-118,142,PAROXETINE,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
503336197,7/15/2014 22:17:56,,1323870145,7/15/2014 22:17:33,clixsense,1,21034659,AUS,4,Brisbane,49.189.2.107,112,142,,,126,152,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,112-118,142,PAROXETINE,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators.",112 118,142,112,142,126,152,1,RO-may_treat,907829,"Lecrubier Y, Bakker A, Dunbar G et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder: Collaborative Paroxetine Panic Study Investigators",panic disorder,Paroxetine
